Back grey_arrow_rt.gif
 
ViiV Healthcare Announces FDA Approval of SELZENTRY® (maraviroc) for Use in Children and Adolescents Living With HIV
 
null.gif
 
 
  1. New York Magazine Top Infectious Disease Doctors in NYC 2010 List
     
  2. ViiV Healthcare Awards $1 Million in Grants for Positive Action for Women in the U.S. - (07/13/17)
     
  3. Gilead is buying Santa Monica biotech firm Kite Pharma - (07/13/17)
     
  4. 'Forgotten Ones': Report Examines Challenges For Aging Latinos With HIV - (07/10/17)
     
  5. FDA Grants Priority Review to HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab - (07/03/17)
     
  6. LabCorp Completes Acquisition of Assets of Mount Sinai Health System Clinical Outreach Laboratories - (06/28/17)
     
  7. Walgreens Partners With LabCorp In New Diagnostic Testing Deal - (06/28/17)
     
  8. Gilead Sciences Makes Lead Gift for HIV/AIDS Clinic Modernization - (06/28/17)
     
  9. ViiV Healthcare's Positive Action Europe Programme awards grants to 14 community-based organisations - (06/14/17)
     
  10. America's Hidden H.I.V. Epidemic - (06/12/17)
     
  11. FDA Approves Generic Truvada - (06/09/17)
     
  12. 'Test And Treat' A Strong New Option For New HIVPatients -Test and Treat started on May 1 in Florida - (05/20/17)
     
  13. Mark Wainberg Unexpectedly Dies - Scientist, Outspoken Social Advocate, Leader - (05/20/17)
     
  14. ViiV Healthcare Expands Commitment to South: Southern Initiative RFP - (04/26/17)
     
  15. Updated - ViiV Grants-Healthcare Expands Commitment to South: Southern Initiative RFP (Live Links) - (04/26/17)
     
  16. FDA warns Mylan over quality concerns at India facility - (04/19/17)
     
  17. Mylan Gets FDA Warning on Drug Quality at Factory in India - (04/19/17)
     
  18. Mark Wainberg Unexpectedly Dies - Scientist, Outspoken Social Advocate, Leader - (04/13/17)
     
  19. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease / Amgen Offers Refund / 'Value-Pricing' Contract Deals for PCKS9 Cholesterol Drug - (03/22/17)
     
  20. ViiV/IAS HIV-Stigma/Discrimination Prize$$$ Project - (02/09/17)
     
  21. Switching course, Gilead markets HIV drug for prevention [Truvada] - (01/25/17)
     
  22. New HIV Eradication Combo Study - (01/13/17)
     
  23. Gilead Awards More Than $22 Million in Grants to Support HIV Cure Research - (01/13/17)
     
  24. Obamacare Congress - ACA Moving Forward - (01/13/17)
     
  25. Israeli Health Ministry Approves Pre-exposure Prophylaxis for HIV - (01/13/17)
     
  26. HepHIV 2017 Conference:HIV and Viral Hepatitis: Challenges of Timely Testing and Care Jan 31 2017 - (01/13/17)
     
  27. In South Florida, decades-old laws restrict access to clean needles - (12/22/16)
     
  28. Access to Medicine Index - J&J Ranked #2 - (12/05/16)
     
  29. America's Riskiest Places for HIV: new diagnosis - Miami, Lousiana.... - (12/05/16)
     
  30. Access to Medicine Index - J&J Ranked #2 - (12/05/16)
     
  31. Dominique Limet to step down as CEO of ViiV Healthcare; Deborah Waterhouse to succeed him - (12/05/16)
     
  32. Access to Medicine Index - J&J Ranked #2 - (12/02/16)
     
  33. GSK leads Access to Medicine Index 2016 - (12/02/16)
     
  34. ViiV Healthcare Announces FDA Approval of SELZENTRY® (maraviroc) for Use in Children and Adolescents Living With HIV - (11/10/16)
     
  35. Janssen Therapeutics Announces Funding in Support of Improved Retention in Care and Access to Treatment for Blacks and African Americans Living with HIV in Southern United States and other Rural Areas - (11/03/16)
     
  36. Alzheimer's disease could be treated with gene therapy, suggests animal study - (10/12/16)
     
  37. Untangling a cause of memory loss in neurodegenerative diseases - (10/12/16)
     
  38. HIV: The Long View Initiative Launches With Advocates Urging Actions To Address Barriers To Long-Term Health Among People Living With HIV - (09/30/16)
     
  39. MIV-711 Osteoarthritis Trial: Recommendation to Go Ahead based on independent review of safety data, and first patient enrolled in extension study - (09/30/16)
     
  40. MIV-711, a highly selective cathepsin K inhibitor, reduces biomarkers of bone resorption and cartilage degradation in healthy subjects - (09/30/16)
     
  41. Press Release: Aurobindo Pharma receives USFDA tentative approval for Dolutegravir - (09/30/16)
     
  42. New Orleans group joins federal complaint against HIV drug costs/ lawsuit vs Humana for overcharges/access - (09/26/16)
     
  43. Strong Leg Muscles Improve Brain Functioning - 2 studies report: Kicking Back Cognitive Ageing: Leg Power Predicts Cognitive Ageing after Ten Years in Older Female Twins - (09/26/16)
     
  44. New HIV Adherence Smartphone App - 'Putting prevention in their pockets' - (09/26/16)
     
  45. European Commission Grants Marketing Authorization for Gilead's Once-Daily Truvada® For Reducing the Risk of Sexually Acquired HIV-1 - (09/26/16)
     
  46. Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research - (09/26/16)
     
  47. HIV Cure Remains On Distant Horizon - (09/19/16)
     
  48. At the end of 2015, US$ 19 billion was invested in the AIDS response in low- and middle-income countries (not including the countries that have recently transitioned into high-income categories). - (08/15/16)
     
  49. Expanding the benefits of HPV vaccination to boys and men - (08/12/16)
     
  50. Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study - (08/12/16)
     
  51. Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection - (08/10/16)
     
  52. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy - (08/10/16)
     
  53. Can immunotherapy cure HIV? - meeting at Fred Hutchinson Cancer Research Center last week - (08/10/16)
     
  54. Genentech's PD-L1 agent approved for bladder cancer - (08/10/16)
     
  55. Major treatment expansion could essentially eliminate hepatitis C in R.I. by 2030 - (08/10/16)
     
  56. SUNY Downstate's STAR Program Receives $1.9 Million to Expand HIV Prevention Services - PEP / PrEP - (08/10/16)
     
  57. England NHS - August update on the commissioning and provision of Pre Exposure Prophylaxis (PREP) for HIV prevention - (08/10/16)
     
  58. New Body fat Drug - (08/10/16)
     
  59. Smartphone app could help high-risk HIV men stay on their meds - (08/10/16)
     
  60. Smartphone app could help high-risk HIV men stay on their meds - (08/01/16)
     
  61. Zika Sexual transmission from Woman to Man in NYC / Florida - transmission by mosquitos, blood donations stopped - (08/01/16)
     
  62. Florida investigation links four recent Zika cases to local mosquito-borne virus transmission - (08/01/16)
     
  63. Zika infections increasing rapidly in Puerto Rico - (08/01/16)
     
  64. NIH Meeting: Strategies for an HIV Cure 2016 November 14-16, 2016 - (08/01/16)
     
  65. CDC 10 Leading Causes of death in USA - (07/15/16)
     
  66. Suspected Female-to-Male Sexual Transmission of Zika Virus - New York City, 2016 - "first reported occurrence of female-to-male sexual transmission of Zika virus" - (07/15/16)
     
  67. No HIV transmission from condomless sex when partner is on ART, study shows - (07/15/16)
     
  68. University of Pittsburgh Researchers Part of "BELIEVE" Team that Received $28 Million, Five-Year NIH Award to Find HIV/AIDS Cure - (07/15/16)
     
  69. South Africa - new HIV era - (07/15/16)
     
  70. African Americans, HIV, and mass incarceration - (07/15/16)
     
  71. FACT SHEET: Obama Administration Takes More Actions to Address the Prescription Opioid and Heroin Epidemic - (07/14/16)
     
  72. NIH Expands Investment in HIV Cure Research... $150 Million for HIV Cure Research - (07/14/16)
     
  73. New Obama Medical Project - Genetics, not HCV - (07/10/16)
     
  74. A look at the graying of HIV....."veterans of a war..... HIV accelerates the aging process..." - (06/29/16)
     
  75. ViiV Healthcare joins PENTA Foundation in search for strategies to achieve remission in children living with HIV - (06/29/16)
     
  76. Cuomo Expands H.I.V. Benefits in New York City / Could do the same for HCV if Governor wanted to - or for that matter so could The White House if they wanted to - (06/27/16)
     
  77. European Commission Grants Marketing Authorization for Gilead's Single Tablet Regimen Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for the Treatment of HIV - (06/24/16)
     
  78. Immunotherapy has the potential to address many cancers, and has become one of the hottest fields in drug R&D.....Two of the drugs are PD-1 receptor blockers. - (06/22/16)
     
  79. 5 things to know about the treatment that destroyed Jimmy Carter's cancer - (06/22/16)
     
  80. Early Days of HIV/1982 - HIV 5 Died at NYU, Mycobacterium avium-intracellulare / PCP in LA - (06/20/16)
     
  81. The Doctor - Dr. Michael Gottlieb - Who First Saw AIDS Believes in a 'Possible Cure' / Early Days of HIV: Rare cancer seen in 41 gays in NY & LA / Linda Laubenstein - (06/20/16)
     
  82. UN AIDS Meeting June 9 2016 NYC - (06/15/16)
     
  83. ViiV Healthcare announces FDA approval to lower the weight limit for dolutegravir in children and adolescents living with HIV - (06/15/16)
     
  84. Promising gene therapies pose million-dollar conundrum; cancer drug costs too - (06/15/16)
     
  85. Excluded Groups Say They Should Be Part of UN AIDS Meeting - (06/08/16)
     
  86. Nivolumab shows promise in first-ever trial for patients with refractory, metastatic anal cancer - (06/08/16)
     
  87. Evidence of Sexual Transmission of Zika Virus; oral sex? - (06/07/16)
     
  88. Frontier Biotech's Long-acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results of a Phase 3 Trial - (06/06/16)
     
  89. ViiV Healthcare announces public tender agreement with Botswana Ministry of Health for dolutegravir - (06/03/16)
     
  90. Gilead's 2015 Corporate Contributions in the Chronicle of Philanthropy - (06/02/16)
     
  91. ViiV Healthcare and the International Association of Providers of AIDS Care (IAPAC) to Collaborate on Fast-Track Cities - (06/01/16)
     
  92. Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa - (05/18/16)
     
  93. Zika Death in PR / HIV Infection & Zika Virus / 1st case of Zika in HIV+ - (05/09/16)
     
  94. ViiV Healthcare extends Medicines Patent Pool licence agreement for dolutegravir to cover all lower middle-income countries press release - (05/09/16)
     
  95. European Commission Grants Marketing Authorization for Gilead's Fixed-Dose Combination Descovy® (Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV press release - (05/09/16)
     
  96. Long Time AIDS Nursing Home Rivington House Sold for $116 Million, Patients Booted Out - (04/15/16)
     
  97. Gene Editing "Cure Trials Predicted to Start Within 3 Years - (04/05/16)
     
  98. GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world's poorest countries - (04/05/16)
     
  99. HHS Issues Guidance on the Use of Federal Funds for Syringe Services Programs - (04/05/16)
     
  100. Johns Hopkins performs first transplants between donors, recipients infected with HIV - (04/05/16)
     
  101. NHS England stalls plans for HIV prevention drug....."NHS England officials, who had been involved in early discussions about Prep, say providing it is not their responsibility." - (04/05/16)
     
  102. Janssen Therapeutics Announces Funding for Organizations Focused on Improving Care and Treatment for Vulnerable Populations Living with HIV - (04/05/16)
     
  103. HIV & Online Hookup Sites for Meeting Sexual Partners Among Men Who Have Sex with Men in Rhode Island, 2013: A Call for Public Health Action ....."More than 60 percent of Rhode Island men who have sex with men (MSM) diagnosed with HIV in 2013 reported meeting sexual partners online" - (03/15/16)
     
  104. FDA STRIBILD Label Update - (03/15/16)
     
  105. GSK's global HIV business ViiV Healthcare completes transactions to acquire Bristol-Myers Squibb's R&D HIV assets - (02/22/16)
     
  106. Merck's Investigational Once-Daily Formulation of ISENTRESS® (raltegravir) Meets Primary and Secondary Endpoints in Pivotal Phase 3 Study - (02/22/16)
     
  107. HHS Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents - (02/11/16)
     
  108. NIH Funding Editorial - (02/11/16)
     
  109. Johns Hopkins approved to perform HIV-positive to HIV-positive organ transplants - (02/11/16)
     
  110. Johns Hopkins Wins Approval to Perform H.I.V.-Positive Organ Transplants - (02/11/16)
     
  111. BUDGET EXACT LANGUAGE ON DRUG PRICING, $20 Mill for Prep, New Funding for HCV Screening/Care in HIV+ (I think its $9 mill) - (02/11/16)
     
  112. HCV/HIV Coinfection New $9 Milion Federal Funded Program - (02/11/16)
     
  113. Obama Releases FY 2017 Budget: [HHS] drug pricing, PrEP, HCV in HIV+ - (02/11/16)
     
  114. Kidney Function 101 - (02/11/16)
     
  115. Natural protein points to new inflammation treatment - (02/05/16)
     
  116. Atlanta / Fulton Health Introduces New HIV Strategies-PrEP Clinic and Rapid Entry - (02/05/16)
     
  117. ACS/Deductibles -Many Say High Deductibles Make Their Health Law Insurance All but Useless - (02/05/16)
     
  118. Abbott to Acquire Alere, a Maker of Medical Tests - (02/05/16)
     
  119. The Latest Study on Depo-Provera and HIV: Far More Complex Than Most Headlines Suggest - (02/05/16)
     
  120. State Of Florida Ranks Highest In New HIV Cases In The US - (02/05/16)
     
  121. HIV+ Life Insurance - HIV, CD4 counts and life insurance - (02/05/16)
     
  122. Breakthrough agreement to accelerate HIV cure research achieved - (01/20/16)
     
  123. AbbVie Announces the Launch of Robust Phase 3 Clinical Trial Program Evaluating ABT-494, an Investigational Selective JAK1 Inhibitor, for the Treatment of Rheumatoid Arthritis - (01/13/16)
     
  124. Roche receives FDA approval for HIV-1 viral load test on the cobas® 6800/8800 Systems - (01/08/16)
     
  125. Roche receives FDA approval for HIV-1 viral load test on the cobas® 6800/8800 Systems - (01/05/16)
     
  126. Trends in U.S. HIV Diagnoses, 2005-2014: Gay, Bisexual, and other Men who have Sex with Men- Latinos, African-American Men & Women - (12/21/15)
     
  127. Martin Shkreli Arrested on Securities Fraud Charges - (12/21/15)
     
  128. GSK's global HIV business ViiV Healthcare to acquire Bristol-Myers Squibb's R&D HIV assets - (12/21/15)
     
  129. Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare - (12/21/15)
     
  130. Abbott to Acquire Alere, a Maker of Medical Tests - (12/21/15)
     
  131. Funders Concerned About AIDS released their annual "Philanthropic Support to Address HIV/AIDS" - (12/18/15)
     
  132. Microplastics in the seas - (12/18/15)
     
  133. Plastic in the food chain: Artificial debris found in fish - (12/18/15)
     
  134. National Health Spending In 2014: Faster Growth Driven By Coverage Expansion And Prescription Drug Spending - (12/18/15)
     
  135. Obamacare Funding Troubles - (12/18/15)
     
  136. New Cholesterol Drugs/PCSK9: PBM Deals - (12/08/15)
     
  137. NYC End AIDs Plan: video - ON WORLD AIDS DAY, MAYOR DE BLASIO, SPEAKER MARK-VIVERITO & CITY COUNCIL ANNOUNCE NYC COMMITMENT TO END THE EPIDEMIC - (12/08/15)
     
  138. GOVERNOR CUOMO ANNOUNCES NEXT PHASE OF STATE'S PLAN TO END THE AIDS EPIDEMIC - (12/08/15)
     
  139. De Blasio promises new AIDS funding, but wants more money from state - (12/08/15)
     
  140. Johnson & Johnson Marks World AIDS Day with Major New Global Commitments to End HIV Infection in Adolescent Girls and Women - (12/08/15)
     
  141. ViiV Healthcare highlights its continued commitment to end mother to child transmission of HIV - grants/funding - (12/08/15)
     
  142. Mobile dating apps spur HIV epidemic among Asia's teenagers, says UN [HCV too] - (12/08/15)
     
  143. Obstacles imperil year-end budget deal (NIH) - (12/08/15)
     
  144. The Medicines Patent Pool Signs Licensing Agreement with MSD for Paediatric Formulations of Raltegravir - (11/10/15)
     
  145. Roche expands cobas 4800 System menu with HIV-1, HCV and HCV Genotyping Tests - (11/05/15)
     
  146. SF Funding Aims to Completely Halt HIV/AIDS Transmission - (11/05/15)
     
  147. ViiV Healthcare Awards Innovative Grants for HIV Programs Focused on MSM Youth - (11/05/15)
     
  148. Cherokee Nation gets $1.5 million grant to target hepatitis C - (11/05/15)
     
  149. Healthy 'Aging with HIV' Strategies Focus of Federal Grant to Pitt Public Health - MACS - (10/21/15)
     
  150. Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone - (10/20/15)
     
  151. Roche receives FDA approval for viral load tests and cobas 6800/8800 Systems " Next Generation Viral Load Tests: HBV & HCV....under FDA review for HIV-1 and cytomegalovirus (CMV)" - (10/20/15)
     
  152. The Passing of Dr. Primm - (10/20/15))
     
  153. STDs Rising: NYC's Epidemic of Neglect, NYC HIV Testing Cuts- is this anyway to run the NY Ends AIDS Project? - (09/18/15)
     
  154. Economic burden associated with diagnosed diabetes (all ages) and undiagnosed diabetes, GDM, and prediabetes (adults) is estimated to be $322 billion - (09/18/15)
     
  155. National HIV/AIDS Strategy Updated to 2020 - (07/31/15)
     
  156. FDA approves new cholesterol drug - at $14,600 a year - (07/29/15)
     
  157. Regeneron and Sanofi Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients - (07/29/15)
     
  158. FDA Review Safety/Liver - Efficacy - New Cholesterol Drug Alirocumab - (07/29/15)
     
  159. Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events - (07/29/15)
     
  160. Lowering LDL Cholesterol Is Good, but How and in Whom? Editorial - (07/29/15)
     
  161. FDA Approves First PCSK9 Inhibitor - (07/29/15)
     
  162. PCSK-9 inhibitors achieve next milestone, plus 4 more FDA actions, $150 Billion Annual Cost projected Dwarfing HCV - (06/22/15)
     
  163. REPRIEVE Study To Evaluate Statin Therapy to Prevent or Reduce Heart Disease in HIV+ - (05/29/15)
     
  164. Merck Cancer Therapies/PD-1 - (05/29/15)
     
  165. ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV - (05/29/15)
     
  166. EUROPEAN MEDICINES AGENCY VALIDATES GILEAD'S MARKETING APPLICATION FOR FIXED-DOSE COMBINATION OF EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FOR HIV TREATMENT - (05/29/15)
     
  167. H.I.V. Treatment Should Start at Diagnosis, U.S. Health Officials Say - (05/29/15)
     
  168. Start HIV Treatment Regardless of CD4 Count, NIH Funded Study Finds - (05/29/15)
     
  169. GSK and UNC-Chapel Hill announce novel partnership to accelerate search for HIV cure - GSK press release - (05/11/15)
     
  170. Johnson & Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV - (05/11/15)
     
  171. Aetna, Cigna & several additional insurers Lower HIV Meds Costs - (04/15/15)
     
  172. NIH Funds Study of Fully Personalized Immunotherapy AGS-004 Combined With a Latency Reversing Therapy for the Treatment of HIV - (04/13/15)
     
  173. Gov Declares Emergency-HIV & HCV Outbreaks in Southeastern Indiana Due to IV Drug Use of Prescription Medication - (04/01/15)
     
  174. Cuomo New Budget / Health - Negotiate HIV & HCV Drug Rebates - (04/01/15)
     
  175. Janssen Therapeutics Announces Support for Organizations Focused on Improving Care and Treatment for People Who Inject Drugs Living with HIV and/or Hepatitis C - (04/01/15)
     
  176. Merck Announces Collaboration with the Medicines Patent Pool to Expand Access to Pediatric Formulations of Raltegravir in Developing Countries - (02/24/15)
     
  177. The Centers for Disease Control and Prevention's (CDC) annual HIV Surveillance Report titled Diagnoses of HIV Infection in the United States and Dependent Areas, 2013 - (02/24/15)
     
  178. Press release: 'The Corporate Reputation of Pharma in 2014 -the Patient Perspective', and how the corporate reputation of pharma companies has changed over the past four years - (02/18/15)
     
  179. Merck says hepatitis C treatment to lose "breakthrough" status - (02/05/15)
     
  180. mtDNA Damage Affects immunity, Inflammation, Aging - new study - (02/05/15)
     
  181. U.S. Food and Drug Administration Approves Bristol-Myers Squibb's Evotaz™ (atazanavir and cobicistat) for the Treatment of HIV-1 Infection in Adults - BMS press release - (02/04/15)
     
  182. Obama administration seeks to negotiate Medicare drug prices - (02/04/15)
     
  183. ViiV Healthcare Announces $10 Million Initiative to Accelerate Response to HIV/AIDS Among Black Gay and Bisexual Men - (02/04/15)
     
  184. FDC Atazanavir/Cobicistat FDA Approves - (01/30/15)
     
  185. PREZCOBIX™ (darunavir/cobicistat) Approved in the U.S. for the Treatment of Adults Living With HIV-1 - (01/30/15)
     
  186. Affordable Care Act: HIV "Discrimination"/Coinsurance/High-Tiered ARTs-new study - "ATP enrollees had an average annual cost per drug of more than triple that of enrollees in non-ATPs ($4,892 vs. $1,615)" - (01/30/15)
     
  187. Affordable Care Act (ACA) and the Ryan White Program Integration Discussion at PACHA Meeting Feb 12 - (01/28/15)
     
  188. Weighing the risk of new, FDA-approved obesity fighter - (01/21/15)
     
  189. EnteroMedics Announces FDA Approval of VBLOC® Vagal Blocking Therapy for the Treatment of Obesity - (01/21/15)
     
  190. FDA approves first-of-kind device to treat obesity - (01/21/15)
     
  191. Mylan Launches Generic Epivir-HBV® Tablets - (01/16/15)
     
  192. Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen - (01/07/15)
     
  193. Obama Administration to Investigate Insurers for Bias Against Costly Conditions - 'what took so long?' - (01/07/15)
     
  194. Group Sues Aetna, Claiming Discrimination Against H.I.V. Patients - (01/07/15)
     
  195. Obamacare may mean high drug costs for Floridians with HIV - (01/07/15)
     
  196. Humana & Cigna Settle HIV Discimination Lawsuits, Agree to Lower Costs to Florida Patients in Obamacare Plans - (01/07/15)
     
  197. Roche launches next-generation HIV & HCV viral load testing assays for new molecular diagnostic platforms in markets accepting the CE mark - (01/07/15)
     
  198. Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report - GSK - (01/07/15)
     
  199. GSK statement on first phase 1 trial results of a candidate Ebola vaccine - (01/07/15)
     
  200. Ebola Vaccine - An Urgent International Priority Perspective - (01/07/15)
     
  201. GILEAD ANNOUNCES AMENDED AGREEMENTS WITH JANSSEN TO DEVELOP AND COMMERCIALIZE TENOFOVIR ALAFENAMIDE-BASED SINGLE TABLET REGIMENS FOR HIV TREATMENT - press release - (01/05/15)
     
  202. Janssen Announces Collaboration with Gilead to Develop PREZISTA®-based Single-tablet Regimen for the Treatment of People Living with HIV - (01/05/15)
     
  203. Mylan's tentative FDA approval for paeds formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and CHAI - (12/09/14)
     
  204. European Commission Approves REZOLSTA®, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat - (11/25/14)
     
  205. Janssen Collaborates for Continued Evaluation of Multidrug-Resistant Tuberculosis Treatment Regimens with SIRTURO® (bedaquiline) - (11/06/14)
     
  206. HRC Endorses PrEP & Calls for Expanded Access - (10/22/14)
     
  207. CHMP Announces Positive Opinion for REZOLSTA™, a New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir and Cobicistat - (09/30/14)
     
  208. The First HIV/AIDS Generation Reaches Retirement Age - (09/22/14)
     
  209. PD-1 Inhibitors - new type of cancer drug are approved - (09/10/14)
     
  210. PAN Assistance for HIV co-payments, under-insurance, deductibles, co-insurance - (08/28/14)
     
  211. Advocates: Insurance Companies Making HIV, AIDS Drugs Unaffordable Under Obamacare Exchange - (08/28/14)
     
  212. 3 ways insurers can discourage sick from enrolling......."Some insurers are requiring patients to make large, initial payments for HIV medications"...... - (08/28/14)
     
  213. HIV PrEP in Tampon - UW researchers work to create a fast-acting HIV protection in dissolvable fabric - (08/25/14)
     
  214. FDA Approval of Bedaquiline  The BenefitRisk Balance for Drug-Resistant Tuberculosis - (08/22/14)
     
  215. HIV drug fraud in Medicare plagues Miami....& New York - (08/18/14)
     
  216. HIV Groups File Federal Complaint Against Insurance Companies for "Discrimination" - "Overly Restrictive" "Unduly Limits Access", Charging High Copays & Coinsurance - (07/16/14)
     
  217. US National Survey Results on Potential Barriers to HIV Treatment Use Announced Today - (06/30/14)
     
  218. Cuomo Plan Seeks to End New York's AIDS Epidemic - (06/30/14)
     
  219. United Healthcare To Allow HIV/AIDS Patients to "Opt-Out" of Mail-Order Rx - (06/03/14)
     
  220. Welcome to the John Does I-V v. UnitedHealthcare Insurance Company Settlement website - (06/03/14)
     
  221. 'Chemsex' culture upping HIV risk amongst gay males - (05/29/14)
     
  222. Gilead Sciences' New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA - (04/22/14)
     
  223. Patient Access Network: assistance for copayments, underinsured, deductibles, coinsurance - (04/21/14)
     
  224. Bristol-Myers Squibb Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1 - (04/15/14)
     
  225. H.I.V.'s Grip on the American South - (04/11/14)
     
  226. European Researchers Invited to Submit Study Proposals for Bristol-Myers Squibb's Partnering for CureŞ Virology Research Programme - (04/09/14)
     
  227. President Obama Announces Douglas M. Brooks, MSW, as Director of the Office of National AIDS Policy - (04/04/14)
     
  228. ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool - (04/03/14)
     
  229. Janssen Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat as Part of Combination HIV Therapy - (04/02/14)
     
  230. New HIV Care Collaborative Announced by Merck - (04/02/14)
     
  231. ViiV Positive Action Community Grants Application Process - (04/01/14)
     
  232. ViiV Healthcare Announces Next Round of the Positive Action Southern Initiative to Support Linkages to HIV/AIDS Care and Treatment Adherence: commitment to Hard-Hit Southern US - (03/21/14)
     
  233. Why GSK sales shift is a turning-point for pharma - (02/28/14)
     
  234. Cipla to market MSD's HIV drug 'raltegravir' in India - (02/21/14)
     
  235. Lambda Legal Sues Blue Cross Louisiana for Not Accepting the federally-funded premium subsidies/Ryan White that enable low-income Louisianans living with HIV to purchase health insurance - (02/21/14)
     
  236. Crowdfunded free HIV vaccine: as unlikely as it sounds - (02/19/14)
     
  237. New program helps reduce HIV-risk in African-American women - (02/19/14)
     
  238. Radioactive tracers map spread of HIV analogue - (02/19/14)
     
  239. British HIV Association guidelines for HIV-associated malignancies 2014 - (02/18/14)
     
  240. Roche announces launch of the Dual Target [early diagnosis] HIV-1 Qualitative Test in markets accepting the CE mark - (02/18/14)
     
  241. HIV Groups Protest Insurers' Rejection Of Third-Party Payments For Premiums - (02/18/14)
     
  242. With New Mayor and Different Governor at the Helm, Increased HIV/AIDS Housing Subsidy to Become a Reality - (02/18/14)
     
  243. NIH makes wary return to India for studies - (02/14/14)
     
  244. Crowd-funded HIV vaccine project sparks debate - (02/14/14)
     
  245. In search of a cure, scientists look for where HIV hides - (02/10/14)
     
  246. Exclusive: AIDS patients in Obamacare limbo as insurers reject checks - (02/10/14)
     
  247. STI/HIV/HCV infection rates among gay men reach 'crisis' levels - (02/10/14)
     
  248. HIV Leaders Urge Comprehensive ART Coverage for 50,000 patients: Strategies for Health Insurers to Optimize Coverage for People with HIV - A Joint Statement from the HIV Medicine Association and the American Academy of HIV Medicine - (02/07/14)
     
  249. Experts warn of rise in gay 'slamming' in London: increased HIV & HCV transmission risk - (02/07/14)
     
  250. Tory MP defends screening migrants for HIV & HBV before they enter Britain - (02/05/14)
     
  251. Bristol-Myers Squibb-Sponsored Partnering for CureTM Program Names Three European Award Winners for Research Projects Focused on Cure in Viral Diseases - (02/03/14)
     
  252. Improving the health of the tuberculosis drug pipeline - (01/31/14)
     
  253. GMHC Controversy - (01/17/14)
     
  254. Heroin Upsurge: Pills to Heroin - (01/17/14)
     
  255. Vertex Announces Appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President of Global Medicines Development - (01/15/14)
     
  256. Merck Voluntarily Recalls One Lot of Gardasil - (12/23/13)
     
  257. Grant Colfax Gay nat'l AIDS director to depart White House - (12/23/13)
     
  258. Insurance Changes (ACA, Medicaid, Ryan White) Raise Concerns for H.I.V. Patients in Texas - (12/18/13)
     
  259. Glaxo Says It Will Stop Paying Doctors to Promote Drugs - (12/18/13)
     
  260. GSK announces changes to its global sales and marketing practices to further ensure patient interests come first - (12/18/13)
     
  261. Enough Is Enough: Stop Wasting Money on Vitamin and Mineral Supplements - (12/18/13)
     
  262. HIV Patients Asked to Pay More Under Obamacare - (12/18/13)
     
  263. AIDS Coalition Says ACA Plans Discourage HIV Patients - "a number of disturbing trends" in plans on the insurance exchanges, plans that don't cover all available HIV drugs and what it termed "egregious cost-sharing designs - (12/18/13)
     
  264. AIDS advocates say drug coverage in some marketplace plans is inadequate - "We never expected these drugs to be completely left off some formularies" - (12/18/13)
     
  265. U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen Complera® for Patients Switching from a Stable Regimen - (12/16/13)
     
  266. Reyataz Licensed by BMS for Broader Global Generic Version to UN Medicines Patent Pool - (12/12/13)
     
  267. New Janssen HIV ART Pediatric Program Donates Darunavir & Etravirine to Africa - (12/11/13)
     
  268. VACCINATION IMPORTANT FOR IMMUNOCOMPROMISED PATIENTS - (12/04/13)
     
  269. Obama pledges up to $5 billion to global (AIDS/TB/Malaria) infectious diseases fund - (12/03/13)
     
  270. FDA Drug Safety Communication: FDA requires removal of some prescribing and dispensing restrictions for rosiglitazone-containing diabetes medicines - (11/26/13)
     
  271. Roche at AASLD - (11/26/13)
     
  272. European Medicines Agency recommends approval of new HIV medicine Dolutegravir Integrase Inhibitor - (11/25/13)
     
  273. Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV - (11/25/13)
     
  274. EUROPEAN COMMISSION APPROVES GILEAD'S VITEKTA™, AN INTEGRASE INHIBITOR FOR THE TREATMENT OF HIV-1 INFECTION - (11/18/13)
     
  275. CytoDyn Submits Phase IIb Protocol for PRO 140 Clinical Trial to FDA - (10/31/13)
     
  276. New HIV & HCV Rapid Tests - (10/30/13)
     
  277. ViiV Healthcare files marketing authorisation application in Europe for three-drug HIV pill (integrase dolutegravir) - (10/28/13)
     
  278. ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV - (10/23/13)
     
  279. Roche Shutting Down 454 Sequencing Business - (10/15/13)
     
  280. In $75M Deal, PacBio will Develop Clinical Dx Sequencing System and Assays for Roche - (10/15/13)
     
  281. Bristol-Myers Squibb Supports HarborPath to Help Uninsured Individuals Living with HIV/AIDS Access Prescription Medicines - (10/13/13)
     
  282. "the first and only preventative HIV vaccine based on a genetically modified killed whole virus (SAV001-H) holds tremendous promise for success in the final phases of clinical testing now that the first hurdle has been accomplished" - (09/23/13)
     
  283. Dolutegravir ADAP Pricing - (08/30/13)
     
  284. New HIV Test for Antigen for Acute HIV Detection Gets FDA Approval - (08/14/13)
     
  285. US Congress moves to protect FDA pharma industry user fees - (07/24/13)
     
  286. Rosiglitazone News Avandia's Future Still Bleak? - (06/11/13)
     
  287. 1-minute HIV test to debut in S.A. - (05/30/13)
     
  288. Pfizer sells Viagra online to combat fakes - (05/27/13)
     
  289. GSK/Merck & Co cut HPV vaccine prices for poor - (05/27/13)
     
  290. 4 HIV babies born in Broward, PBC Florida - first in years - (05/27/13)
     
  291. Gilead Receives Complete Response Letters from U.S. Food and Drug Administration for Elvitegravir and Cobicistat - (05/1/13)
     
  292. University of Minnesota doctors try to cure boy of HIV, cancer in risky operation - (04/22/13)
     
  293. No confirmed link between Okla. clinic, diseases - (04/20/13)
     
  294. Medicare drug rebate bills enter US Congress - (04/18/13)
     
  295. UnitedHealth units hit with $500 million verdict in hepatitis case - (04/11/13)
     
  296. Bristol-Myers Squibb Announces Appointment of Francis Cuss as Executive Vice President and Chief Scientific Officer, Effective July 1; Elliott Sigal Plans to Retire - (04/09/13)
     
  297. European CHMP Adopts Positive Opinion for Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection - (03/22/13)
     
  298. Medicines Patent Pool and ViiV sign paediatric HIV pact - (02/28/13)
     
  299. ViiV Healthcare announces a voluntary licence agreement with the Medicines Patent Pool to increase access to HIV medicines for children - (02/27/13)
     
  300. Mediterranean Diet Shown to Ward Off Heart Attack and Stroke[by 30%] [exercise too] -new study - (02/27/13)
     
  301. F.D.A. Approves a New Roche Drug for Advanced Breast Cancer - (02/25/13)
     
  302. New FDA Approval Process: "Breakthrough therapy" - (02/22/13)
     
  303. Recent changes to the Reyataz (atazanavir sulfate) capsule labeling - (02/12/13)
     
  304. HCV-Infected Victims at Abortion Clinic; doctor did not realise danger, court told - (02/12/13)
     
  305. Immune system protein in semen boosts HIV spread in female genital tissue - (02/11/13)
     
  306. How men with HIV can safely become dads - (02/06/13)
     
  307. UC San Diego Funded by NIMH to Study Successful Aging in Adults with HIV - (02/05/13)
     
  308. ViiV Healthcare Expands Positive Action Southern Initiative to Fight HIV/AIDS and Support Community Action - (02/04/13)
     
  309. [uncontrolled new cases] HIV incidence in men who have sex with men in England and Wales 2001-10: a nationwide population study - (02/01/13)
     
  310. Co-Pay Programs for HIV Antiviral Medications - (01/31/13)
     
  311. Second N.Y. hospital warns of HIV infection risk from insulin pens - (01/31/13)
     
  312. FDA Labeling changes for Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) - (01/31/13)
     
  313. Kaletra (lopinavir/ritonavir) label update: drug interaction information - (01/24/13)
     
  314. Florida men accused of sex with boy, not revealing HIV status - (01/24/13)
     
  315. Aspirin Linked to Age-Related Eye Disorder - (01/24/13)
     
  316. HIV, AIDS patients upset over Blue Cross' new drug policy in SF: 'required mail-order pharmacy' - (01/24/13)
     
  317. "cannabis-related stroke is not a myth" new literature, authors conclude - (01/24/13)
     
  318. Health Insurers Raise Some Rates by Double Digits - (01/16/13)
     
  319. Pharma Rated by Patient Groups: Lundbeck tops patient groups' pharma "reputation table" - (01/15/13)
     
  320. India to issue compulsory licences on Roche, B-MS drugs - (01/15/13)
     
  321. New York prescription drug change (requiring mail-order pharmacy for "specialty medications includes HIV & HCV) putting lives in danger? - (01/13/13)
     
  322. High-risk drug practices tighten grip on London gay scene....risk for HIV & HCV transmission - (01/13/13)
     
  323. Transmission of Hepatitis C Virus Among People Who Inject Drugs: Viral Stability and Association With Drug Preparation Equipment - (01/13/13)
     
  324. Living with Stigma and Ignorance: HIV on the Rise in Belarus - (01/10/13)
     
  325. FDA approves first anti-diarrheal drug for HIV/AIDS patients - (01/07/13)
     
  326. Russia reports 12% rise in HIV - 200 new cases a day - (01/04/13)
     
  327. HIV Functional Cure-new study experimental therapeutic vaccine - (01/04/13)
     
  328. New Vaccine Approach Gives Hope to Those Living with HIV - (01/04/13)
     
  329. Energy Drinks and Caffeine-Related Adverse Effects.......Risks of Energy Drinks Mixed With Alcohol - (01/02/13)
     
  330. Bedaquiline: Drug-Resistant Tuberculosis Drug Backed By FDA Panel - (01/02/13)
     
  331. Endurance training such as that done for track competitions may protect against the effects of aging in older individuals - (01/02/13)
     
  332. New Type of TB Drug Wins FDA Panel Support - (01/02/13)
     
  333. New Type of TB Drug Deemed Safe by FDA - (01/02/13)
     
  334. Young Women Skip Mammo After USPSTF Recs - (01/02/13)
     
  335. NEW TB Drug for Drug resistant TB Receives FDA Approval - (01/02/13)
     
  336. J&J Sirturo Wins FDA Approval to Treat Drug-Resistant TB - (01/02/13)
     
  337. FDA Grants Accelerated Approval for SIRTURO™ (bedaquiline) as Part of Combination Therapy to Treat Adults with Pulmonary Multi-Drug Resistant Tuberculosis - (01/02/13)
     
  338. Aspirin Use Tied to Rare Eye Disorder - (12/20/12)
     
  339. Taking aspirin for 10 years could double the risk of sight loss - (12/20/12)
     
  340. Regular Aspirin Use May Boost Risk of Eye Problem - (12/20/12)
     
  341. Lifestyle Matters: diet, exercise Extend Life Overindulgence May Lower Life Expectancy - (12/20/12)
     
  342. Tracking the Origins of HIV - new study - (12/20/12)
     
  343. Ten Pharmaceutical Companies Unite to Accelerate Development of New Medicines - (12/18/12)
     
  344. ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada - (12/18/12)
     
  345. Black MSM/CDC Funding - (12/18/12)
     
  346. Can Black Clergy Reframe AIDS Fight? - (12/18/12)
     
  347. Doubling Down on Amyloid in Alzheimers - (12/18/12)
     
  348. HIV Black MSM/CDC Funding - (12/15/12)
     
  349. CVD death rate in US declines, but one in three still dying from cardiac causes. HIV & CVD - (12/14/12)
     
  350. FDA Approves Prescribing Information Update for EDURANT® (rilpivirine) to Include 96-Week Data in HIV-1-Infected Treatment-Naive Adult Patients - (12/11/12)
     
  351. Public Health Triumph: US Preventive Task Force Recommendations Lift Critical Barriers to Routine HIV Screening - (12/06/12)
     
  352. Court: Off-Label Drug Marketing Is 'Free Speech' - (12/06/12)
     
  353. More than half of young HIV-infected Americans are not aware of their status - CDC Report: HIV Infection, Testing, and Risk Behaviors Among Youths - (12/06/12)
     
  354. Merck puts Alzheimer's drug into Ph II/III - (12/04/12)
     
  355. Pharma R&D returns still falling, but future looks bright - (12/04/12)
     
  356. Global HIV Trouble Spots: Ukraine, Greece, Israel, Asia, Indonesia Ukraine fights spreading HIV epidemic - (12/03/12)
     
  357. FDA Advisory Committee Recommends Accelerated Approval of Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline - (12/03/12)
     
  358. Advocates Slam Task Force (USPSTF) for Not Backing Hepatitis C Tests for Baby Boomers - (11/29/12)
     
  359. Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings - (11/29/12)
     
  360. Positive Outlook on Aging Helps Seniors Heal - (11/26/12)
     
  361. Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial - (11/26/12)
     
  362. Aspirin resistance tied to size, severity of ischemic stroke - (11/26/12)
     
  363. Job loss has same MI risk as smoking/diabetes - (11/26/12)
     
  364. New Breast Cancer Mammography Controversy Over New Study Suggesting Breast Cancer Overdiagnosis - (11/26/12)
     
  365. The benefits and harms of breast cancer screening: an independent UK review - (11/26/12)
     
  366. GSK pays 650 million to up stakes in India, Nigeria units - (11/26/12)
     
  367. Routine HIV Testing Recommended for all 15-64 by Federal Panel USPSTF - (11/20/12)
     
  368. Screening for HIV: Systematic Review to Update the 2005 U.S. Preventive Services Task Force Recommendation - (11/20/12)
     
  369. FDA Approves New 800mg PREZISTA® (darunavir) Tablet - (11/14/12)
     
  370. Study examines cardiovascular risks detected by cardiac MRI: heart disease risk in HIV+ asymptomatic - (11/14/12)
     
  371. Risk, Responsibility, and Generic Drugs Perspective - (11/08/12)
     
  372. Shionogi and ViiV Healthcare announce new agreement to commercialise and develop integrase inhibitor portfolio - (10/29/12)
     
  373. PREZISTA® (darunavir) ORAL SUSPENSION RECEIVES EUROPEAN COMMISSION APPROVAL FOR YOUNG CHILDREN WITH HIV-1 INFECTION - press announcement by Janssen - (10/29/12)
     
  374. Chronic Air Pollution Exposure and Endothelial Dysfunction - (10/29/12)
     
  375. Antibody Builds Bone, Slows Its Loss in Women - (10/16/12)
     
  376. More HIV-Positive Patients Receive Organ Transplants - (10/15/12)
     
  377. OraSure Technologies' CEO presents OraQuick In-Home HIV Test Launches (conference call Transcript); Magic Johnson Partners - (10/11/12)
     
  378. Magic Johnson Partners: Orasure's OraQuick In-Home HIV Test is available in stores - (10/10/12)
     
  379. A Medicaid HMO, Magic Johnson and UM doctors are combining to provide healthcare for HIV/AIDS patients - (10/09/12)
     
  380. Health Department Recommends Vaccination for Hiv-Positive Men at High Risk of Meningitis - (10/05/12)
     
  381. Myocardial infarction in relation to mercury and fatty acids from fish: a risk-benefit analysis based on pooled Finnish and Swedish data in men - (10/04/12)
     
  382. Fish linked to heart failure risk, omega-3 results mixed - (10/04/12)
     
  383. Meningitis Alert Issued For New York City Gay Guys and "Men Who Have Sex With Men" - (10/04/12)
     
  384. NYC HEALTH DEPARTMENT INVESTIGATING INVASIVE MENINGOCOCCAL DISEASE CASES AMONG GAY MEN AND MEN WHO HAVE SEX WITH MEN - (10/04/12)
     
  385. Roche's new dual-target HIV-1 viral load test now available in US - (10/04/12)
     
  386. "Responsible" meds use can save $500B/year globally: Janssen healthcare report - (10/04/12)
     
  387. J&J's Bedaquiline Advisory Cmte. Could Test Strength Of Phase II Argument For Tuberulosis Drugs - (10/01/12)
     
  388. Tentative approval of Lamivudine, Nevirapine and Zidovudine Fixed Dose Combination Scored Tablets for Oral Suspension - (10/01/12)
     
  389. Insomnia, Anxiety Drugs (Ambien) May Raise Dementia Risk - (10/01/12)
     
  390. BI exits virology research as hep C drugs move down pipeline - (09/20/12)
     
  391. Dolutegravir (DTG; S/GSK1349572) + Abacavir/Lamivudine Once Daily Statistically Superior to Tenofovir/Emtricitabine/Efavirenz: 48-Week Results - SINGLE (ING114467) - ViiV Healthcare ICAAC Media Statement - (09/20/12)
     
  392. Common Patient Assistance Program Application Tool Effective Today - (09/20/12)
     
  393. Biobusiness Briefs: Trial watch: HIV integrase inhibitor-based regimen beats market leader (dolutegravir, elvitegravir, raltegravir) - (09/04/12)
     
  394. HIV-positive women find support in struggle to date again - (08/31/12)
     
  395. FDA OKs Opioid for Diabetic Pain - (08/31/12)
     
  396. Spain: govt drug spending falls 24% - (08/31/12)
     
  397. FDA approves new combination pill for HIV treatment for some patients - QUAD  - (08/28/12)
     
  398. Viread labeling updates expand pediatric indication and add 240 week data - (08/28/12)
     
  399. Green light in USA for Gilead's four-in-one HIV pill - (08/28/12)
     
  400. Statins linked with development of cataracts - (08/17/12)
     
  401. Pipeline Setback at Bristol-Myers - (08/07/12)
     
  402. Mylan launches 18 HIV drugs in India/ Gilead's Tenofovir - (08/07/12)
     
  403. Pipeline Setback at Bristol-Myers - (08/06/12)
     
  404. Bristol weighs writedown of hepatitis drug - (08/06/12)
     
  405. Some US pharmacies "selling entire inventories to gray market" - (08/01/12)
     
  406. ViiV Healthcare Expands Support for HIV Prevention and Education in Hard-Hit U.S. Region - (08/01/12)
     
  407. Going door-to-door to fight HIV in Philadelphia - (07/30/12)
     
  408. NIH to test dapivirine (Tibotec's TMC120) vaginal ring for HIV prevention in women - (07/30/12)
     
  409. Greece's Latest Crisis: Rising HIV Cases - up 1500% among IDUs - (07/27/12)
     
  410. Janssen HIV ART Price Reductions-Etravirine-UPDATES Access/TB Drug/Peds/Long-Acting Rilpivirine/PrEP - (07/25/12)
     
  411. Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV - (07/25/12)
     
  412. HIV Cure Is Closer As Patient's Full Recovery Inspires New Research - (07/19/12)
     
  413. ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment - (07/18/12)
     
  414. IVIG Stops Alzheimer's in Its Tracks - (07/18/12)
     
  415. Alzheimer's Treatment Study Reports Three Years With No Decline In Memory And Function At AAIC 2012 - (07/18/12)
     
  416. Small Molecule May Play Big Role in Alzheimer's Disease - (07/18/12)
     
  417. Janssen New HIV Electronic/Web-Based Records/E-Prescribing - (07/18/12)
     
  418. J&J 2Q profit down by half on lower sales, charges - (07/18/12)
     
  419. GSK buys HGS for $3.00 billion - (07/17/12)
     
  420. PrEP Truvada - (07/17/12)
     
  421. GSK rumoured to have sealed HGS buy for $2.80 billion - (07/16/12)
     
  422. US biopharma: 187 drugs for mental illnesses now in R&D - (07/16/12)
     
  423. Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla in Test - (07/16/12)
     
  424. Implications of the Drug That Can Prevent 90% of HIV Infections - (07/16/12)
     
  425. Gene mutation defends against Alzheimer's disease - (07/16/12)
     
  426. Alzheimer's Markers Seen Way Before Symptoms - (07/16/12)
     
  427. Colorado Health Dept. Issues HIV, HCV Warning About Colorado Dentist - (07/13/12)
     
  428. Global pharma spending "to hit nearly $1.2 trillion by 2016" - (07/13/12)
     
  429. Merck halts Ph III trial of osteoporosis drug on success - (07/13/12)
     
  430. Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect - (07/13/12)
     
  431. Maraviroc & Transplant Rejection: Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease - (07/12/12)
     
  432. Drug [maraviroc] raises hope for better bone marrow transplant recovery - (07/12/12)
     
  433. Maraviroc Cuts Post-Transplant GVHD Rate in Hematologic Cancers - (07/12/12)
     
  434. Gilead Submits New Drug Application to U.S. FDA for Boosting Agent Cobicistat - (07/10/12)
     
  435. Gilead Submits New Drug Application to U.S. FDA for HIV Integrase Inhibitor Elvitegravir for Treatment-Experienced Patients - (06/27/12)
     
  436. Bristol Will Buy Diabetes Drug Maker - (07/10/12)
     
  437. BMS and AstraZeneca link up for Amylin Diabetes acquisition - (07/10/12)
     
  438. Janssen Research & Development Submits New Drug Application to FDA for Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline (TMC207) - (07/10/12)
     
  439. FDA Approves OraSure's Over-The-Counter Home HIV Test - (07/10/12)
     
  440. HIV drugs pumped into Africa - (07/10/12)
     
  441. IAS: New optimism about stemming spread of AIDS virus; Early HAART; Door-To-Door HIV Testing in Hard-Hit Zip Code - (07/10/12)
     
  442. HIV Stats Point to Need for Annual Testing- "particularly blacks/African Americans and injection drug users" - (07/10/12)
     
  443. Generics set to dominate antivirals market: report - (07/10/12)
     
  444. Abbott signs up for R&D projects in Russia - (07/10/12)
     
  445. FDA approves first over-the-counter home use HIV test kit - (07/10/12)
     
  446. Caffeine May Lower Risk of Common Skin Cancer - (07/10/12)
     
  447. Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases - study suggests vaccine may be ok for patients with immune-mediated disorders - (07/10/12)
     
  448. Walgreen to offer free HIV tests in CDC pilot - (06/27/12)
     
  449. Tenative approval for efavirenz tablets, 600 mg for PEPFAR - (06/27/12)
     
  450. Roche to cut 1,000 research jobs in the US - (06/27/12)
     
  451. Innovative CDC Effort Expands HIV Testing into Pharmacies - CDC press release - (06/27/12)
     
  452. CDC trying out free AIDS tests at drugstores - (06/27/12)
     
  453. Theratechnologies Provides Regulatory Update on Tesamorelin - (06/27/12)
     
  454. Roche bags rights to AC Immune Alzheimer's drug in $418 million deal - (06/21/12)
     
  455. Walgreens/Boots merger creates world's largest pharmacy - (06/21/12)
     
  456. HIV in Wash DC Update - (06/21/12)
     
  457. USPSTF Policies Questioned - (06/21/12)
     
  458. New drug-screening method yields long-sought anti-HIV compounds - (06/14/12)
     
  459. Pharma Patent Expirations/Novartis to top pharma sales league by 2018 - (06/14/12)
     
  460. More impressive data for Merck & Co insomnia drug - (06/14/12)
     
  461. Trends in the Black-White Life Expectancy Gap, 2003-2008: HIV is a leading cause in racial health dispaity - (06/14/12)
     
  462. New HCV Outbreak in LA: 1-800-GET-THIN clinics put patients at risk, lawsuit alleges - (06/13/12)
     
  463. n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia - (06/13/12)
     
  464. Vitamin D/Calcium Supplementation Not Recommended by Fed Panel USPSTF, Public Commentary Invited - (06/13/12)
     
  465. CT Radiation Concerns Rise With Patients' Exposure - (06/13/12)
     
  466. J&J Cancer Drug - ZYTIGA Plus Prednisone Show Improvements in Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer - (06/11/12)
     
  467. BMS Cancer Drug - New drugs may help immune system fight cancer - (06/11/12)
     
  468. New Hampshire Hospital - 10 now linked with hep C outbreak: Public health director: Viral outbreak 'clearly tied' to hospital laboratory - (06/11/12)
     
  469. Truvada PrEP - FDA delays decision on drug to prevent HIV, Extends Review 3 Months - (06/11/12)
     
  470. FDA approves Perjeta for type of late-stage breast cancer - FDA NEWS RELEASE - (06/11/12)
     
  471. FDA okays Perjeta, Roche's new HER2 breast cancer drug - (06/11/12)
     
  472. J&J Prostate Cancer Data/Roche presents stunning data on T-DM1 for breast cancer - (06/11/12)
     
  473. The not-so-long run: Mortality benefit of running less than 20 miles per week - (06/11/12)
     
  474. ASCO: Early RT (chest radiation therapy in childhood) Hikes Risk for Breast Cancer - (06/05/12)
     
  475. ASCO: Paclitaxel Bests New Drugs in Breast Cancer - (06/05/12)
     
  476. ASCO: Targeted Tx Stalls Melanoma Progress - (06/05/12)
     
  477. Roche Breast-Cancer Treatment Advances: targeted therapy - (06/04/12)
     
  478. Roche Cancer Breakthroughs: difficult to treat recurrent Ovarian, metatastic Colorectal and HER2-positive metastatic breast cancer studies - (06/04/12)
     
  479. Dark Chocolate: Sweet Prevention for CV Events - (06/03/12)
     
  480. VNSNY CHOICE Acquires New York-Presbyterian SelectHealth Health plan for people living with HIV/AIDS - (06/01/12)
     
  481. Grammy-winner Jon Secada shares family's message: Don't stay silent with a silent disease, Hepatitis C - (06/01/12)
     
  482. Antiretroviral prophylaxis for HIV prevention reaches a key milestone - Commentary The Lancet - (06/01/12)
     
  483. Approval of generic nevirapine formulations - (05/30/12)
     
  484. Tentative approval of lopinavir and ritonavir tablets 200 mg/50 mg - (05/30/12)
     
  485. Orasure: Pennsylvania firm pioneers rapid medical tests - (05/30/12)
     
  486. Drug Restores Normal Orgasm in Men - (05/30/12)
     
  487. FDA Issues Complete Response Letter for 800mg Prezista (Darunavir) Tablet - (05/30/12)
     
  488. Bristol-Myers Squibb Announces Global Collaboration with Leading Academic Institutions to Advance Science of Immuno-Oncology - (05/30/12)
     
  489. Isentress FDA label update includes 156-week safety and efficacy data - (05/23/12)
     
  490. NSAID-Related Anemia Doubles Arthritis Costs - (05/23/12)
     
  491. FDA Committee Recommends HIV PrEP, Concerns Persist - (05/23/12)
     
  492. US Senate call to scrap HIV drug patents - (05/23/12)
     
  493. Keeping the Faith: African American Faith Leaders' Perspectives and Recommendations for Reducing Racial Disparities in HIV/AIDS Infection- new published study interviews/survey with clergy in Philadelphia- barriers & suggested solutions - (05/23/12)
     
  494. CDC recommends hepatitis C tests for all baby boomers: Hepatitis C is an unrecognized health crisis in the United States - (05/23/12)
     
  495. Association of Coffee Drinking with Total and Cause-Specific Mortality - (05/17/12)
     
  496. Congressional Briefing - Beginning to End the AIDS Epidemic: What's the Research Agenda? (PrEP/treatment-as-prevention/vaccines/cure) - (05/16/12)
     
  497. FDA PANEL Recommends 17-0 to Approve HIV Home Test - (05/16/12)
     
  498. USA boosts Alzheimer's funding as prevention trial is launched - (05/16/12)
     
  499. Taking Truvada to Prevent H.I.V. Also Comes With Risks - (05/16/12)
     
  500. African-Americans face roadblocks to HIV therapy, untreated depression makes it worse - (05/16/12)
     
  501. FDA Panel Reviews first rapid, take-home test for HIV: On May 15, 2012, the committee will discuss as a device panel the evaluation of the safety and effectiveness of the OraQuick In-Home HIV Test. - (05/15/12)
     
  502. FDA panel recommends Gilead's Quad for HIV - FDA Briefing Document attached, below are summary excerpts from the document at the bottom of this report - (05/15/12)
     
  503. OraSure HIV Test Has Risks of False Results, FDA Says - (05/15/12)
     
  504. GSK goes hostile with $2.60 billion HGS bid - (05/11/12)
     
  505. Truvada for HIV Prevention: FDA Review Is Favorable - (05/09/12)
     
  506. First drug to prevent HIV Truvada takes a step closer to approval - (05/09/12)
     
  507. Small study links Tasers to cardiac arrest - (05/04/12)
     
  508. FDA approves Viagra rival from Vivus - (04/30/12)
     
  509. New York State HIV Guidelines- NEW: Human Immunodeficiency Virus Type 2 (HIV-2) - (04/17/12)
     
  510. New Office Procedure/System Changes Increase Lipid Screening - (04/17/12)
     
  511. New Hepatitis Trials Clinic in Miami- With Cures on Horizon, Miller School Dedicates Schiff Center for Liver Diseases - (04/17/12)
     
  512. New Office Procedure/System Changes Increase Lipid Screening - (04/16/12)
     
  513. Amgen buys KAI Pharma and its SHPT drug for $315 million - (04/11/12)
     
  514. For the Elderly, Emergency Rooms of Their Own at NYC Hospital - (04/11/12)
     
  515. Hepatitis C in New York State - (04/10/12)
     
  516. Singer Jon Secada honors father's death with hepatitis C campaign - (04/10/12)
     
  517. Hepatitis C poses a silent crisis in Albany NY - (04/10/12)
     
  518. FDA advisory committee to review OTC availability of HIV test in May - (04/10/12)
     
  519. ViiV US/Global Community Programs - (04/04/12)
     
  520. Shionogi - ViiV Healthcare announces initial data from Pivotal Phase III study of dolutegravir in HIV - (04/04/12)
     
  521. FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1, Following Priority Review - (03/29/12)
     
  522. Red Meat & Mortality - 2 articles - (03/29/12)
     
  523. WHO Updated TB Guidance Report: More than 900 000 lives saved by protecting people living with HIV from TB - (03/29/12)
     
  524. GSK sharpens digital strategy with Infosys, Fabric pact - (03/20/12)
     
  525. J&J's Hepatitis C Drug Wins U.K. Cost Agency's Backing, also Victrellis - (03/16/12)
     
  526. Hepatitis C Infection Increasing Among Adolescents, Young Adults - (03/14/12)
     
  527. New Greek law says industry must cover pharma overspend - (03/03/12)
     
  528. New indicator diseases reveal hidden HIV in Europe - (03/02/12)
     
  529. New York State Hepatitis C Legislative Awareness Day - (03/02/12)
     
  530. FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury - (03/02/12)
     
  531. FDA: New Warning Labels for Statins - Comments on FDA Warning. FDA said patients should not be scared off statins. "The value of statins in preventing heart disease has been clearly established" - (02/29/12)
     
  532. FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs - (02/29/12)
     
  533. New study finds big risk for sleeping pills - (02/29/12)
     
  534. Boomers Urged To Get Hep C Tests To Counter Rising Liver Disease Deaths - (02/27/12)
     
  535. Janssen Launches New HCV Support for Patients - (02/27/12)
     
  536. Scripps Florida receives NIH grant to create novel HIV inhibitors - (02/27/12)
     
  537. Novartis explains stance over India patent law challenge - (02/27/12)
     
  538. Targeted Roche Drug Scores Again in Melanoma for Patients with Advanced Melanoma - (02/27/12)
     
  539. An Orange a Day Keeps Stroke Away & Improves Inflammation & Perhaps Neuroinflammation - (02/27/12)
     
  540. Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia - (02/23/12)
     
  541. Vaccine Discovered For hep C by Michael Houghton who discovered HCV in 1989 - (02/23/12)
     
  542. Walgreen to buy BioScrip units for $225 million - (02/19/12)
     
  543. Jon Secada joins Hepatitis C awareness campaign - (02/17/12)
     
  544. Singer Jon Secada Joins Merck and American Liver Foundation's 'Tune In to Hep C' Public Awareness Campaign - English & Spanish language versions - (02/17/12)
     
  545. Activists slam Mayor's AIDS/HIV care cuts - (02/17/12)
     
  546. Jon Secada joins Hepatitis C awareness campaign - (02/16/12)
     
  547. Merck & Co sets up Brazilian joint venture/Generics - (02/16/12)
     
  548. Air Pollution Tied to Stroke, Cognitive Slide - 3 articles below - (02/15/12)
     
  549. HIV Therapeutic Vaccine Vacc-4x 'lowered viral load in patients off ART' - (02/15/12)
     
  550. As Global HIV Funds Dry Up (Russia), NGOs Fear Change in Priorities - (02/15/12)
     
  551. White House Report: Fighting the HIV/AIDS Epidemic and Supporting People Living with HIV/AIDS - (02/15/12)
     
  552. Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc. - (02/14/12)
     
  553. Bristol-Myers completes Inhibitex tender offer - (02/14/12)
     
  554. U.S. FDA Grants Priority Review for Truvada® for Reducing the Risk of Acquiring HIV Infection - (02/14/12)
     
  555. HCV FUNDING & HIV Funding and the New Obama Budget - (02/14/12)
     
  556. South Africa, Swiss company to produce cheaper HIV drugs - (02/13/12)
     
  557. High-Dose Capsaicin Patch Approved for Shingles - (02/10/12)
     
  558. Pain Patch Rejected for HIV Neuropathy - (02/10/12)
     
  559. FDA Issues Warning on Acid Reflux Drugs - (02/10/12)
     
  560. FDA Issues Draft Guidance for Biosimilar Products - (02/10/12)
     
  561. Study Suggests Racial Role in Kidney Transplants - (02/10/12)
     
  562. Tobira Therapeutics Continues Management Team Expansion - (02/09/12)
     
  563. 2012 adult immunization schedule broadens recommendations for HPV and hepatitis B vaccinations; extends HPV vaccine to Men 11-21 & Through Age 26 for HIV+ - full text, editorial - (02/08/12)
     
  564. Report: Florida women (of color) face high rates of HIV and unplanned pregnancies - (02/08/12)
     
  565. Pfizer in talks with buyer for Sandwich, FDA approves Inlyta - (02/03/12)
     
  566. Once Weekly Diabetes Drug Wins FDA Approval on Third Try - (02/03/12)
     
  567. FDA approves Roche's skin cancer drug Erivedge - (02/03/12)
     
  568. Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol - (02/03/12)
     
  569. US Medicaid Rx drug move will save $17.7B, says govt - (02/03/12)
     
  570. EU Commission tells Italy: "comply with rules on generics" - (02/03/12)
     
  571. Spain cut Rx spending 8.8% in 2011, but owes drugmakers 6.3B euros - (02/03/12)
     
  572. Gilead tops table for antivirals - (01/27/12)
     
  573. Celgene Now a Hep C Stock With Avila Buy - (01/27/12)
     
  574. Federal Injunction Blocks Ranbaxy from Marketing in U.S. - (01/27/12)
     
  575. Statins May Stave Off Liver Cancer in People With Hepatitis B: statins & cirrhosis - (01/27/12)
     
  576. Vertex outlines its survival plan for next-gen hep C combo, nucleotides - (01/24/12)
     
  577. Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir for the Treatment of HIV - (01/24/12)
     
  578. [Street] Sales of HIV Meds Catch Lawmakers' Eyes - (01/23/12)
     
  579. Vertex's Alios Nucleotides - (01/19/12)
     
  580. U.S. Food and Drug Administration Approves New Formulations of Viread® for Use by Children Living With HIV - (01/19/12)
     
  581. Treat risk and not LDL-cholesterol targets, new perspective argues - (01/19/12)
     
  582. Condoms in Porn Movies - (01/19/12)
     
  583. Vertex's Alios Nucleotides - (01/18/12)
     
  584. Generics market to boom as blockbusters go off-patent; 'generics slow down in 2013' - (01/18/12)
     
  585. Global health fund urges Ukraine to step up fight against HIV/AIDS epidemic - (01/18/12)
     
  586. Cancer Among Minorities with HIV/AIDS: most common non-AIDS-defining cancers in patients with HIV are anal, lung, and liver cancers and Hodgkin lymphoma.....prevention efforts are especially important for racial and ethnic minorities - (01/18/12)
     
  587. Novartis cuts nearly 2,000 jobs in USA, takes major charges - (01/14/12)
     
  588. Gilead now has 95% of Pharmasset shares - (01/14/12)
     
  589. Bristol-Myers Raised Offer 30% to Beat Competitor for Inhibitex - (01/14/12)
     
  590. INX189 Hepatitis C drug set to give Cardiff University financial boost - (01/12/12)
     
  591. The Fate of Health Care Reform - What to Expect in 2012 - Perspective - (01/12/12)
     
  592. To optimize exercise, heed your heart rate training zone - (01/10/12)
     
  593. US retail Rx drug spending rose just 1.2% in 2010, says govt - (01/10/12)
     
  594. To optimize exercise, heed your heart rate training zone - (01/10/12)
     
  595. Bristol-Myers Agrees to Acquire Inhibitex for $2.5 Billion - (01/09/12)
     
  596. Pharma Acquistions Expected: J.P. Morgan Healthcare Conference for drugmakers - (01/09/12)
     
  597. Idenix Leads Hepatitis Drug Developers Higher on Inhibitex - (01/09/12)
     
  598. FDA Approves Merck's ISENTRESS® (raltegravir) for Use in Children Ages Two Years and Older as Part of HIV-1 Combination Therapy - (01/07/12)
     
  599. Drug to Treat HIV in Children Shows Promise Via Stony Brook-Led National Study - (01/07/12)
     
  600. Roche's Novel Tests for the Management of Hepatitis C Virus Infection Receive CE Mark - (01/05/12)
     
  601. Janssen Therapeutics Announces Latest Recipients of LINCC Funding Initiative - (01/06/12)
     
  602. Promising Results of Novel J&J HIV Combination Vaccine - (01/06/12)
     
  603. Paper denying HIV-AIDS link secures publication - (01/06/12)
     
  604. Sustiva labeling update / dosing adjustment with rifampin - (01/06/12)
     
  605. Herpes Vaccine Fails to Protect Women - (01/06/12)
     
  606. Herpes Drugs Work, but Not Forever - (01/06/12)
     
  607. National Black HIV/AIDS Awareness Day CDC Announces - (01/06/12)
     
  608. HCV Vaccine Therapeutic/Preventive: Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man - (01/06/12)
     
  609. Hep C Vaccine Shows Promise In First Trial - (01/06/12)
     
  610. Inhibitex Shares Whipsawed by Cautious Analyst Comment - (01/05/12)
     
  611. CDC Awards $339 Million to Health Departments for High-Impact HIV Prevention - (01/04/12)
     
  612. Bristol-Myers Squibb and the Gladstone Institutes Enter Three-Year Discovery Partnership in Alzheimer's Disease - (01/04/12)
     
  613. BRISK-PS Study with Investigational Compound Brivanib in Hepatocellular Carcinoma Completed - (01/04/12)
     
  614. Louisiana has long waiting list for HIV drugs - (01/01/12)
     
  615. FY 2012 NIH Budget Includes $577M for NCATS - (01/01/12)
     
  616. Congress to Restore Federal Syringe Exchange Funding Ban as Part of 2012 Spending Package - (01/01/12)
     
  617. HIV Test & Treat limitations - (12/30/11)
     
  618. Peregrine Provides Update on HCV Clinical Program - (12/30/11)
     
  619. Cat Allergy Depends on When You Get the Cat - (12/30/11)
     
  620. Life Spans in City Exceed U.S. Average: largely due to reduced deaths & successful programs in HIV - (12/30/11)
     
  621. Three get hepatitis from Kentucky donor-Organs and tissue had been tested - (12/30/11)
     
  622. Misread of HCV Test Leads to Transplant Infections - (12/30/11)
     
  623. CDC reports hepatitis C transmission via transplants - (12/30/11)
     
  624. HCV Transmission from Transplant 1 donor, missteps, 3 infected patients - (12/30/11)
     
  625. Tentative approval of emtricitabine/tenofovir disoproxyl fumarate tablets for PEPFAR - (12/30/11)
     
  626. FDA Approves Issentress (raltegravir): pediatric dosing recommendations and 2 chewable tablet formulations for pediatric dosing - (12/22/11)
     
  627. French Doctor Yves Benhamou Sentenced to Time Served in Tipping Case - (12/22/11)
     
  628. Spike Seen in Transplants for Fatty Liver Disease - (12/22/11)
     
  629. Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes - (12/22/11)
     
  630. Isentress (raltegravir): pediatric dosing recommendations and 2 chewable tablet formulations for pediatric dosing - (12/22/11)
     
  631. Aging, Adiposity, and Calorie Restriction - (12/22/11)
     
  632. Extending Healthy Life Span-From Yeast to Humans - (12/22/11)
     
  633. A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction - (12/22/11)
     
  634. Merck and the ADAP Crisis Task Force Announce New Agreement to Improve Access and Care for People with HIV - (12/21/11)
     
  635. HCV Landscape Change: Safety Scare Tilts Balance in Hepatitis C Drug Battle - (12/21/11)
     
  636. Bristol-Myers Squibb and ADAP Crisis Task Force Announce Enhanced Multi-year Support for AIDS Drug Assistance Programs (ADAPs) and People Living with HIV/AIDS - (12/21/11)
     
  637. Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound - (12/21/11)
     
  638. GSK divests OTC brands for 426 million - (12/21/11)
     
  639. NIH Spending Barely Budges, CDC Stays Flat as Congress Finalizes FY 2012 Budget - (12/21/11)
     
  640. Eating Less Delays Aging: Skinny Mice Offer Clue to Delayed Aging - (12/21/11)
     
  641. Number of Floridians on AIDS drug waiting list increasing again - (12/21/11)
     
  642. Interview: Vertex CEO concerned about investors' 'hyper-focus' on hep C - (12/21/11)
     
  643. Elevation of the Chimp May Reshape Research - (12/21/11)
     
  644. Gilead Sciences Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Truvada® for Reducing the Risk of Acquiring HIV - (12/19/11)
     
  645. HIV: Sooner Is Better for Treatment (Immediate HAART in Early Infection)) - (12/19/11)
     
  646. FDA Clout Needed to Prevent Drug Shortages - (12/19/11)
     
  647. Diabetes, Obesity Overshadow Lower CV Death Rate - (12/19/11)
     
  648. FDA Grants Priority Review for KALYDECO™ (ivacaftor), the First Potential Medicine to Target the Underlying Cause of Cystic Fibrosis - (12/19/11)
     
  649. NIH, DOE Appear Headed For Small Budget Increases in 2012 - (12/19/11)
     
  650. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial - (12/15/11)
     
  651. Virco Launches Electronic Health Record and Data Reporting Module Designed Specifically for the HIV/AIDS Treatment Community: AVIGA™ and AVIGA REPORTER™ - (12/15/11)
     
  652. Tough 2012 for pharma but industry still rated highly - (12/15/11)
     
  653. Vertex Announces CEO Succession Plan for 2012 - (12/15/11)
     
  654. Statins and safety: can we finally be reassured? - (12/14/11)
     
  655. Nutrition and the risk of stroke - (12/14/11)
     
  656. Vitamin, Diet Link to Stroke Risk Assessed - (12/14/11)
     
  657. Biotie tests cocaine dependence treatment in USA - (12/14/11)
     
  658. Roche - Nature Medicine Symposium on Cancer Immunology and Immmunotherapy - (12/12/11)
     
  659. High prevalence of right ventricular involvementin endurance athletes with ventricular arrhythmias - (12/12/11)
     
  660. Exercise-induced arrhythmogenic right ventricular cardiomyopathy: fact or fallacy? Editorial - (12/12/11)
     
  661. Class of once-weekly diabetes drugs poised for approval - (12/12/11)
     
  662. Obama pledges $50M to combat HIV/AIDS: $35 million for ADAP, additional $15 million to provide services and treatment to an increased number of patients at HIV medical clinics - (12/12/11)
     
  663. 2010 NIAID Year in Review Includes Summary of HIV/AIDS Research Accomplishments - (12/12/11)
     
  664. Linagliptin demonstrates meaningful improvement in glycaemic control in initial combination therapy with metformin - (12/12/11)
     
  665. FDA: Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots - (12/12/11)
     
  666. Abbott pays out $400 million for access to more Reata antioxidant inflammation modulators compounds - (12/12/11)
     
  667. The Hepatitis C Market: Biotech's Version of the Daytona 500 - (12/12/11)
     
  668. Chinese hepatitis C outbreak not caused by clinic's needles: initial probe - (12/12/11)
     
  669. Transcript/President Obama's Remarks on World AIDS Day 2011 - (12/12/11)
     
  670. ADAP Crisis Task Force Announces Enhanced Support From Janssen Therapeutics (Tibotec) for ADAPs in the United States - (12/12/11)
     
  671. Gilead Announces Two-Year Data From Pivotal Phase 3 Study of Elvitegravir, an Integrase Inhibitor for HIV - (12/12/11)
     
  672. FDA Drug Safety Communication: Modified Risk Evaluation and Mitigation Strategies (REMS) for Nplate (romiplostim) and Promacta (eltrombopag) - (12/12/11)
     
  673. Gilead Sciences and World Health Organization Establish New Five-Year Initiative to Prevent Deaths from Visceral Leishmaniasis - (12/12/11)
     
  674. Endurance Athletes May Incur Heart Damage - (12/12/11)
     
  675. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes - (12/12/11)
     
  676. FDA Label Safety revisions to Norvir (ritonavir) tablets, capsules and oral solution labeling - (12/12/11)
     
  677. AHA: Women Prone to 'Broken Hearts' - (12/08/11)
     
  678. Babyboomers Most at Risk for Hepatitis C Virus - (12/08/11)
     
  679. Gilead's Boosting Agent, Cobicistat, Meets 48-Week Primary Objective in Pivotal Phase 3 Study - (12/08/11)
     
  680. N.J. Assembly passes bill to allow over-the-counter sales of hypodermic needles - (12/08/11)
     
  681. A Fish a Week Keeps the Brain at Its Peak - (12/07/11)
     
  682. Generic Lipitor: New Era for Statins? Statins for Everyone Over 35 Yrs Old? - (12/07/11)
     
  683. Teva gets tentative OK for generic Lipitor as senators seek answers - (12/07/11)
     
  684. Productivity of pharma R&D down 70% - study - (12/07/11)
     
  685. Gilead Sciences and ADAP Crisis Task Force Announce New Initiatives to Support AIDS Drug Assistance Programs (ADAPs) - (12/07/11)
     
  686. ADAP Crisis Task Force Announces Enhanced Support from Gilead Sciences for ADAPs in the United States; Additional Federal and State Funding Critical - (12/07/11)
     
  687. Children with HIV 'falling through cracks' - (12/07/11)
     
  688. ADAP Crisis Task Force Announces Enhanced Support from Gilead Sciences for ADAPs in the United States; Additional Federal and State Funding Critical - (12/01/11)
     
  689. Gilead Sciences and ADAP Crisis Task Force Announce New Initiatives to Support AIDS Drug Assistance Programs (ADAPs) - (12/01/11)
     
  690. NYC Recommends AIDS Drugs For Any Person With HIV - (12/01/11)
     
  691. Gilead Receives European Marketing Authorization for Eviplera(R), a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Naïve Adults - (11/30/11)
     
  692. Lipitor, the world's best-selling drug, goes off-patent in the USA today - (11/30/11)
     
  693. HIV+ Only 28% Are Virally Suppressed, "collect cd4 & viral load tests for those diagnosed to identify those not in care": CDC - (11/30/11)
     
  694. The HIV and Aging Consensus Project: Recommended Treatment Strategies for Clinicians Managing Older Patients with HIV - (11/30/11)
     
  695. Alvin Ailey American Dance Theater Premieres Home, A New Work Inspired by the Winning Photos and Essays from the 2011 REYATAZ® (atazanavir sulfate) "Fight HIV Your Way" Contest, an Initiative of Bristol-Myers Squibb - (11/30/11)
     
  696. Gilead could have had Pharmasset cheap: founder - (11/28/11)
     
  697. Global Fund for World Health Halts New Programs - (11/28/11)
     
  698. Poor economy halts new funding for AIDS,TB and malaria treatment - (11/28/11)
     
  699. Global disease fund must "change or wither", says panel. - (11/28/11)
     
  700. Global disease fund hit by cash crisis: who are funders & how much - (11/28/11)
     
  701. Lifetime Costs of new HIV cases will top $4B in Canada, report says - (11/28/11)
     
  702. Lifetime Cost And Life Expectancy For Current HIV Care In The U.S. 2006 - published study in journal, full text below - (11/28/11)
     
  703. Newer drugs and earlier treatment: Impact on lifetime cost of care for HIV-infected adults - (11/28/11)
     
  704. Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz® (atazanavir sulfate) in Brazil - (11/21/11)
     
  705. Hillary Clinton Calls For AIDS-free Generation - (11/21/11)
     
  706. U.S. Conference on AIDS - Highlights of Day 1 - (11/21/11)
     
  707. Medivir HCV Report: Nucleotide Preclinical Development Started - (11/21/11)
     
  708. Gilead Sciences Finalizes Agreement with Tibotec Pharmaceuticals to Develop and Commercialize a Single-Tablet Regimen of Prezista(R) with Emtriva(R), GS 7340 and Cobicistat - (11/21/11)
     
  709. Walgreens HIV Centers of Excellence Pharmacies Now Top 500 Nationwide in Areas Most Impacted by HIV/AIDS - (11/10/11)
     
  710. Magic Johnson: 20 Years Later, Still Alive, Still Lively - (11/07/11)
     
  711. Gilead Submits New Drug Application to U.S. FDA for Once-Daily, Single-Tablet "Quad" HIV Regimen - (11/07/11)
     
  712. White House AIDS Czar Jeff Crowley Leaving Post - (11/04/11)
     
  713. Purging Cells in Mice Is Found to Combat Aging Ills - (11/04/11)
     
  714. Isentress Package Insert Update - (11/04/11)
     
  715. Vertex Announces Recipients of Special Grants Initiative to Support People with Hepatitis C - (11/04/11)
     
  716. San Francisco Mayoral candidates talk hep B and C - (11/03/11)
     
  717. Isentress Package Insert Update - (11/03/11)
     
  718. White House Rejects Marijuana Legalization Petition - (11/03/11)
     
  719. Lipitor drives Pfizer sales again with patent loss days away - (11/01/11)
     
  720. India plans to price-control 60% of pharma market - (11/01/11)
     
  721. Innovative transdermal patch for delivery of HIV medicine featured at AAPS Annual Meeting - (11/01/11)
     
  722. Lipitor drives Pfizer sales again with patent loss days away - (11/01/11)
     
  723. Vertex Breaks Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again - (10/31/11)
     
  724. Gilead Submits New Drug Application to U.S. FDA for Once-Daily, Single-Tablet "Quad" HIV Regimen - (10/31/11)
     
  725. First major drug company draws on HIV/AIDS patent pool - (10/31/11)
     
  726. Merck profits soar as Januvia, Gardasil sales impress; boceprevir sales - (10/31/11)
     
  727. ARBs blood pressure med may cut risk of Alzheimer's disease - (10/31/11)
     
  728. American Academy of Pediatrics calls for HIV screening of teens who have sex - (10/31/11)
     
  729. New England Journal of Medicine Publishes Additional Efficacy and Safety Data for GARDASIL® in Males - (10/26/11)
     
  730. Vitamin E and the Risk of Prostate Cancer - (10/25/11)
     
  731. Vitamins E and C in the Prevention of Prostate and Total Cancer in Men - (10/25/11)
     
  732. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers - Initial Publication - (10/25/11)
     
  733. Gilead and GlobeImmune Announce License and Collaboration Agreement to Develop Therapeutic Vaccine Products for Treatment of Chronic Hepatitis B Infection - (10/25/11)
     
  734. The tenofovir 'magic' gel that slashes a woman's risk of HIV and herpes - (10/25/11)
     
  735. HPV infection linked to MI, stroke in women, inflammation - (10/25/11)
     
  736. Topical Tenofovir, a Microbicide Effective against HIV, Inhibits Herpes Simplex Virus-2 Replication - (10/25/11)
     
  737. Bristol-Myers Squibb and Gilead Sciences Announce Licensing Agreement for Development and Commercialization of New Fixed-Dose Combination Pill for People Living with HIV - (10/25/11)
     
  738. Time for zero deaths from tuberculosis - Comment - (10/24/11)
     
  739. Global funding for infectious diseases: TB or not TB? Editorial - (10/24/11)
     
  740. Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals - press release - (10/21/11)
     
  741. Abbott Spinoff May Fetch $54 Billion in Takeover as Humira Tempts Rivals - (10/21/11)
     
  742. Global Fund suspends $28m AIDS grant in Mali after its investigators find money being misused - (10/21/11)
     
  743. Mobile telephones and brain tumours - editorial - (10/21/11)
     
  744. FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment - (10/21/11)
     
  745. ViiV Healthcare's Positive Action for Children Fund announces 16 new grantees for the year 2011/2012 - (10/18/11)
     
  746. Vitamin Studies Spell Confusion for Patients - (10/18/11)
     
  747. Diabetes Drug (Pioglytazone) May Have Plaque Benefit - (10/13/11)
     
  748. Prostate Test Recommendation Draws Mixed Reviews - (10/13/11)
     
  749. Brown signs bill letting CA minors get STD vaccine, and PEP/PrEP? - (10/13/11)
     
  750. Gov. Jerry Brown signs bills expanding drug user access to syringes The measures are intended to combat the spread of hepatitis C and HIV. - (10/13/11)
     
  751. Merck's ISENTRESS® (raltegravir) in Combination Therapy Demonstrated Virological and Immunological Efficacy Versus the Efavirenz Regimen at 192 Weeks of Treatment in Previously Untreated Adults with HIV-1- press release - (10/13/11)
     
  752. Teen Sex Down, Condom Use Up - (10/13/11)
     
  753. PrEP, H.I.V. Drug Faces Trial And Raises Questions, Questions on Tactic to Prevent H.I.V. - (10/12/11)
     
  754. ViiV Global Programs: - 'ViiV Healthcare Effect' Brings ViiV Healthcare's Positive Action Partnerships to Life- - (10/12/11)
     
  755. ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV - (10/11/11)
     
  756. Bristol-Myers Squibb Foundation Announces Collaboration with World Health Organization's Stop TB Department to Strengthen Community Based Care of Tuberculosis Including HIV Co-Infection in Five African Countries - (10/11/11)
     
  757. Some common vitamin supplements could increase death risk, study finds - (10/11/11)
     
  758. Florida ADAP Failure: Thousands at risk as waiting lists grow for HIV medications - (10/09/11)
     
  759. Contraceptive May Double HIV Transmission Risk - (10/09/11)
     
  760. Boehringer signs away HIV rights to focus on hep C - (10/09/11)
     
  761. Global AIDS Funding Shake-Up - (10/09/11)
     
  762. Gilead and Boehringer Ingelheim Sign License Agreement for Novel HIV Non-Catalytic Integrase Inhibitors - (10/07/11)
     
  763. ViiV Healthcare Reaffirms Commitment to U.S. Regions Hardest Hit by HIV/AIDS - (10/06/11)
     
  764. A Dizzying Second Twist in Trial of Anti-HIV Drugs as Preventives: new tenofovir prevention preliminary study result - (10/06/11)
     
  765. MTN Statement on Decision to Discontinue Use of Oral Tenofovir Tablets in VOICE, a Major HIV Prevention Study in Women - (10/06/11)
     
  766. ViiV Healthcare Reaffirms Commitment to U.S. Regions Hardest Hit by HIV/AIDS - (10/06/11)
     
  767. Can Age-Associated Memory Decline Be Treated? - (10/06/11)
     
  768. Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir - (09/30/11)
     
  769. Opinion: California needs a logical, uniform needle-exchange program - (09/29/11)
     
  770. Comparing Gardasil & Cervarix Gardasil 'more cost effective' than Cervarix - (09/29/11)
     
  771. Comparing bivalent and quadrivalent HPV vaccines - Editorial - (09/29/11)
     
  772. Slightly raised blood pressure, pre-hypertension linked to stroke risk - (09/29/11)
     
  773. Diabetes experts debate CV risk prediction in type 2 diabetes - (09/26/11)
     
  774. Postprandial (after eating), but not fasting, glucose predicts CV risk in type 2 diabetes - (09/26/11)
     
  775. Impressive data on Roche's Herceptin successor T-DM1 - (09/26/11)
     
  776. Viramune® (nevirapine) prolonged-release once-daily formulation for the treatment of HIV-1 infection receives approval in the EU - press release - (09/24/11)
     
  777. Obama seeks $135B drug price cuts over 10 years - (09/24/11)
     
  778. EDURANT(R) (rilpivirine) Receives Positive Opinion From the Committee for Medicinal Products for Human Use (CHMP) for Use in Treatment-Naive Adults with HIV-1 - (09/24/11)
     
  779. European CHMP Adopts Positive Opinion for Eviplera(R), a Once-Daily Single-Tablet Regimen for the Treatment of HIV Infection - (09/24/11)
     
  780. New Data on Odanacatib, Merck's Phase III Investigational Cat-K Inhibitor for Osteoporosis, Presented at the Annual Meeting of The American Society for Bone and Mineral Research - press release - (09/22/11)
     
  781. Diabetes Linked to Alzheimer's Risk - (09/21/11)
     
  782. Mylan's Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment: HIV Generics coformulated TDF/3TC/NVP, Reyataz - (09/21/11)
     
  783. Diabetes Predicts 10-Year Fracture Risk - (09/21/11)
     
  784. Obama Plan Cuts Billions from Medicare, Medicaid - (09/21/11)
     
  785. INCIVO® (Telaprevir) Approved In Europe Offering Higher Cure Rates for Genotype-1 Chronic Hepatitis C Compared To Standard Treatment - press release - (09/21/11)
     
  786. HIV Gene Therapy Safe, Well Tolerated - (09/21/11)
     
  787. No Microvascular Benefit With Intense BP, Glucose Control - (09/21/11)
     
  788. Biomarkers May Predict CAD, Death in Diabetics - (09/21/11)
     
  789. Intensive Glucose Control Cuts Renal Risks - (09/16/11)
     
  790. No Microvascular Benefit With Intense BP, Glucose Control - (09/16/11)
     
  791. Biomarkers May Predict CAD, Death in Diabetics - (09/16/11)
     
  792. Computer models that predict response to treatment published in the international journal AIDS - (09/14/11)
     
  793. Diabetes in HIV & Globally - "turn attention to the diabetes epidemic, which he estimated will affect nearly 600 million people within 20 years." - (09/14/11)
     
  794. TWO DOSES (or maybe even 1) OF HPV VACCINE MAY BE AS PROTECTIVE AS FULL COURSE - (09/14/11)
     
  795. Editorial: Less Is More: A Step in the Right Direction for Human Papillomavirus (HPV) Vaccine Implementation (first clinical evidence to support the efficacy of fewer than three doses of the bivalent HPV16/18 vaccine) - (09/14/11)
     
  796. Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine - (09/14/11)
     
  797. Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment - (09/14/11)
     
  798. NeurogesX Submits Supplemental New Drug Application for Qutenza (capsaicin) 8% Patch for HIV-Associated Peripheral Neuropathy (HIV-PN) - (09/12/11)
     
  799. More label changes expected for osteoporosis drugs - (09/12/11)
     
  800. FDA approves HIV drug NNRTI Rilpivirine (TMC-278) developed by University researchers - (09/12/11)
     
  801. FDA Panel: Osteoporosis Drugs Need Better Labels - (09/12/11)
     
  802. Reclast Bone drug (zoledronic acid: once-yearly intravenous infusion) Gets FDA Kidney Failure Warning - (09/09/11)
     
  803. F.D.A. to Review Safety of Popular Bone Drugs - (09/09/11)
     
  804. BMS completes $475m takeover of Amira: "stable of drugs for inflammatory and fibrotic diseases" - (09/09/11)
     
  805. Roche to keep focus on targeted personalized therapies - 'future drug development' - (09/08/11)
     
  806. Past as Prologue: The Refractory and Evolving HIV Epidemic Among Men Who Have Sex With Men - (09/08/11)
     
  807. PSI-938 Pharmasset hepatitis drug may get faster review - (09/08/11)
     
  808. HIV Experts Create the Roadmap for Providing PrEP to Uninfected Individuals to Reduce the Risk of HIV Infection - (09/08/11)
     
  809. Boehringer/Lilly's diabetes drug gets Europe OK - (09/08/11)
     
  810. LabCorp Introduces HCV Resistance Testing Through Monogram Biosciences With The Launch Of HCV GenoSure® NS3/4A - (09/08/11)
     
  811. transformation of ART outcomes in clinical practice for most patients receiving treatment: Dramatic Decline in the HIV-1 RNA Level Over Calendar Time in a Large Urban HIV Practice (Hopkins), Antiretroviral Therapy: Now "It Just Works" - (09/08/11)
     
  812. Blood Pressure Measurements at Emergency Department Visits by Adults: United States, 2007-2008 - (09/08/11)
     
  813. Association of Unconscious Race and Social Class Bias With Vignette-Based Clinical Assessments by Medical Students -full text below and Editorial - (09/08/11)
     
  814. Boehringer/Lilly's diabetes drug gets Europe OK - (09/08/11)
     
  815. Heart-healthy foods lower LDL-C better than low-saturated-fat diet - (09/08/11)
     
  816. Calcium Scans Pick Up Controversy in Cardiology - (09/08/11)
     
  817. Physical Activity and Public Health : Updated Recommendation for Adults From the American College of Sports Medicine and the American Heart Association - (09/08/11)
     
  818. Biomarkers Flunk Alzheimer's Test - (09/08/11)
     
  819. US Deficit panel told: how to save $100B-plus on Rx drugs over 10 years - (09/08/11)
     
  820. Evotec licenses Alzheimer's deal to Roche in $820m deal - (09/08/11)
     
  821. Menopause found to have no effect on women's CVD risk - (09/08/11)
     
  822. Theratechnologies enters new phase of drug testing for tesamorelin - (09/08/11)
     
  823. Treatment as prevention for HIV - Editorial - (09/03/11)
     
  824. Cranberries & Immunity: Research shows health benefits of cranberries Full of antioxidants, can cut bad cholesterol and fight infections - (09/03/11)
     
  825. Ryan White Funds delayed to local health organizations/clinics for HIV care - (09/03/11)
     
  826. Low-dose, long-term radiation exposure: Does the body adapt for protection? - (09/03/11)
     
  827. Vessel (artery) Calcium Points to Brain Disease - (09/03/11)
     
  828. Medivir Subsidiary BioPhausia AB Sells Generics Business - (09/03/11)
     
  829. Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection - Press Release - (09/03/11)
     
  830. Non-Small Cell Lung Cancer Drug Gets FDA Nod - (09/03/11)
     
  831. Triglycerides & Heart Disease-new study: Cream and Sugar Study sheds light on triglyceride interpretation - (09/03/11)
     
  832. Taiwan: 5 Get Organs With H.I.V., Transplant Error - (09/03/11)
     
  833. Why HIV Virus Infection Rates Are on the Rise - (09/03/11)
     
  834. Drug Companies Feeling the Profit Pressures - (09/03/11)
     
  835. Who Owns Federally Funded Research (Roche v Stanford HIV Viral Load Case)? The Supreme Court and the Bayh-Dole Act - Perspective - (09/03/11)
     
  836. Chocolate good for the heart and brain, according to new meta-analysis - (09/03/11)
     
  837. Actos Looked at for Alzheimer's - (08/24/11)
     
  838. Libyan/Bulgaria HIV- Probe into medics' torture Re-opens - (08/24/11)
     
  839. New drug could cure nearly any viral infection - (08/23/11)
     
  840. Health Canada Approves INCIVEK (telaprevir) for People With Hepatitis C - (08/23/11)
     
  841. Not smoking, eating healthy, getting enough exercise, and drinking alcohol moderately -- were 63% less likely to die - (08/23/11)
     
  842. New Anti-Aging Drug: Drug Is Found to Extend Lives of Obese Mice - (08/22/11)
     
  843. Hep C Testing At Baseball Stadiums by Merck Step up to the plate against Hepatitis C - (08/22/11)
     
  844. Four Lifestyle Factors Prevent Cancer, Diabetes, and CVD: never smoking/BMI<30/3.5 hrs exercise weekly/healthy diet Reduced risk by 78% of chronic illness disease - (08/22/11)
     
  845. National HIV Prevention Conference - Highlights of Day 3 - (08/22/11)
     
  846. Two new drugs extend survival for melanoma patients - (08/18/11)
     
  847. FDA approves melanoma drug Zelboraf from Roche - (08/18/11)
     
  848. Switch in Cell's 'Power Plant' Declines with Age, Rejuvenated by Drug: anti-aging blood pressure drug losartan - (08/18/11)
     
  849. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation (phase 3 study results) - (08/18/11)
     
  850. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma - (08/18/11)
     
  851. Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma - (08/18/11)
     
  852. FDA approves Zelboraf and companion diagnostic test for late-stage skin cancer: Second melanoma drug approved this year that improves overall survival - (08/18/11)
     
  853. FDA Approves Zelboraf (Vemurafenib) and Companion Diagnostic for BRAF Mutation-Positive Metastatic Melanoma, a Deadly Form of Skin Cancer - Genentech press release - (08/18/11)
     
  854. FDA Approves Zelboraf (Vemurafenib) and Companion Diagnostic for BRAF Mutation-Positive Metastatic Melanoma, a Deadly Form of Skin Cancer - Genentech press release, Patient Access Programs - (08/18/11)
     
  855. Two new drugs extend survival for melanoma patients - (08/18/11)
     
  856. Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement to Conduct Combination Studies with YERVOY (ipilimumab) and Vemurafenib - (08/18/11)
     
  857. Investigational Compound Ipilimumab Demonstrates Improved Overall Survival in Phase 3 Trial of Previously-Treated Patients with Metastatic Melanoma - (08/18/11)
     
  858. FDA Approves YERVOY (ipilimumab) for the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer - (08/18/11)
     
  859. Gap Seen Between HIV Diagnosis and Care: More than four people in 10 diagnosed with HIV do not remain in care/racial disparities, a CDC analysis suggests - (08/18/11)
     
  860. HCV, Wrestling & Razor Blades - (08/18/11)
     
  861. Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment - (08/17/11)
     
  862. CDC National HIV Prevention Conference - Highlights of Day 2 Aug 14-17, 2011 Atlanta - (08/17/11)
     
  863. Observing National HIV/AIDS and Aging Awareness Day in an Aging Epidemic - (08/17/11)
     
  864. CDC Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS - (08/17/11)
     
  865. National HIV Prevention Conference Aug 14-17 2011 Atlanta - Highlights of Day 1....HHS Hepatitis Action Plan Announced - (08/17/11)
     
  866. US (medicare part D) seniors "don't realise how much specialty drugs will cost them" - (08/17/11)
     
  867. HIV in America: Studies zero in on technology identifying trouble spots - (08/17/11)
     
  868. Experts Concerned About Rising HIV Rates Among Poor, Minorities: CDC Natl HIV Prevention Conference 2011 - (08/17/11)
     
  869. Enzyme Works for Hard-to-Treat Gout - (08/17/11)
     
  870. HIV Co-Infection Common With Syphilis - (08/17/11)
     
  871. Bristol-Myers Squibb Announces the Winners of the 2011 REYATAZ(R) (atazanavir sulfate) "Fight HIV Your Way" Contest - (08/15/11)
     
  872. Gilead's Investigational Antiretroviral Quad (integrase Elvitegravir) Regimen Meets 48-Week Primary Objective in Pivotal Phase 3 Clinical Study 102 - (08/15/11)
     
  873. Drugmakers warn Obama over Medicare price cuts - (08/15/11)
     
  874. Smoking cessation: crucial to target women as well as men - editorial - (08/15/11)
     
  875. HHS Outlines New States' Health Insurance Exchanges/Affordable Health Act, awards $185M in exchange grants - (08/15/11)
     
  876. Increased risk of coronary heart disease among women smokers compared with men - (08/15/11)
     
  877. FDA Approval of Complera: emtricitabine/rilpivirine(TMC278)/tenofovir DF fixed dose combination - (08/11/11)
     
  878. Gilead Sciences Announces Agreement With Tibotec Pharmaceuticals to Develop and Commercialize a New Fixed-Dose Combination of Cobicistat and Prezista(R) FOSTER CITY, Calif., Jun 28, 2011 (BUSINESS WIRE) -- - (08/10/11)
     
  879. U.S. Food and Drug Administration Approves Gilead Sciences' Complera™, a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Naïve Adults - (08/10/11)
     
  880. Stigma Remains a Significant Barrier to Routine HIV Testing by African-American Physicians, Survey Finds - (08/08/11)
     
  881. Pharmasset HCV Update - (08/08/11)
     
  882. HIV Rising Among Young Black MSM, Stable Overall - (08/04/11)
     
  883. Young Meth Users at Higher HIV Risk - (08/04/11)
     
  884. HCV in Pakistan: Around 24,000 people die of HCV - (08/03/11)
     
  885. VICTRELIS™ Approved in Canada: First in new class of drugs to significantly improve clearance of chronic hepatitis C virus from the body - (08/03/11)
     
  886. India emerging as the global Hepatitis capital, (India) organized an awareness programme for students - (08/03/11)
     
  887. Low vitamin-D levels linked to atherosclerosis: 'the study is cross-sectional, we cannot establish yet a causal relationship' - (08/03/11)
     
  888. Midlife CV risk linked to brain atrophy, cognitive decline - (08/03/11)
     
  889. The Stanford HIV Aging Cohort Recruiting - (08/02/11)
     
  890. Merck Bocerevir sales: Don't declare a hep C victor yet - (08/02/11)
     
  891. Egypt takes on hepatitis C virus - (08/02/11)
     
  892. Muscle Mass Knocks Out Insulin Resistance - (08/01/11)
     
  893. More jobs slashed at Merck & Co as sales and profits rise - (08/01/11)
     
  894. Vertex Earnings: Incivek's Boffo Launch - (07/28/11)
     
  895. US prescription drug spending to rise 10.7% in 2014, officials forecast - (07/28/11)
     
  896. Abbott's HIV Combo Test Detects Infections Earlier, Provides Valuable Information to Help Prevent Further HIV Transmission and May Save Treatment Costs - (07/28/11)
     
  897. Incivek storms hep C market with $75M launch - (07/28/11)
     
  898. 10 Million IDUs HCV+ Globally - 6.4 HBV+ - (07/28/11)
     
  899. Viramune® (nevirapine) prolonged-release once-daily formulation for the treatment of HIV-1 infection receives CHMP recommendation for approval - (07/27/11)
     
  900. HBA1c may sharpen cardiovascular-event prediction in diabetics - (07/27/11)
     
  901. Strong quarter for GSK - 'our strategy is delivering' - CEO - (07/27/11)
     
  902. IAS: Raltegravir Remains Effective over Long Term - (07/24/11)
     
  903. IAS: Novel HIV Drug Lersivirine NNRTI Looks Promising - (07/24/11)
     
  904. Merck's ISENTRESS (raltegravir) in Combination Therapy Demonstrated Efficacy in a Phase II Study Extending to Nearly Five Years in Previously Untreated Adults with HIV-1 - (07/24/11)
     
  905. The first official WHO World Hepatitis Day, 28 July 2011: WHO (World Health Organization: About 130-170 million people are chronically infected with hepatitis C virus, and more than 350 000 people die from hepatitis C-related liver diseases each year. 130 million with Hep C and Hep B in SE Asia. - (07/24/11)
     
  906. Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events - (07/23/11)
     
  907. Janssen Therapeutics Announces 2011 Request for Applications: LINCC™(Linking In-Need Communities to Care) - increase access and consistent engagement with the healthcare system for HIV-positive individuals not currently receiving care - (07/23/11)
     
  908. IAS: The Rome Statement for an HIV Cure: Major HIV/AIDS Stakeholders Call for HIV Cure Research to be Accelerated: sign onto this letter - (07/20/11)
     
  909. EU approves Merck's hepatitis C drug Victrelis (boceprevir) - (07/19/11)
     
  910. Walgreens Specialty Pharmacy Drives Adherence for Hepatitis C Patients Through Therapy Management Program - (07/19/11)
     
  911. Abbott Confirms Long-Term Commitment to HIV Care with the Planned Development of New Formulations - Press Release - (07/19/11)
     
  912. Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing - media release - (07/19/11)
     
  913. Chantix Smoking Cessation Treatment Linked to Heart Disease Risk, Questions Whether Pfizer Reported Side Effects to FDA, France Removes Reimbursement - (07/18/11)
     
  914. 78% Prevention HIV-Infection...97% Adherence-Explains Success - (07/14/11)
     
  915. New PrEP Studies Results Report ARTs Can Prevent HIV Sex Transmission in Heterosexuals - (07/14/11)
     
  916. Two Major Studies Prove HIV Pre-Exposure Prophylaxis (PrEP) Works in in Heterosexual Women and Men; Build on iPrEx Data Showing PrEP Reduces HIV Infections in Men Who Have Sex with Men - (07/14/11)
     
  917. J&J Has to Resolve Hepatitis C Drug Conflict, Medivir CEO Says - (07/14/11)
     
  918. Smoke Exposure Linked to Learning Disorders - (07/12/11)
     
  919. NIH funds new research toward an HIV cure - (07/12/11)
     
  920. Gilead Licence Expands Access, But Several Countries Left Out - (07/12/11)
     
  921. Gilead kickstarts patent pool for AIDS drugs - (07/12/11)
     
  922. Hepatitis C Among Young Adults on the rise in northern Wisconsin - (07/08/11)
     
  923. NSAIDs (for example, ibuprofen) Linked to Afib Risk (heart condition) - (07/08/11)
     
  924. Chantix, Quit-Smoking Drug, Safety Concerns, Pfizer defends Chantix as study claims 72% heart risk - (07/07/11)
     
  925. BMS signs $465 million cancer pact with France's Innate - (07/07/11)
     
  926. Association of Prenatal and Postnatal Exposure to Lopinavir-Ritonavir and Adrenal Dysfunction Among Uninfected Infants of HIV-Infected Mothers - full text pdf attached - (07/07/11)
     
  927. CV risk with smoking cessation drug varenicline: New meta-analysis - (07/07/11)
     
  928. CNN: 30 years of HIV & AIDS Established & Changing - (07/05/11)
     
  929. Vivus submits ED drug avanafil in the USA - (07/05/11)
     
  930. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial - (06/29/11)
     
  931. Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infectedpatients switching to abacavir or tenofovir - (06/29/11)
     
  932. HCV/HBV in Pakistan 8% - (06/29/11)
     
  933. Tobira Therapeutics Initiates Phase IIb Trial of Cenicriviroc, a Novel CCR5/CCR2 Antagonist for the Treatment of HIV Infection - press release - (06/29/11)
     
  934. Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz(R) (atazanavir sulfate) in sub-Saharan Africa and India - (06/29/11)
     
  935. Vertex Tops Merck in Early Hep C Drug Launch - (06/29/11)
     
  936. Vertex & Merck HCV Ads HCV Disease Focused - (06/28/11)
     
  937. 347 Million Diabetics Counted Worldwide - (06/28/11)
     
  938. TIBOTEC PHARMACEUTICALS ANNOUNCES AGREEMENT WITH GILEAD SCIENCES TO DEVELOP AND COMMERCIALIZE A NEW FIxED-DOSE COMBINATION OF PREZISTA® AND COBICISTAT - (06/28/11)
     
  939. HIV Medicare fraud nets 20-year prison sentence for Miami physician - (06/28/11)
     
  940. FDA EPO Safety Alert- FDA modifies dosing recommendations for Erythropoiesis-Stimulating Agents : Cites increased risk of cardiovascular events when used to treat chronic kidney disease - (06/27/11)
     
  941. Fourth generation HIV Ag/Ab combination assay - pdf attached - (06/27/11)
     
  942. Results of the Expanded HIV Testing Initiative --- 25 Jurisdictions, United States, 2007--2010 - (06/27/11)
     
  943. Supreme Court Strikes Down Ban on Data-Mining - (06/24/11)
     
  944. Georgia waiting list grows for HIV/AIDS drugs - (06/24/11)
     
  945. Breaking the Chain: 'Molecular Cap' Blocks Processes That Lead to Alzheimer's, HIV - 3 articles below - (06/24/11)
     
  946. Group Expands on Possible Cell Phone Cancer Link - (06/23/11)
     
  947. Carcinogenicity of radiofrequency electromagnetic fields - (06/23/11)
     
  948. Benefit Concert to be Held in New York on July 27, the Eve of World Hepatitis Day - (06/22/11)
     
  949. High-dose statin therapy increases the risk of diabetes: Meta-analysis - (06/22/11)
     
  950. Gregg Allman Never Thought Twice About Death Before Liver Transplant, Playing Allman Brothers Hepatitis C Benefit Gig - (06/22/11)
     
  951. FDA Drug Safety Communication: Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease - (06/20/11)
     
  952. Learning Lessons from an HIV Cure: inflammation - (06/20/11)
     
  953. Insulin Resistance Tied to Early Heart Problems - (06/20/11)
     
  954. Ensuring HIV treatment for all in the USA (ADAP Editorial) - (06/20/11)
     
  955. Healthcare Penny Sales Tax: Solution for Jackson Memorial may be found in Tampa - (06/20/11)
     
  956. Olive Oil Use Reduces Heart Disease - (06/16/11)
     
  957. FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer - (06/16/11)
     
  958. Report Finds 16,000 DC Residents Living with HIV/AIDS - (06/16/11)
     
  959. Low-Fat Diet Affects Alzheimer's Biomarker - (06/14/11)
     
  960. New Report Labels Formaldeyhde a Cause of Cancer - (06/14/11)
     
  961. Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment - (06/14/11)
     
  962. Treat Alzheimer Disease Before It Is Symptomatic - (06/14/11)
     
  963. Vitamin D Ups Bisphosphonate Response (from Jules: and calcium levels too perhaps) - (06/13/11)
     
  964. Malawi govt. ends stipends to HIV+ employees; accuses them of buying booze, sex - (06/13/11)
     
  965. AIDS survivors suffer premature aging, Needs/NIH Response - (06/13/11)
     
  966. Gilead under investigation over manufacture of drugs - (06/13/11)
     
  967. GHD (growth hormone) Patients See Rise in Hepatic Lipids With Exercise - (06/13/11)
     
  968. Growing Older With H.I.V. - (06/13/11)
     
  969. Roche, Merck Partner on Cancer Therapy Diagnostics - (06/13/11)
     
  970. Updated HRSA Guide for HIV/AIDS Clinical Care/Comorbidities now Available Online - see excerpted highlights on comorbidities below - (06/13/11)
     
  971. France and Germany pull Takeda's Actos over cancer link - (06/10/11)
     
  972. French regulators suspend pioglitazone citing cancer risk - (06/10/11)
     
  973. Testosterone & Cancer Link - (06/10/11)
     
  974. Nature HCV Supplement - (06/09/11)
     
  975. AIDS at 30: The Real Story by Laurie Garrett and Larry Kramer - (06/06/11)
     
  976. New Prostate Cancer Drugs - (06/06/11)
     
  977. Melanoma Survival Benefit Called 'Astounding' - full text publication below - (06/06/11)
     
  978. Perspective: Test and treat this silent killer - "Hepatitis C is A Disease of the Marginalized" - (06/06/11)
     
  979. Melanoma Combo Improves Overall Survival - full text below - (06/06/11)
     
  980. AIDS Virus May Accelerate Aging, Scientists Say - (06/06/11)
     
  981. Annual HIV Testing for MSM May Not Be Enough - (06/04/11)
     
  982. The Man Who Had HIV and Now Does Not - (06/03/11)
     
  983. AIDS turns 30: big strides, new challenges: Aging at Hawaii Ceter for AIDS, Cecilia Shikuma MD - (06/03/11)
     
  984. Aging with AIDS: More are living longer, living with loss - (06/03/11)
     
  985. HIV/AIDS Pandemic Hits 30-Year Mark With Hope - (06/02/11)
     
  986. 30 Years With HIV/AIDS: '30 Years In, We Are Still Learning From AIDS' - (06/02/11)
     
  987. WHO Says Cell Phones May Cause Cancer - (06/02/11)
     
  988. New polypill data predict a halving of CV events - (06/01/11)
     
  989. NIH pulls plug on AIM-HIGH trial with niacin (niacin+statin) - (06/01/11)
     
  990. Older AIDS survivors face new challenges - (06/01/11)
     
  991. No more Darvon for U.S. market: FDA - Did You Know Darvon Was Pulled off Market by FDA in Nov 2010 Because It Can Cause Heart Problems, In The Video Attached FDA Says Its a Low Risk - (06/01/11)
     
  992. Teva gets FDA OK for generic Combivir - (06/01/11)
     
  993. Exercise and inflammation - (05/26/11)
     
  994. Fighting Inflammation - diet & exercise - (05/26/11)
     
  995. UK HIV Treatment Guidelines 'Thrifty Changes' - (05/26/11)
     
  996. NICE (in Europe) to appraise hep C drugs Victrelis and telaprevir - (05/26/11)
     
  997. Exercise & Inflammation & Cancer........ - (05/26/11)
     
  998. Canadian Man Convicted in 2009 of HIV Sex Transmission to Multiple People in Canada.... - (05/26/11)
     
  999. Promising Phase III data for new Novartis gout drug - (05/26/11)
     
  1000. Cardiovascular risk during androgen deprivation therapy for prostate cancer Editorial- pdf attached - (05/26/11)
     
  1001. Promising Phase III data for new Novartis gout drug - (05/25/11)
     
  1002. FDA Approval of Edurant (rilpivirine) a new NNRTI) for the treatment of HIV in treatment naive patients - (05/23/11)
     
  1003. Global Fund Disbursed Record $3B In 2010, Faces More Than $1B Shortfall For 2011-13, Report Says; "as much as two-thirds of some grants" are lost to corruption" - (05/23/11)
     
  1004. (Global Fund to Fight AIDS) AIDS Funds Frozen for China in Grant Dispute - (05/23/11)
     
  1005. Abbott's PCR-based HCV Test Cleared by FDA - (05/23/11)
     
  1006. More controversial findings for ezetimibe - (05/23/11)
     
  1007. FDA approves Incivek for hepatitis C - (05/23/11)
     
  1008. FDA Approves INCIVEK (telaprevir) for People with Hepatitis C - Vertex press release, Patient Assistance Program Info - (05/23/11)
     
  1009. Telaprevir News Bites - (05/23/11)
     
  1010. Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes - (05/21/11)
     
  1011. Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone - (05/21/11)
     
  1012. Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting - "physicians should pay careful attention to this possible risk." - (05/21/11)
     
  1013. Diabetes and Risk of Parkinson's Disease - (05/21/11)
     
  1014. FDA places more restrictions on GSK's Avandia, Pioglitazone & Bladder Cancer Risk - (05/21/11)
     
  1015. FDA Advisers Punt on Trilipix - (05/21/11)
     
  1016. FDA Approves EDURANT(TM) (rilpivirine) for Use in Treatment-Naive Adults With HIV-1 Friday, May 20, 2011 - (05/21/11)
     
  1017. Medicare trust fund projected to run dry by 2024 - (05/19/11)
     
  1018. Medicare to Run Dry in 2024 - (05/19/11)
     
  1019. Age-Based vs Risk Based HCV Screening - (05/18/11)
     
  1020. 'Early' Treating (HAART) HIV-infected People with Antiretrovirals Protects Partners from Infection - (05/18/11)
     
  1021. John Martin: Gilead's Disease hunter - Gilead Goes After Cancer - (05/18/11)
     
  1022. Merck's Hepatitis C Drug Wins F.D.A. Approval - NY Times - (05/18/11)
     
  1023. FDA clears new Merck drug for hepatitis C - Reuters - (05/18/11)
     
  1024. Merck gets to finish line first with new anti-viral drug for Hepatitis C: "the first step on a long road.'' Nwk Star-Ledger - (05/18/11)
     
  1025. Roche and Merck Establish Strategic Agreements in Fight Against Chronic Hepatitis C - Media Release - (05/18/11)
     
  1026. Merck, Roche to Work Together on Marketing Hepatitis C Treatments in U.S. - (05/18/11)
     
  1027. F.D.A. Approves New Drug for Hepatitis C - Boceprevir HCV Protease Inhibitor - (05/18/11)
     
  1028. Launch of HHS Action Plan to Prevent, Care and Treat Viral Hepatitis - (05/18/11)
     
  1029. Kidney donor at UPMC passes virus (HCV) on - (05/11/11)
     
  1030. UCSD Project To Bring HIV Testing To Homes: door-to-door HIV testing in 10,000 homes with mobile van in San Diego - (05/11/11)
     
  1031. EMA accused of putting pharma profits before patients - access to all trials' data - (05/11/11)
     
  1032. Janssen Identifies Trace Amounts of TBA in 5 Batches of PREZISTA (darunavir) in the EU and Canada - (05/11/11)
     
  1033. Gay Men Diagnosed With Cancer at Higher Rates, Researchers Say - (05/09/11)
     
  1034. HCV/Heroin Epidemic in Youth Nationwide - (05/07/11)
     
  1035. HHS New Hepatitis Action Plan Announced May 12 Wash DC Press Meeting - (05/07/11)
     
  1036. Osteoporosis Drugs Hike Femur Fracture Risk - (05/06/11)
     
  1037. Mostly Clear Path Through States for CDC HIV Testing Guidelines for Routine Testing - (05/06/11)
     
  1038. ViiV Healthcare Expands Positive Action U.S. Southern Initiative to Fight HIV/AIDS in Hard-hit Region - (05/06/11)
     
  1039. Lopinavir HIV drug could prevent cervical cancer - (05/06/11)
     
  1040. Strict Exercise Regimen Beats Back Blood Sugar - pdf attached - (05/06/11)
     
  1041. Surgery Shows Survival Benefit in Early Prostate Cancer - pdf original study attached - (05/06/11)
     
  1042. Protein Inhibitor May Bring a Topical Treatment for HPV: "We have developed a protein inhibitor that blocks HPV protein expression in cell culture, a first step toward a topically-applied treatment for this cancer-causing virus" - (05/04/11)
     
  1043. Non-Hodgkin's lymphoma drug market "will more than double" by 2019 - (05/04/11)
     
  1044. Steven Tyler's "Lucky to be Alive!", he has HCV - (05/04/11)
     
  1045. Lopinavir HIV drug could prevent cervical cancer - (05/04/11)
     
  1046. Salt Study Discounts Link to Hypertension - (05/04/11)
     
  1047. New York State Medicaid Ending HIV ART Carve-Out - (05/04/11)
     
  1048. Fed panel OKs Vertex & Merck drug - (05/02/11)
     
  1049. HHS Reveals New Viral Hepatitis Plan May 12 in Wash DC - (05/02/11)
     
  1050. Kidney Risk Determined Early in Life- Diet/Metabolics - (05/02/11)
     
  1051. A big week for treatment of Hepatitis C Virus: 2 new drugs get FDA panel OK - miraculous breakthrough for patients with HCV..... - (05/02/11)
     
  1052. Fed panel OKs Vertex & Merck drug - (04/30/11)
     
  1053. Congress Briefing: Report by U.S. Department of Health and Human Services,' Action Plan for the Prevention and Treatment of Viral Hepatitis - pdf attached - (04/26/11)
     
  1054. Vertex' HCV Protease Discovery Telaprevir: On the long, hard road to a breakthrough - (04/25/11)
     
  1055. With possible eligibility cuts, funding shortages, Florida's AIDS Drug Assistance Program remains in crisis - (04/25/11)
     
  1056. Merck, Vertex Prep for Hep C Drug Panels - (04/25/11)
     
  1057. Calcium & CVD Risk: Calcium Builds Bones But May Weaken Heart - (04/20/11)
     
  1058. Lipodystrophy drug?, Novel Agent Promising for Rare Metabolic Disorder - (04/20/11)
     
  1059. Trans Fat in Dairy and Beef Not Benign - (04/20/11)
     
  1060. Diet and exercise key for treating high triglycerides: New AHA statement - (04/20/11)
     
  1061. HIV Aging & Brain New research at University of Nebraska: "HIV infection of the nervous system leads to inflammatory responses, changes in brain cells, and damage to neurons. This is the first study to show such neuronal loss during initial stages of HIV infection in a mouse model." - (04/20/11)
     
  1062. APOBECs New HIV Research: U of M scientist gets five-year, $10 million grant to direct innovative HIV research program - (04/19/11)
     
  1063. HIV prevention trial with Truvada halted prematurely for lack of efficacy - (04/19/11)
     
  1064. FDA Advisory Committee meeting to consider boceprevir and telaprevir, April 27 and April 28, 2011 - (04/18/11)
     
  1065. April 28, 2011: Telaprevir Antiviral Drugs Advisory Committee Meeting Announcement - (04/18/11)
     
  1066. April 27, 2011: Boceprevir Antiviral Drugs Advisory Committee Meeting Announcement - (04/18/11)
     
  1067. JUPITER: Best CVD event reduction in patients with very low LDL-cholesterol levels - (04/18/11)
     
  1068. Bureau of HIV/AIDS chief confirms possible AIDS Drug Assistance Program eligibility reduction - pdf attached - (04/13/11)
     
  1069. HIV risk higher for teens who had syphilis, gonorrhea - (04/09/11)
     
  1070. NAACP Tackles African American HIV/AIDS Crisis - (04/09/11)
     
  1071. Food Addiction Acts in Brain as Drug Addiction Does - (04/07/11)
     
  1072. Ruling says landlords must let AIDS patient keep his dog - (04/07/11)
     
  1073. FDA approves one-pill, once-daily Viramune® XR™ (nevirapine) extended-release tablets for use in combination with other antiretroviral agents for treatment of HIV-1 infection in adults - (04/07/11)
     
  1074. U.S. FDA approves once-daily Viramune® XR tablet for use in combination with other antiretroviral agents for treatment of HIV-1 infection in adults - (04/04/11)
     
  1075. Nevirapine/Aptivus Expanded Access/Cost Program - (04/04/11)
     
  1076. EASL: Boehringer Ingelheim's Lead Hepatitis C Compound Moves into Phase 3 - the First Within the BI HCV Portfolio - (04/04/11)
     
  1077. EASL: Merck, J&J's New Hepatitis C Treatments Fetch $31,000 in France - (04/04/11)
     
  1078. Preventative drugs could slash breast cancer risk, experts say - (03/30/11)
     
  1079. GSK pledges to cut carbon footprint, charity donations rise - (03/30/11)
     
  1080. Texas Deprioritizing ADAP, Texas Committee Votes to Reduce Health Cuts - (03/28/11)
     
  1081. Capsaicin Patch Eases HIV Neuropathy Pain - (03/28/11)
     
  1082. US meeting on HIV drug gives Avexa shares a boost - (03/28/11)
     
  1083. Fertility treatment can use semen from men with HIV - (03/28/11)
     
  1084. Phase III Clinical Trial of Gilead's Investigational Elvitegravir Meets 48-Week Primary Objective - (03/24/11)
     
  1085. Low Perceived Risk and High HIV Prevalence Among a Predominantly African American Population Participating in Philadelphia's Rapid HIV Testing Program - (03/24/11)
     
  1086. OraSure Technologies applies for FDA approval to expand use of rapid Hepatitis C test - (03/24/11)
     
  1087. Phase III Clinical Trial of Gilead's Investigational Elvitegravir Meets 48-Week Primary Objective - (03/23/11)
     
  1088. OraSure Technologies Submits CLIA Waiver Application for OraQuick(R) HCV Rapid Test - (03/23/11)
     
  1089. Low radioactivity seen heading towards N.America - (03/21/11)
     
  1090. Kidney Transplant Leads to HIV Infection - (03/21/11)
     
  1091. Growing Challenges in HIV Care, IOM Warns - (03/21/11)
     
  1092. Bristol-Myers Squibb Awards Grant to the American College of Physicians Foundation to Address U.S. HIV Medical Workforce Shortage - (03/18/11)
     
  1093. Norvir Access Updates: Co-Pay card, PAP, Welvista - see attached pdf - (03/17/11)
     
  1094. Pharmasset Hep C Data Wows Investors (EASL March/April 2011) - (03/16/11)
     
  1095. New Data on Telaprevir and VX-222 for the Treatment of Hepatitis C Accepted For Presentation at EASL Annual Meeting - (03/16/11)
     
  1096. Roche acquires PVT to strengthen diagnostics unit - (03/16/11)
     
  1097. Japan Reactor Crisis Triggers Run on Iodide Pills in L.A. - (03/16/11)
     
  1098. FDA Panel To Review Merck, Vertex Hepatitis Drugs In Late April - (03/15/11)
     
  1099. Pfizer to chop off 40% of its business? - (03/15/11)
     
  1100. Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial - pdf attached - (03/10/11)
     
  1101. Kaletra (lopinavir/ritonavir): Label Change - Serious Health Problems in Premature Babies - (03/10/11)
     
  1102. Pharmacists Fight the Rise of [mandatory prescription] Mail Order - (03/10/11)
     
  1103. Biomarkers the way forward for pharma, in HIV - (03/10/11)
     
  1104. Pharmasset to Challenge Vertex Hepatitis C Treatment, BMO Says - (03/10/11)
     
  1105. Safety Review update of Abacavir: no statistically significant association seen between myocardial infarction and ABC - (03/05/11)
     
  1106. Kaletra (lopinavir/ritonavir) Oral Solution label changes related to toxicity in preterm neonates - (02/28/11)
     
  1107. Novartis asked to end challenge to Indian patent law - (02/28/11)
     
  1108. Indian govt to probe pharma MNC takeovers - (02/24/11)
     
  1109. Cell Phones Affect Brain Activity - (02/24/11)
     
  1110. Bethlehem-based OraSure gets FDA approval for hepatitis C test - (02/24/11)
     
  1111. BMS Foundation allots $1 mn to eradicate hepatitis in China, India - (02/23/11)
     
  1112. Merck victorious in first state trial of Fosamax 'jaw death' link - (02/15/11)
     
  1113. Drug approval rates worse than first thought - BIO report - (02/15/11)
     
  1114. We found that the use of cannabis and other illicit substances was associated with an earlier age at onset of psychotic disorders - (02/14/11)
     
  1115. Wash D.C. Mayor Gray names gay physician head of D.C. AIDS office - (02/14/11)
     
  1116. GSK profits slump on legal costs and Avandia slowdown - (02/14/11)
     
  1117. ViiV Healthcare's Positive Action and the International HIV/AIDS Alliance Tackle HIV Stigma in Six Central American Countries - (02/14/11)
     
  1118. Idenix drops after FDA loosens one hold but slaps on another - (02/13/11)
     
  1119. The Impact of the AIDS Drug Assistance Program (ADAP) on Use of Highly Active Antiretroviral and Antihypertensive Therapy Among HIV-Infected Women: ADAP enrollment increased the likelihood of using HAART..... pdf attached - (02/13/11)
     
  1120. Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada and TMC278 - (02/12/11)
     
  1121. HIV Gene Therapy Data Reported This Month - (02/12/11)
     
  1122. Clinical Hold on GSK761 NNRTI - (02/12/11)
     
  1123. The FDA places GSK2248761 ('761', formerly IDX899) a NNRTI on clinical hold - (02/11/11)
     
  1124. SF Mayor's Hep C Task Force Recommends Supervised Injection Facilities (Press Release) - (02/11/11)
     
  1125. Training AIDS Patients for Careers - (02/11/11)
     
  1126. GSK761 NNRTI & Idenix HCV Drug On Hold FDA - (02/11/11)
     
  1127. HIV Black Awareness Day: health disparities in HIV, and HCV - (02/10/11)
     
  1128. ADAP Cuts Kill People: Florida/throughout USA....Budget squeeze could make HIV treatment costlier, rarer....Illinois among financially challenged states facing cutbacks - (02/10/11)
     
  1129. CRP Testing+Statin Therapy Cost Effective To Prevent Heart Disease/death - (02/10/11)
     
  1130. Canadian study affirms cancer risk from heart imaging - (02/10/11)
     
  1131. Use of cannabis and other illicit substances was associated with an earlier age at onset of psychotic disorders - (02/09/11)
     
  1132. An H.I.V. Strategy Invites Addicts In - (02/09/11)
     
  1133. Racial Disparities in Cancer Mortality Still Remain - (02/08/11)
     
  1134. SF task force backs legal intravenous drug center - (02/08/11)
     
  1135. IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology - pdf attached - (02/06/11)
     
  1136. Disparities Seen in RA (rheumatoid arthritis) Drug Therapy - (02/06/11)
     
  1137. Pay for performance Medical Care fails to boost UK hypertension care/outcomes - (02/06/11)
     
  1138. Pfizer Moves May Dim Prospect for New Antibiotics...... - (02/06/11)
     
  1139. 2011 Emergency ADAP Summit Attendees Send Letter to President Obama Seeking Fix to Ongoing ADAP Crisis; Uncertainty Fuels Growing Frustration among HIV/AIDS Activists - (02/06/11)
     
  1140. HCV drug Telaprevir......anticipate accelerated approval by May 23rd.....A target review date of May 23, 2011 - (02/06/11)
     
  1141. US pharma: "299 heart disease/stroke drugs now in R&D" - (02/06/11)
     
  1142. CDC Study HCV Testing in >50 years Old Baby Boomers in Doctor's Offices - (02/06/11)
     
  1143. Pfizer profits soar, UK Sandwich site to be shuttered - (02/06/11)
     
  1144. Florida sidesteps AIDS drug crisis - for now 6,500 would have lost access to medications - (02/06/11)
     
  1145. Peregrine's Monoclonal Antibody completes patient enrolment in phase I b HCV/HIV co-infection trial - (02/06/11)
     
  1146. Monogamy & HIV - Lovers Can't Agree on Whether They Agreed to Embrace Monogamy - (02/06/11)
     
  1147. Uganda: Government Rejects Experts Call for Early HIV Treatment - (02/06/11)
     
  1148. Tibotec Signs Multiple Agreements With Generic Manufacturers to Provide Access to New HIV Treatment (TMC278) - (01/27/11)
     
  1149. San Francisco Hepatitis C Task Force Releases Recommendations for Fighting Epidemic - (01/25/11)
     
  1150. Fraud Plagues Global Health Fund (AP) - (01/25/11)
     
  1151. Genentech (Roche) Dear Healthcare Provider (Alcohol Swab Recall-Pegasys/Fuzeon): (pdf letter attached) - (01/25/11)
     
  1152. Gilead Says FDA Won't Accept Filing for AIDS Pill - (01/25/11)
     
  1153. Officials: Florida 'very close' to a solution to HIV/AIDS medication funding crisis - (01/24/11)
     
  1154. Pharma growth expected to slow - (01/24/11)
     
  1155. Egrifta (Tesamorelin) is Available - (01/24/11)
     
  1156. Glaxo Ends Resveratrol Drug Study - (01/24/11)
     
  1157. Commentary: Curing HIV? - (01/24/11)
     
  1158. Stroke Risk May Be Higher in HIV Patients: AIDS drugs may boost susceptibility, study suggests - (01/20/11)
     
  1159. New hope for hepatitis C, an often hidden disease - (01/19/11)
     
  1160. ADAPs with Waiting Lists (5,387 individuals in 10 states*, as of January 13, 2011) (NASTAD) - (01/19/11)
     
  1161. US cancer care costs could rise 66% by 2020, says study - (01/19/11)
     
  1162. Exercise Improves Brain Function - (01/19/11)
     
  1163. Cancer Care Costs in the United States: Projections 2010-2020 - pdf attached - (01/19/11)
     
  1164. Genentech Informs Customers of Important Information About Triad Group's Alcohol Prep Pads (Recall of Alcohol Swabs used with Fuzeon & Pegasys) - (01/16/11)
     
  1165. Cardiovascular Risk & NSAID Use - full study text below with pdf - (01/16/11)
     
  1166. Quick Reference Card for Insomnia Screening and Treatment in HIV-Infected Patients (NYS DOH AIDS Institute 1/11/11) - pdf of document attached - (01/16/11)
     
  1167. LGBT groups react to N.C. Rep. Larry Brown'scomments about HIV/AIDS (ADAP) funding - (01/14/11)
     
  1168. Merck & Co stock battered on vorapaxar study problems - (01/14/11)
     
  1169. Common painkillers (NSAIDS) raise CV risk, study finds - (01/14/11)
     
  1170. Exercise/Walking Reduces Fat/Diabetes Risk - (01/14/11)
     
  1171. N.C. State Rep Brown criticized for remarks about HIV "perverted lifestyles" - (01/13/11)
     
  1172. Too much TV ups risk of death, cardiovascular events - (01/13/11)
     
  1173. Peregrine Initiates Randomized Phase II Trial of Bavituximab in Chronic Hepatitis C - (01/13/11)
     
  1174. Inhibitex Reports Positive Interim Safety and Antiviral Data from Ongoing Phase 1b Study of HCV Nucleotide Inhibitor INX-189 - (01/13/11)
     
  1175. Gilead Sciences Extends Phase 3 Elvitegravir Clinical Trial - (01/13/11)
     
  1176. FDA Still Uncertain About Lantus Cancer Risk - (01/13/11)
     
  1177. FDA risk evaluation plan 'REMS' benefits "impossible to measure" - (01/13/11)
     
  1178. Sitting Too Much, TV-Time May Increase CVD & Death Risk - (01/13/11)
     
  1179. Sitting Time and Mortality from All Causes, Cardiovascular Disease, and Cancer - pdf attached - (01/13/11)
     
  1180. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Jan 10, 2011 - full guidelines pdf attached - (01/13/11)
     
  1181. Aging with HIV: As HIV population grows older, diseases of aging are a new dilemma New Aging Study/Clinic at SFGH - (01/08/11)
     
  1182. Vertex Announces Key Business Objectives To Support Planned Launch of Telaprevir in Hepatitis C - Preparing for Launch of Telaprevir - (01/10/11)
     
  1183. Harm reduction/Methadone/HAART in Russia/Ukraine, Asia too - (01/10/11)
     
  1184. Pioglitazone slows CAD progression by improving HDL, triglycerides in analysis, fluid retention, bone fracture, heart failure risks - (01/10/11)
     
  1185. Will autism fraud report be a vaccine booster? - (01/08/11)
     
  1186. Brian Deer: Piltdown medicine: The missing link between MMR and autism (BMJ) - (01/08/11)
     
  1187. Report Linking Vaccine to Autism 'Fraudulent,' Says British Medical Journal - (01/08/11)
     
  1188. Wakefield's article linking MMR vaccine and autism was fraudulent - Editorial - (01/08/11)
     
  1189. Merck Beats Vertex to FDA Hep C Filing - (01/08/11)
     
  1190. US health spending growth at historic low but Rx spend up - (01/08/11)
     
  1191. HbA1c Testing Can Find Prediabetes - (01/08/11)
     
  1192. Identification of Those at Risk for Diabetes Mellitus (HbA1c): (Commentary) - (01/08/11)
     
  1193. How the (autism) case against the MMR vaccine was fixed - pdf attached - (01/08/11)
     
  1194. Identifying Adults at High Risk for Diabetes and Cardiovascular Disease Using Hemoglobin A1c: (pdf attached) - (01/08/11)
     
  1195. Certain Genetic Factors Related To Side Effects May Indicate Risk Of Early Antiretroviral Therapy Discontinuation - (01/07/11)
     
  1196. Drugmakers "aggressively changing the way they do R&D" - (01/06/11)
     
  1197. Exposure to Room Light before Bedtime Suppresses Melatonin Onset and Shortens Melatonin Duration in Humans - pdf attached - (01/04/11)
     
  1198. ViiV Healthcare Launches New Patient Assistance Program and Participation in Welvista Program for ADAP Waitlist Patients - (01/04/11)
     
  1199. J&J Blood test for cancer gets US boost - (01/04/11)
     
  1200. FDA: Don't Eat Certain Lots of Tiny Greens Brand Alfalfa Sprouts or Spicy Sprouts Sprouts may contain Salmonella - (01/04/11)
     
  1201. Profectus BioSciences Announces Initiation of Clinical Trial of IL-12 Enhanced Therapeutic HIV DNA Vaccine Delivered Using Electroporation - (01/04/11)
     
  1202. NY City's Graphic HIV Prevention Ad on the Dangers of H.I.V. Is Dividing Activists - (01/04/11)
     
  1203. Radio Ablation Safe, Effective in Liver Cancer Patients - (01/03/11)
     
  1204. Melatonin - (01/03/11)
     
  1205. FDA Approves New Dosage Strength 200mg Tablet for INTELENCE - (01/03/11)
     
  1206. Treatment for Metabolic Abnormalities associated with Lipodystrophy - (12/30/10)
     
  1207. Diabetes care raises alarm: Deadly hepatitis outbreak at an assisted-living home throws harsh light on training, state's rules. - (12/30/10)
     
  1208. 'Magnet' couples (serodiscordant) forge relationships despite challenges - (12/30/10)
     
  1209. Difference Is the Norm on These (HIV) Dating Sites - (12/30/10)
     
  1210. Better HIV screening worthwhile in U.S., study finds: 'one-time screening of all adults would prevent 81,000 HIV-infections' - (12/30/10)
     
  1211. Sotomayor Guides Court's Liberal Wing on HIV Case - pdf of her decision attached - (12/30/10)
     
  1212. Annual HIV Screening Every Adult Prevents Up to 24% of New Infections: The Cost-Effectiveness and Population Outcomes of Expanded HIV Screening and Antiretroviral Treatment in the United States - published pdf attached - (12/30/10)
     
  1213. Under-25s 'should have routine HIV tests' - (12/23/10)
     
  1214. FDA Purges Press Office Of Older Employees - (12/23/10)
     
  1215. New Drug Strategy VIR-576, HIV Entry Inhibitor Against gp41 Fusion) Shows Promise Against HIV - (12/23/10)
     
  1216. Gardasil HPV Vaccine Approved by the FDA for Anal Cancer Prevention - (12/23/10)
     
  1217. Farrah Fawcett Died From Anal Cancer - (12/23/10)
     
  1218. New Intelence (etravirine) dosage approved - (12/23/10)
     
  1219. US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL - (12/23/10)
     
  1220. Discovery suggests new way to prevent HIV from infecting human cells (Vif & APOBEC3F) - (12/23/10)
     
  1221. VIR-576 (Active substance against HIV infection), New HIV Entry Inhibitor Against gp41 Fusion Peptide - VIRO Pharmaceuticals GmbH & Co. KG - (12/23/10)
     
  1222. Gardasil FDA Briefing Document - (12/23/10)
     
  1223. Bristol-Myers Squibb and Oncolys BioPharma Enter Global Licensing Agreement for Investigational HIV Compound (Festinavir, OBP-601, NRTI) - (12/22/10)
     
  1224. No link between vitamin-D levels and cardiovascular mortality in sunny California- - 3 articles questioning benefit of vitamin D for chronic diseases - (12/22/10)
     
  1225. B-MS gets licence to HIV drug in $286 million deal - (12/22/10)
     
  1226. Telaprevir EMA Approval Request Submitted in Europe - (12/22/10)
     
  1227. Vertex Provides Update to Ongoing Phase 2 Study Evaluating Combinations of Telaprevir and VX-222 for the Treatment of Hepatitis C - (12/22/10)
     
  1228. Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2 - pdf attached - (12/22/10)
     
  1229. Drug Susceptibility Profile of OBP-601, a novel NRTI, Using a Comprehensive Panel of NRTI and/or NNRTI Resistant Viruses - (12/22/10)
     
  1230. Yale Licenses Potential Anti-HIV Agent (Festinavir) to Oncolys BioPharma of Japan - (12/22/10)
     
  1231. Aging HIV, Diabetes and Kidney Disease - (12/22/10)
     
  1232. Higher HDL-C levels may curb Alzheimer's disease risk - (12/22/10)
     
  1233. Prospects for Minocycline Neuroprotection - pdf attached - (12/22/10)
     
  1234. Cancer: Full immunity needed to fight cancer -see attached published article in Cancer Cell - (12/19/10)
     
  1235. ADAP Crunch in Virginia: HIV/AIDS patients scrambling to cover cost of medications - (12/19/10)
     
  1236. Thousands on HIV drugs desperate amid budget woes - (12/19/10)
     
  1237. A Powerful and Perplexing New HIV Prevention Tool - PrEP Iprex Study Commentary by Jon Cohen Science Mag - (12/19/10)
     
  1238. Stem Cells Transplant HIV Cure in Berlin Patient - (12/19/10)
     
  1239. NYC HIV Prevention Ad Controversy: "It's Never Just HIV," part of the city's campaign against a growing sense of indifference toward what it's like to live with HIV. - (12/16/10)
     
  1240. New Grant Request: Global Agenda for elimination of Mother-to-Child transmission of HIV: Positive Action for Children Fund calls for proposals to fill the gaps - (12/16/10)
     
  1241. University of Michigan study on teenagers finds marijuana use on the rise, alcohol use on the decline - (12/16/10)
     
  1242. Acute hepatitis C in HIV-infected individuals - recommendations from the NEAT consensus conference ('screen every 6 months after initial screening') - publication pdf attached - (12/16/10)
     
  1243. Once Daily Darunavir FDA Approved For patients With No Darunavir Resistance Mutations - (12/15/10)
     
  1244. Marijuana Component Eases Diabetic Heart Woes - pdf publication attached - (12/13/10)
     
  1245. U.S. Life Expectancy Drops Slightly: Deaths from stroke, infant mortality decline, federal report finds; increased deaths in 6 diseases, most prominently alzheimer's - (12/13/10)
     
  1246. Stroke Down, Alzheimer's Up in 2008 Death Stats - (12/13/10)
     
  1247. Recent Trends in Microbicide Formulations - (12/13/10)
     
  1248. Abbott's New HCV Study: ABT450+ABT072+Ribavirin - (12/13/10)
     
  1249. Roche provides update on leading late-stage pharmaceutical pipeline (see HCV polymerase R7128 below) - (12/13/10)
     
  1250. Evidence for the cure of HIV infection by CCR5{Delta}32/{Delta}32 stem cell transplantation - publication pdf attached - (12/13/10)
     
  1251. The Berlin Patient" : Der Mann, der HIV besiegte man who defeated The HIV - (12/13/10)
     
  1252. Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation Brief Report - publication pdf attached - (12/13/10)
     
  1253. Atypical Femoral Fractures and Bisphosphonate Use - (12/09/10)
     
  1254. China: drug price cuts averaging 19% this week - (12/09/10)
     
  1255. Prevalence of Sexual Activity and Associated Factors in Men Aged 75 to 95 Years A Cohort Study - (12/09/10)
     
  1256. Sex Still Important to Older Men - (12/09/10)
     
  1257. FDA Hepatitis Update - FDA seeking new members with Hep Cexperience for its Antiviral Drugs Advisory Committee - (12/08/10)
     
  1258. FDA approves 60-second HIV test - (12/05/10)
     
  1259. IOM Says No Need to Megadose Vitamin D - IOM Brief Report below with pdf attached - (12/02/10)
     
  1260. Tests for H.I.V. Reach a Record - (12/02/10)
     
  1261. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men - pdf attached - (12/02/10)
     
  1262. New Diet Study Examines Low Glycemic Index and High vs Low Protein - (12/02/10)
     
  1263. Institute of Medicine urges ramp-up of AIDS prevention in Africa - November 29, 2010 - (12/02/10)
     
  1264. Gynecologic Care for Women With Human Immunodeficiency Virus - pdf attached - (12/01/10)
     
  1265. Bristol-Myers Squibb and Alvin Ailey American Dance Theater Announce First-of-Its-Kind Collaboration to Express the Stories of People Impacted by HIV/AIDS Through Dance - (12/01/10)
     
  1266. NEW: 2010 Linda Laubenstein Award - (12/01/10)
     
  1267. BMS ADAP Welvista Collaboration - (12/01/10)
     
  1268. Tibotec Therapeutics Announces Recipients of LINCC Funding Initiative - (12/01/10)
     
  1269. Gilead: Preventing HIV Infection With a Pill; CDC Truvada Prevention Guidelines Forthcoming - (11/30/10)
     
  1270. Idenix rises after HIV drug milestone payment - (11/30/10)
     
  1271. Gilead Sciences Submits New Drug Application to U.S. FDA for Once-Daily Single-Tablet Regimen of Truvada and TMC278 for HIV - (11/30/10)
     
  1272. Vertex Seeks FDA Green Light for Hepatitis C Drug; Chomps at the Bit For Fast Review - "Six-Month Priority Review Requested " - (11/29/10)
     
  1273. Vertex seeks fast approval for drug Hepatitis therapy, 15 years in the making, has a rival - (11/29/10)
     
  1274. Ob/Gyn Guidelines Set for HIV-Positive Women - (11/29/10)
     
  1275. New Focus on Care for HIV+ Women as More Live Longer with the Disease - (11/29/10)
     
  1276. The Economic Burden of Late Entry Into Medical Care for Patients With HIV Infection - pdf attached - (11/22/10)
     
  1277. HIV Late Presenters Cost Much More & Die Earlier - (11/22/10)
     
  1278. Lipid Combo simvastatin/ezetimibe (Vytorin) Cuts CVD Risk in Kidney Disease - (11/22/10)
     
  1279. New Anti-Inflammatory Drug Improves Kidney Function in Diabetics - (11/22/10)
     
  1280. Therapeutic HIV Vaccine Promising in Early Study - (11/21/10)
     
  1281. HRSA Awards $1.6 Million to Improve Availability and Expansion of Hepatitis C (HCV) Treatment - (11/21/10)
     
  1282. 'Unprecedented': Cholesterol drug called dramatic success - (11/21/10)
     
  1283. Philadelphia clergy increase AIDS awareness and Host HIV Testing - (11/18/10)
     
  1284. Vitamin D Levels Tied to Fatal Stroke in Whites, But Not Blacks - (11/18/10)
     
  1285. Pioglitazone Diabetes Drug Promising in Model of Kidney Disease - (11/18/10)
     
  1286. Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease - pdf attached full publication - (11/18/10)
     
  1287. Study explains why HIV so tough to beat, gp41 HIV Antibodies/Vaccine Research - published article in Nature journal below - (11/18/10)
     
  1288. HIV Epidemic in Blacks in USA: Local Philadelphia black clergy unite to fight HIV/AIDS - (11/15/10)
     
  1289. FDA Approves Tesamorelin - (11/15/10)
     
  1290. Sodas Boost Gout Risk in Women - (11/15/10)
     
  1291. Lowering Uric Acid Cuts Cardiac Death Rate - (11/15/10)
     
  1292. Cardiovascular Pipeline Merely a Drip - (11/15/10)
     
  1293. A Tale of Vioxx, Opioids, and Falls (Vioxx missed by patients) - (11/15/10)
     
  1294. FDA Approves EGRIFTATM (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy - (11/15/10)
     
  1295. INTERIM ANALYSIS OF PHASE II TRIAL OF TAT VACCINE IN HIV-INFECTED PATIENTS - pdf of published study attached - (11/15/10)
     
  1296. Researchers/Bruce Walker identify protein fragment that allows HIV patients to control disease without medication - (11/10/10)
     
  1297. HIV immunity (Proteins Discovered) is all in the amino acids - (11/10/10)
     
  1298. The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation - pdf of published article attached - (11/10/10)
     
  1299. virco®TYPE HIV-1 resistance test achieves CE-Marking approval - (11/10/10)
     
  1300. White House Meeting on HIV/Aging - (11/01/10)
     
  1301. FDA and CONRAD Chart U.S. Regulatory Path for 1% Tenofovir Gel for HIV Prevention: FDA has granted Fast Track approval designation for 1% tenofovir gel - (11/01/10)
     
  1302. Telaprevir Update: VX222+telaprevir, coinfection study, FDA filing - (10/28/10)
     
  1303. Aging & Bone Disease in HIV - (10/28/10)
     
  1304. New CEO for Idenix - (10/28/10)
     
  1305. AIDS, HIV still a big problem in Phila., witnesses at City Council hearing say - (10/28/10)
     
  1306. Aspirin May Improve Prostate CA Outcomes - (10/28/10)
     
  1307. Diabetes Incidence Expected to Rise - (10/27/10)
     
  1308. Kadmon Pharmaceuticals Acquires Three Rivers Pharmaceuticals - (10/27/10)
     
  1309. Roche Receives FDA Approval for a Second-Generation Hepatitis C Viral Load Test - (10/27/10)
     
  1310. US cancer care plan "splits doctors' income from drug sales" - (10/27/10)
     
  1311. Press Release Global HIV/AIDS Testing Market to Exceed US$3.5 Billion by 2015, According to a New Report by Global Industry Analysts, Inc. - (10/27/10)
     
  1312. Former ImClone Chief Acquires Drug Company Three Rivers Pharma - (10/27/10)
     
  1313. ImClone Ex-CEO Waksal Is Back (3 Rivers Acquisition) - (10/27/10)
     
  1314. Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor - Phase III Treatment-naive and Treatment-experienced Trials Underway for S/GSK1349572 ('572) - (10/22/10)
     
  1315. Cytheris Announces Initiation of ORVACS-Sponsored Phase II Clinical Study to Attack Viral Reservoir of HIV Patients - (10/22/10)
     
  1316. Low-Dose Aspirin Cuts Colon Cancer Risk - (10/22/10)
     
  1317. HIV Transmitted by Blood Donor, CDC Reports - (10/22/10)
     
  1318. FDA Drug Safety Communication: Invirase (saquinavir) labels now contain updated risk information on abnormal heart rhythms - (10/22/10)
     
  1319. Early Bone Loss Marker Predicts Fracture Risk Later - (10/21/10)
     
  1320. Vitamin D Has Retinopathy Link - (10/21/10)
     
  1321. Vitamin D Levels Linked to Mortality - (10/21/10)
     
  1322. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C - (10/21/10)
     
  1323. Novartis' osteoporosis once-yearly bone drug Reclast long-term trial results - (10/18/10)
     
  1324. Bone Drug Improves Results of Jaw Surgery - (10/18/10)
     
  1325. Low Vitamin D Increases Risk of Pediatric MS - (10/18/10)
     
  1326. Army finds simple blood test to identify mild brain trauma - (10/18/10)
     
  1327. FibroGen Reports Combinations of FG-3019 plus ACEi and FG-3019 Plus ARB Prevented and Reversed Arterial Stiffness Significantly Better than ACEi or ARB Alone in Preclinical Models of Diabetes - (10/18/10)
     
  1328. New Kidney Disease Therapy Research (anti-fibrotic therapy) - (10/18/10)
     
  1329. FibroGen starts liver fibrosis study - (10/18/10)
     
  1330. U.S. Food and Drug Administration Approves BARACLUDE (entecavir) as a Treatment for Chronic Hepatitis B Patients with Evidence of Decompensated Liver Disease - (10/18/10)
     
  1331. Bone-Building Drug denosumab Targets Periphery hip, new imaging study identifies sub-regions of bone change with therapy - (10/18/10)
     
  1332. Kids Gain Bone Mass, Size from Exercise - (10/18/10)
     
  1333. Bisphosphonates (Osteoporosis Drugs): Label Change - Atypical Fractures Update - (10/17/10)
     
  1334. Non-stick Coating of a Protein Found in Semen Reduces HIV Infection of Immune Cells - pdf of published study attached - (10/17/10)
     
  1335. Walking Correlates With Brain Volume, Cognitive Ability - published pdf attached - (10/17/10)
     
  1336. National Latino AIDS Awareness Day Friday Oct 15: New York City Council members and Community Leaders call for increased HIV testing and prevention efforts in response to the impact of HIV/AIDS epidemic - (10/17/10)
     
  1337. ViiV Healthcare Expands Patient Assistance Program, Continues its Patient Savings Card Program, and Joins Welvista Program - (10/17/10)
     
  1338. Anadys Raises $25M for ANA598 Phase 2b in 1st Qtr 2011 - (10/17/10)
     
  1339. U.S. Hispanics Have 1 in 52 Estimated Lifetime Risk of HIV, 3-5 Times Risk vs Whites - (10/17/10)
     
  1340. EU Hepatitis Summit Oct 14-15 2010: Experts Rally To Get European Commitment To Halting The Hepatitis B And C Epidemic - (10/17/10)
     
  1341. Vitamin D levels lower in African-Americans - (10/17/10)
     
  1342. ViiV Healthcare Expands Patient Assistance Program, Continues its Patient Savings Card Program, and Joins Welvista Program - (10/14/10)
     
  1343. BMS Licenses Anti-Inflammatories - (10/08/10)
     
  1344. Delayed-Release Form of Risedronate Approved - (10/08/10)
     
  1345. Panel Calls for Biomarkers in Routine Clinical AD Diagnosis - (10/08/10)
     
  1346. New Neuro Drug: Researchers Target HIV-Related Brain Difficulties - (10/08/10)
     
  1347. InterMune Sells Danoprevir Rights to Roche for $175 Million - (10/07/10)
     
  1348. Achillion's HCV Pipeline Progresses - (10/06/10)
     
  1349. Sex in the U.S.: Survey Finds 'Enormous Diversity' - (10/06/10)
     
  1350. Drug Firms Face Overseas Bribery Probe - (10/06/10)
     
  1351. HbA1c Not a Sure-Fire Tool for Diabetes Dx - (10/04/10)
     
  1352. FDA warns Gilead on manufacturing plant - (09/30/10)
     
  1353. HIV-1 patients with an undetectable viral load can switch to VIRAMUNE regardless of their CD4 count - (09/30/10)
     
  1354. Study Finds More Health Benefits From Starting HIV Treatment Very Early, within 6 months of infection - (09/27/10)
     
  1355. Exercise May Lower Risk of Falls and Fractures - (09/27/10)
     
  1356. Pfizer & HCV RNAi - (09/27/10)
     
  1357. Trimeris settles patent dispute over Fuzeon - (09/27/10)
     
  1358. Millions of Americans Are Living with Hidden Epidemics of Hepatitis B and C, Top Experts Warn - New Recommendations Issued by AASLD - (09/27/10)
     
  1359. EU regulators start safety review of bisphosphonates - (09/27/10)
     
  1360. Peginterferon/ribavirin Uses Expanded in UK: NICE's publishes 200th guidance to better tackle Hepatitis C - (09/24/10)
     
  1361. FDA significantly restricts access to the diabetes drug Avandia - (09/24/10)
     
  1362. EU Recommends Pulling Rosiglitazone GSK's Type 2 Diabetes Drug from the Market - (09/24/10)
     
  1363. Abbott gets rights to Reata kidney drug for $450 million - (09/24/10)
     
  1364. Intensive Therapy in Early Diabetes - (09/24/10)
     
  1365. HIV Prevalence Remains High Among Gay Men - CDC pdf below - (09/24/10)
     
  1366. Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test - (09/24/10)
     
  1367. Raltegravir Could Be Effective Against Herpes - full published text below - (09/24/10)
     
  1368. Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine - (09/23/10)
     
  1369. Cost of dementia to top $600 billion this year - PhRMA firms' "record 313 mental illness drugs now in R&D" - (09/23/10)
     
  1370. Cytheris Initiates INSPIRE 3, a Phase II Clinical Trial of Recombinant Human Interleukin-7 (CYT107) in Chronically Infected HIV Patients - (09/23/10)
     
  1371. Merck Significantly Expands its Patient Assistance Program Offerings to Provide Access to HCV Meds, More Medicines for People in Need - (09/23/10)
     
  1372. Diabetes Group Supports Stricter Drug Approval Standards - (09/23/10)
     
  1373. Precursor to H.I.V. Was in Monkeys for Millenniums - (09/21/10)
     
  1374. New AIDS Movie: 'The Other City - The H.I.V. Epidemic in Washington DC' - (09/21/10)
     
  1375. Studying HIV and cancer link - (09/21/10)
     
  1376. More circumcised men are HIV positive - (09/21/10)
     
  1377. FDA Says It Will Review Pioglitazone Safety - (09/21/10)
     
  1378. FDA Drug Safety Communication: Ongoing Safety Review of Actos (pioglitazone) and Potential Increased Risk of Bladder Cancer After Two Years Exposure (see data summary below) - (09/21/10)
     
  1379. Drugmakers protest new Greek prices - (09/21/10)
     
  1380. ASBMR Task Force Report on Atypical Femoral Fractures Published in the JBMR - (09/17/10)
     
  1381. CDC Awards $6.2 Million For Integration Of HIV & HCV Health Services - (09/17/10)
     
  1382. NIH statement on National HIV/AIDS and Aging Awareness Day Sept. 18, 2010 - not good enough - (09/15/10)
     
  1383. Colchicine Drug-Drug Interactions; HIV Protease Inhibitors Increase Colchicine Levels (see tables below) FDA label pdf attached - (09/15/10)
     
  1384. Insomnia/anxiety drugs increases risk of death - study - (09/15/10)
     
  1385. New HIV Cases High Among French MSM - (09/15/10)
     
  1386. FDA approves new drug for gout - (09/15/10)
     
  1387. Accusations of bias among FDA rosiglitazone panel - (09/15/10)
     
  1388. Pfizer Inks Deal with K.U. Leuven for HIV Drugs with New Mechanism of Action - (09/15/10)
     
  1389. FDA won't disqualify HIV doctor Dr Daniel Berger from drug studies - (09/15/10)
     
  1390. Roche, reMYND sign 500 million euro Alzheimer, Parkinson pact - (09/08/10)
     
  1391. Weighted average drug price cuts of 20% for over 4,000 drugs enforced in Greece as of today - (09/08/10)
     
  1392. Low-Carb Diet is Better When Rich in Veggies - (09/08/10)
     
  1393. Young gay men fuelling HIV epidemic, study warns - (09/08/10)
     
  1394. Bristol-Myers Squibb to Acquire ZymoGenetics (peg-lambda IFN) - (09/08/10)
     
  1395. Vertex Maintains Lead Over Merck In Hepatitis C (new Phase 3 results reported) - (09/08/10)
     
  1396. BMS' Smart Buy - ZymoGenetics (peg-lambda IFN) - (09/08/10)
     
  1397. Drs. Erik De Clercq and Anthony S. Fauci Win 2010 Dr. Paul Janssen Award for Biomedical Research Recognized for Pioneering Work in Unde rstanding and Combating HIV/AIDS - (09/08/10)
     
  1398. FDA halts Idenix HCV drug studies due to side effects - (09/08/10)
     
  1399. Idenix hep C drugs on clinical hold; shares plummet - (09/08/10)
     
  1400. Idenix HCV Update - 3 patients with LFT elevations - (09/08/10)
     
  1401. Is Russia's HIV/AIDS problem worse than Africa's? - (09/08/10)
     
  1402. J&J giving $200 million for health of women, kids (HIV & TB) - (09/08/10)
     
  1403. GSK signs biologics manufacturing deal with Lonza - (09/08/10)
     
  1404. Gout Treatment Colchicine Gets Label Update for HIV Drug Interaction - (09/08/10)
     
  1405. ZymoGenetics Acquisition Highlights Competitive Hepatitis C Treatment Race - (09/08/10)
     
  1406. ViiV Healthcare Awards Southern Initiative Grants to Reduce HIV Disparities Among African Americans and Latinos - (09/08/10)
     
  1407. Diabetes Drug Avandia as Safe as Actos: Study - published journal pdf attached - (09/08/10)
     
  1408. No Cancer Risk with Bisphosphonates - (09/02/10)
     
  1409. Bisphosphonates Tied to Esophageal Cancer - (09/02/10)
     
  1410. Inhibitex Successfully Completes Phase 1a Trial of INX-189, Proof-of-Concept Trial in Patients with Chronic Hepatitis C Planned for Q4 2010 - (09/02/10)
     
  1411. Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment - (09/02/10)
     
  1412. 'Brain Exercise' May Worsen Existing Alzheimer's, after initially slowing decline - (09/02/10)
     
  1413. Behavior Trial Shows Dementia Benefits - (09/02/10)
     
  1414. Tight BP Control Flops for Most CKD Patients - (09/02/10)
     
  1415. Gilead Sciences Submits European Marketing Application for Once-Daily Single-Tablet Regimen of Truvada(R) and TMC278 for the Treatment of HIV Infection - (09/02/10)
     
  1416. Roche Launches Cost-Cutting Plan - (09/02/10)
     
  1417. HIV Testing Is Now a Routine Part of Health Care in New York - press release from New York City - (09/02/10)
     
  1418. NYS Guidelines Updated: Antiretroviral Therapy: Selecting an Initial Antiretroviral Regimen - (09/02/10)
     
  1419. Cirrhosis Outcomes Better When Tx Guidelines Followed - below is full text Editorial and full text article, attached is pdf of published study - (09/02/10)
     
  1420. 70% rise in Americans using five or more Rx drugs per month - (09/02/10)
     
  1421. Hepatitis C liver deaths warning in UK - (08/30/10)
     
  1422. Economy Makes European Cardiologists Think Twice - pressured on treatment costs - (08/30/10)
     
  1423. HIV/Aging & Muscle Loss/Exercise/ Vit D/GSK - Doctors Seek Way to Treat Muscle Loss (see 2nd article below & links) - NY Times - (08/30/10)
     
  1424. Diabetes, Insulin Resistance Linked to Alzheimer's - (08/29/10)
     
  1425. German Star Convicted of Spreading H.I.V. - (08/29/10)
     
  1426. HIV virus hides in the brain - (08/29/10)
     
  1427. Drug Prices Up, but Don't Read Too Much Into It - (08/29/10)
     
  1428. Statins Cleared of Causing Cancer - (08/26/10)
     
  1429. Daily Coffee (1-2 cups) Limbers Up the Heart - (08/26/10)
     
  1430. Vitamin D Status Predicts HF Outcome - (08/26/10)
     
  1431. Mayo Clinic Administrators in Florida Discuss Hepatitis Situation - (08/26/10)
     
  1432. German court finds girl-band singer guilty of infecting partner with HIV - (08/26/10)
     
  1433. One TZD No Safer than Another - (08/26/10)
     
  1434. BPA Linked to Hormonal Effects in Men - (08/26/10)
     
  1435. One TZD No Safer than Another - (08/26/10)
     
  1436. Prosecutor seeks suspended sentence in German HIV trial - (08/25/10)
     
  1437. Pharmacy hepatitis tests "could save thousands of lives" - (08/25/10)
     
  1438. Merck Provides New Funding to Fight HIV/AIDS in Botswana - (08/25/10)
     
  1439. The Responsibilities of Being Young, Beautiful and HIV Positive: HIV Allegations Place Pop Star on Trial 'for transmitting HIV by having unprotected sex 11 yrs ago at age 17' - (08/25/10)
     
  1440. Diabetes Drug Avandia as Safe as Actos: Study - published journal pdf attached - (08/25/10)
     
  1441. Tentative FDA approval of generic atazanavir sulfate capsules, 300 mg - (08/23/10)
     
  1442. Hepatitis E vaccine: not a moment too soon - Commentary - (08/23/10)
     
  1443. Egypt rejects estimates of high hepatitis C levels - (08/23/10)
     
  1444. Famous People & HCV - (08/23/10)
     
  1445. Hepatitis E Vaccine Candidate Completely Blocked Disease - full text below, pdf attached, Commentary in next email - (08/23/10)
     
  1446. Green Veggies Cut Diabetes Risk - full text attached - (08/20/10)
     
  1447. More drug price cuts in Greece - (08/20/10)
     
  1448. Seminal HIV Differs from Virus in Blood - full text attached - (08/20/10)
     
  1449. Amyloid Theory in Alzheimer's Takes Another Hit - (08/15/10)
     
  1450. Older Patients' Share of Office Visits Grows: Care Services for Aging Increased Demand - (08/15/10)
     
  1451. The Cancer Biomarker Conundrum: Too Many False Discoveries - (08/13/10)
     
  1452. Rimonabant (anti-obesity drug) for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial - no CVD benefit, psych side effects found - (08/13/10)
     
  1453. CRESCENDO, rimonabant's (anti-obesity drug) "obituary," published in Lancet - (08/13/10)
     
  1454. Rimonabant: obituary for a wonder drug - Editorial - (08/13/10)
     
  1455. New Black AIDS Institute, in Partnership with Merck, Launches Dynamic National HIV/AIDS Treatment and Care Advocacy Network - (08/13/10)
     
  1456. Global HCV/HIV Coinfection Treatment Access Demanded - (08/13/10)
     
  1457. Is HAART modifying the HIV epidemic? HAART for Prevention - (08/13/10)
     
  1458. Beta-Amyloid Further Implicated in Mental Decline - (08/12/10)
     
  1459. PSI-7977 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection - (08/12/10)
     
  1460. No Cancer Risk with Bisphosphonates - (08/12/10)
     
  1461. WHO H1N1 Scandal - Unveils H1N1 Committee - (08/12/10)
     
  1462. Abbott & Merck Wellvista ADAP HIV ART Access Initiative Q & A - (08/12/10)
     
  1463. Merck & Co signs $289 million Alzheimer's pact with Alectos - (08/12/10)
     
  1464. Gout Worsens Heart Failure Outcomes - full text below - (08/11/10)
     
  1465. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis - (08/11/10)
     
  1466. Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People - full text - (08/11/10)
     
  1467. Sharpen That Needle (3 Biomarkers Predict Alzheimers's) Editorial - (08/11/10)
     
  1468. Beta-Amyloid Further Implicated in Mental Decline - (08/11/10)
     
  1469. Biomarker Trio Detects Alzheimer's - (08/11/10)
     
  1470. Gout Worsens Heart Failure Outcomes - full text below - (08/10/10)
     
  1471. Signs of Puberty Seen Earlier in White Girls - (08/09/10)
     
  1472. Generic & Made in Pakistan Pegylated Interferon - (08/09/10)
     
  1473. Calcium supplements boost heart-attack risk: Meta-analysis - (08/06/10)
     
  1474. TZD Use Linked to Fracture Risk in Women 50 and Older - (08/06/10)
     
  1475. Risk of MI May Go Up With Calcium Supplements - (08/06/10)
     
  1476. CDC Awards $42 Million to Community-Based Organizations to Support HIV Prevention Efforts Across the Nation - (08/06/10)
     
  1477. Update on Timeline for FDA Action Date for Theratechnologies' Tesamorelin New Drug Application - press release - (08/06/10)
     
  1478. Kerry Introduces Bill to Fight Viral Hepatitis - (08/06/10)
     
  1479. Protein in Urine Predicts Acute Kidney Failure - (08/06/10)
     
  1480. Wellcome Trust and India team up for affordable drugs - (08/06/10)
     
  1481. N.J. residents with AIDS remain eligible for ADAP program that pays for medication, Gov. Christie says - (08/06/10)
     
  1482. Vertex Submits Telaprevir Rolling NDA to FDA - (08/06/10)
     
  1483. Vit D - Health & Dosing- Vitamin D May Boost Teens' Arterial Health - (08/06/10)
     
  1484. Schering-Plough acquisition hits Merck earnings but sales soar - (08/06/10)
     
  1485. Mixed Feeling About HPV Vaccine - (08/06/10)
     
  1486. Governor Paterson Signs Bills to Promote HIV Testing and Remove Barriers to Needle Exchange and Syringe Access - (08/06/10)
     
  1487. Calcium Supplementation Meta-Analysis Reports increased heart attack risk - Editorials - (08/06/10)
     
  1488. Polish promoter: Emelianenko has hepatitis C - (08/06/10)
     
  1489. GSK signs Muscle Drug Deal, $500 million cancer pact with Amplimmune - (08/06/10)
     
  1490. OraSure delays filing for oral version of hep C test - (08/06/10)
     
  1491. Genomics: Variations in blood lipids - (08/06/10)
     
  1492. New Gene Variants Linked to Lipid Levels - (08/06/10)
     
  1493. Most Americans "don't believe Chinese, Indian-made drugs are safe" - (08/06/10)
     
  1494. NIH's Fauci Discusses Research on Microbicidal Gel, HIV Prevention post Vienna comments - (07/27/10)
     
  1495. NY Times HCV Article Misleads Public About Treatment & Need for Screening - (07/26/10)
     
  1496. Tibotec Pharmaceuticals Submits New Drug Application for Investigational Once-Daily HIV Treatment TMC278 to U.S. Food and Drug Administration - (07/26/10)
     
  1497. NY Times HCV Article Misleads Public About Treatment & Need for Screening - (07/26/10)
     
  1498. Shionogi - ViiV Healthcare Announces Commitment to Phase III Development Programme for Investigational Once-Daily HIV Integrase - (07/21/10)
     
  1499. 'Opt-Out' HIV Tests Have Modest Success: The study "demonstrates mostly the limitations of opt-out testing rather than its benefits," according to Michael Saag - (07/20/10)
     
  1500. An Update on AIDS Walk San Francisco - (07/20/10)
     
  1501. Keep taking Avandia, say doc groups as analysts ponder future - (07/19/10)
     
  1502. Man in rape case also charged with assault in connection with HIV status - (07/19/10)
     
  1503. Questions About Path of AIDS Walk Money (SF AIDS Foundation) - (07/19/10)
     
  1504. ViiV Healthcare announces further initiatives to improve access to HIV medications for people living in the least developed countries; generics voluntary licensing - (07/19/10)
     
  1505. City's overlooked epidemic - Fueled by ignorance, HIV is still a serious problem in parts of Philadelphia. - (07/19/10)
     
  1506. Reaction to Obama National AIDS Strategy (HCV) - (07/19/10)
     
  1507. Health Department Reports 75% of New Yorkers Living with HIV/AIDS Are 40 or Older and More than a Third Are over 50 - (07/19/10)
     
  1508. Congressmen Request $50 Million Funding for HCV - (07/16/10)
     
  1509. Vicriviroc Discontinued Investigator Letter - (07/15/10)
     
  1510. Keep Rosiglitazone on the Market, FDA Panel Says - (07/15/10)
     
  1511. N.J. sets income cap for free AIDS medications, cutting off nearly 1,000 - (07/14/10)
     
  1512. Rosiglitazone: FDA Prepares for a Verdict - (07/12/10)
     
  1513. Take Rosiglitazone Off the Market, Says FDA Staff - (07/12/10)
     
  1514. Tentative approval of fixed dose combination lamivudine, nevirapine, and zidovudine tablets for Oral Solution, 30 mg/50 mg/60 mg) - (07/12/10)
     
  1515. HPV Linked to Squamous Cell Carcinoma - (07/12/10)
     
  1516. Fish Oil Linked to Lower Breast CA Risk - (07/12/10)
     
  1517. Sex now chief cause of Ukraine's AIDS epidemic - (07/12/10)
     
  1518. Mixed messages from FDA staff over Avandia safety - (07/12/10)
     
  1519. Roche signs neurological pact with UK's MRC - (07/12/10)
     
  1520. Obama To Announce Natl AIDS Strategy - (07/12/10)
     
  1521. Merck & Co to shutter eight R&D, eight manufacturing sites - (07/10/10)
     
  1522. U.S. to Provide $25 Million to Help Buy AIDS Drugs (ADAP) - (07/10/10)
     
  1523. Depression doubles risk of dementia - (07/07/10)
     
  1524. HCV Antiviral Therapy Impacts Esophageal Varices in HCV-Induced Cirrhosis: Study Shows Sustained Virologic Response Prevents EV - (07/07/10)
     
  1525. Three Rivers Pharmaceuticals Announces FDA Approval Of Expanded Labeling of INFERGEN: daily dosing - (07/07/10)
     
  1526. Germany hits pharma, insurers etc with 3.5B euro cuts - (07/07/10)
     
  1527. ViiV Healthcare Announces Positive Action U.S. Southern Initiative, an Innovative Community Support Program to Fight HIV/AIDS - (07/07/10)
     
  1528. For BP (blood pressure) More Control Means Less Benefit in T2D - (07/07/10)
     
  1529. FDA Hepatitis Update - Infergen (interferon alfacon-1) label revision: combination therapy, weight-based dosing, and label format - (07/07/10)
     
  1530. USPSTF Expands Osteoporosis Guidelines - (07/07/10)
     
  1531. Telomere Length May Predict Cancer Risk - (07/07/10)
     
  1532. 320 Ohioans lose aid for HIV drugs (cut from ADAP) - (07/05/10)
     
  1533. ADAP in Texas: Cuts may be ahead for AIDS program - (07/05/10)
     
  1534. Georgia creates waiting list for HIV/AIDS drugs (ADAP) - (07/05/10)
     
  1535. Waiting Lists for HIV Drugs in the U.S.-Again - (07/04/10)
     
  1536. Abbott's billion dollar deal for branded generics & Other Pharma As Well - (07/04/10)
     
  1537. A boost for GSK's first-in-class heart drug? (antiinflammatory CVD drug) - (07/04/10)
     
  1538. ViiV Healthcare Awards Grants from the Positive Action for Children Fund of £3.6m; Eliz Glaser also; Gates Funds Kids/Meternal - (07/01/10)
     
  1539. Quebec to slash generic drug prices - (07/01/10)
     
  1540. Pets Care for HIV+, petsdc.org - (07/01/10)
     
  1541. Economy Hurts Government Aid for H.I.V. Drugs (ADAP) - (07/01/10)
     
  1542. Isentress Label Updated with 96 weeks Data - (07/01/10)
     
  1543. CRP & JUPITER Study Criticism Published in Archives of Internal Medicine - (06/30/10)
     
  1544. NIH Announces Funding & Grant Application Requests For Cure Research - (06/30/10)
     
  1545. Rapid blood test for antibodies to the hepatitis C virus (HCV) approved - (06/29/10)
     
  1546. Generic Peginterferon in USA: Cyplasin Biomedical Prepares A Biosimilar Pegylated Interferon-alpha (C-Pegferon(TM)) for Market Approval in the U.S., E.U. and Major Market Regions - (06/29/10)
     
  1547. New Roche/Ipsen diabetes drug shows promising efficacy - (06/29/10)
     
  1548. GSK backs Avandia again amid renewed pressure for withdrawal-new studies - (06/29/10)
     
  1549. Rosiglitazone Again on the Ropes - (06/29/10)
     
  1550. Rosiglitazone May Benefit CVD Patients - (06/29/10)
     
  1551. Diabetes Responsible for 10% of Vascular Deaths - (06/28/10)
     
  1552. Gilead to acquire CGI for up to $120 mln: they make anti-inflammation drugs - (06/26/10)
     
  1553. OraSure gets FDA nod for hepatitis C test, shares up - (06/26/10)
     
  1554. Pursuit of Six Pack Abs May Trigger New Malady - Low testosterone & Exercise - (06/26/10)
     
  1555. Pursuit of Six Pack Abs May Trigger New Malady - Low testosterone & Exercise - (06/26/10)
     
  1556. Gregg Allman undergoes successful liver transplant - (06/25/10)
     
  1557. Diet Soft Drinks Deplete Urinary Calcium - (06/25/10)
     
  1558. Body Fat Linked to Diabetes Risk in Older People - (06/25/10)
     
  1559. Bisphosphonates Linked to Lower Breast Cancer Risk - (06/25/10)
     
  1560. Antioxidants May Up Insulin Sensitivity - (06/25/10)
     
  1561. GSK leads in making medicines available to the poor - (06/25/10)
     
  1562. An HIV Balm in Gilead, How firms are cooperating to deliver drugs to Africa, for private gain and public good. - (06/23/10)
     
  1563. Famous Model Gia Carangi Died of AIDS in 1986, Lifetime Cable Show at 9pm Monday June 21 2010 - (06/23/10)
     
  1564. Experimental Compound Helps Gout Patients, Lowers Uric Acid - (06/23/10)
     
  1565. Metabolic Benefits Seen with GH Replacement - (06/23/10)
     
  1566. Telephone Management System Cuts Diabetes Costs - (06/23/10)
     
  1567. Fourth Generation HIV Diagnostic Test Approved by FDA, permitting earlier detection of infection - (06/23/10)
     
  1568. Liver at Risk in Diabetes - (06/23/10)
     
  1569. FDA Panel Votes Down Libido-Boosting Drug for Women - (06/20/10)
     
  1570. CDC to offer free HIV testing in 10 cities - (06/18/10)
     
  1571. Preventing Liver Cancer: primary & secondary Prevention - (06/18/10)
     
  1572. New Morning-After Pill Safe, Effective Panel Says 5 Days After Intercourse - (06/18/10)
     
  1573. Mediterranean Diet Improves Heart Function - (06/18/10)
     
  1574. Rheumatoid Arthritis Effects Persist Despite Treatment - (06/18/10)
     
  1575. FDA Panel to Vote on Flibanserin 'Female Viagra Drug' - (06/18/10)
     
  1576. Early New Stem Cell Research in HIV+ with lymphoma given new hope: see interview below - (06/18/10)
     
  1577. Congress Hepatitis Hearing Thursday June 17, 2010 - Lawmakers urge quick passage of bill to boost detection, treatment of hepatitis - (06/18/10)
     
  1578. Benitec Limited (ASX:BLT) Granted Hepatitis C RNA Interference Patent In US - (06/18/10)
     
  1579. Blueberry Ameliorates Hepatic Fibrosis, Study Finds - (06/18/10)
     
  1580. ADAP Crisis Worsens; Waiting Lists Near Historical High - (06/18/10)
     
  1581. Blueberry Ameliorates Hepatic Fibrosis, Study Finds - (06/18/10)
     
  1582. ViiV Healthcare Gives $2mill to Partner with TREAT ASIA/amfar to Optimize HIV Treatment for Infants and Children in Asia - (06/18/10)
     
  1583. Peg Interferon Launched by Pakistan Biotech: Getz Pharma to launch therapy for Hepatitis C patients - (06/18/10)
     
  1584. New CDC Report on New HIV Infections- HIV in the United States: An Overview: "The HIV diagnosis rate has remained stable in recent years" - (06/18/10)
     
  1585. Boehringer's 'female Viagra' not effective - FDA staffers - (06/17/10)
     
  1586. ART Regimen Cuts HIV Transmission from Mother to Child in NEJM, new study - (06/17/10)
     
  1587. Once-a-Week Diabetes Drug Comparable to Standard Meds - (06/17/10)
     
  1588. Higher HDL Might Lower Cancer Risk - (06/16/10)
     
  1589. Pesticides Linked to Parkinson's - (06/16/10)
     
  1590. Novo agrees to temporary Greek price cut and resumes supplies - (06/16/10)
     
  1591. Canadian govt drug price role "does not benefit consumers" - (06/16/10)
     
  1592. FDA approves GSK's prostate cancer combo - (06/16/10)
     
  1593. Human Genome Sciences Inc. gets discouraging feedback from FDA on Zalbin for hepatitis C - (06/14/10)
     
  1594. Pharma firms pool data to speed up brain drugs research - (06/14/10)
     
  1595. ADAP, AIDS drug funds, threatened by Tea Party scare? - (06/12/10)
     
  1596. Wash D.C. AIDS program faces uncertainty after director Hader resigns - (06/11/10)
     
  1597. More ADAP Waitlists, Report from NASTAD - (06/11/10)
     
  1598. Idera Pharmaceuticals Announces Preliminary Data from Phase 1 Clinical Trial of IMO-3100, a Toll-like Receptor Antagonist Drug Candidate for Autoimmune and Inflammatory Diseases - (06/10/10)
     
  1599. Earlier HAART, Updated HIV Therapy Guidelines Would Reduce Risk Of Transmission, Save Lives, Billions In Costs - (06/10/10)
     
  1600. Initiation of the First Safety Trial in Africa of an Antiretroviral-Containing Vaginal Ring Designed to Prevent HIV/AIDs Using TMC120 an NNRTI from Tibotec - press release - (06/10/10)
     
  1601. Earlier HAART, Updated HIV Therapy Guidelines Would Reduce Risk Of Transmission, Save Lives, Billions In Costs - (06/10/10)
     
  1602. Content of OTC Vitamin D Low, Unpredictable - (06/08/10)
     
  1603. Myriad Pharma cuts 21 jobs, suspends HIV program - (06/08/10)
     
  1604. Content of OTC Vitamin D Low, Unpredictable - (06/08/10)
     
  1605. NYC AIDS Budget Faces Reduction - (06/08/10)
     
  1606. New ddI Peds Factory Planned in USA - UN urges BMS to protect Manufacturing of DDI HIV-drug for babies - (06/08/10)
     
  1607. JOHN G. MCHUTCHISON, MD, TO JOIN GILEAD SCIENCES AS SENIOR VICE PRESIDENT, LIVER DISEASE THERAPEUTICS - (06/08/10)
     
  1608. ADAP Crisis Task Force Reaches Agreement with ViiV Healthcare to Assist Struggling ADAPs; - (06/07/10)
     
  1609. Gilead Sciences and ADAP Crisis Task Force Announce New Initiatives to Support AIDS Drug Assistance Programs (ADAPs) - (06/07/10)
     
  1610. White House summit on AIDS' impact on black men - (06/07/10)
     
  1611. WHO H1N1 Flu Controversy - Investigation Raises Questions About WHO's Handling of Pandemic - (06/07/10)
     
  1612. Conflicts of interest and pandemic flu - Editorial - (06/07/10)
     
  1613. Conflicts of Interest: WHO and the pandemic flu "conspiracies" - (06/07/10)
     
  1614. Earlier Colorectal Cancer Screening for Blacks Advised - (06/07/10)
     
  1615. New statement urges caution for primary-prevention aspirin in diabetics - (06/07/10)
     
  1616. More black churches take on AIDS battle - (06/07/10)
     
  1617. Public Health Researchers Push for Shift in Smoking/HIV Research: We Know the Problem, Now Need Solutions, SLU Research Finds - (06/07/10)
     
  1618. Public Health Researchers Push for Shift in Smoking/HIV Research: We Know the Problem, Now Need Solutions, SLU Research Finds - (06/02/10)
     
  1619. FDA approves Amgen's denosumab for osteoporosis - (06/02/10)
     
  1620. Heart Failure Risks: Control Serum Glucose to Reduce HF Risk in Diabetics - (06/02/10)
     
  1621. Ford Foundation Initiative to Tackle Domestic HIV Crisis in U.S. - (06/02/10)
     
  1622. HIV and AIDS among African Americans - (06/02/10)
     
  1623. White House HIV/AIDS Natl AIDS Strategy Outline - (06/02/10)
     
  1624. FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women - (06/02/10)
     
  1625. Vaginal Gel That Kills Herpes, HIV May Be Available by 2012 - (06/01/10)
     
  1626. Danish drugmakers' "no" to Greek price cuts - (06/01/10)
     
  1627. Selzentry (maraviroc) 150 mg and 300 mg tablets, FDA labeling changes for patients with renal impairment - (06/01/10)
     
  1628. Public Health Researchers Push for Shift in Smoking/HIV Research: We Know the Problem, Now Need Solutions, SLU Research Finds - (06/01/10)
     
  1629. The metabolic secrets of good runners - (05/31/10)
     
  1630. Raised HDL may be bad news if inflammation present - (05/31/10)
     
  1631. Clean Teeth/CVD/Inflammation - (05/29/10)
     
  1632. Theratech shares soar on U.S. drug panel ruling recommending approval for tesamorelin which reduced belly fat in HIV+ patients - (05/28/10)
     
  1633. Roche wins pre-market FDA ok for 18-minute hepatitis test - (05/28/10)
     
  1634. Tighter Criteria Introduced for Aspirin Use in Diabetes - (05/28/10)
     
  1635. New Bone Drug: Amgen's Prolia gets European OK for osteoporosis in women and men - (05/28/10)
     
  1636. HIV Treatment Reduces Transmission Risk - (05/27/10)
     
  1637. Telaprevir, New Hep C drug achieves 75 percent cure rate: new phase 3 study results - (05/25/10)
     
  1638. UK/NICE revises hepatitis C treatments recommendations - (05/25/10)
     
  1639. FDA staff: Theratech drug works, but risks weighed - (05/25/10)
     
  1640. FDA: Theratechnologies Drug Cuts Abdominal Fat In HIV Patient and more patients developed diabetes and some patients in the study shifted from pre-diabetes to diabetes during treatment. - (05/25/10)
     
  1641. Illinois ADAP Threatens Restrictions - (05/25/10)
     
  1642. Senate Bill by Coburn & Burr Takes Aim at AIDS Drug Crisis - (05/25/10)
     
  1643. Florida starts waiting list for AIDS drug program: Budget crunch, jump in uninsured forces austerity moves - (05/24/10)
     
  1644. South Carolina Cuts ADAP - AIDS activists protest budget proposal - (05/24/10)
     
  1645. Asda (Walmart) to sell 'not-for-profit' cancer drugs, govt fund next April - (05/24/10)
     
  1646. US government gives biotech $1 billion boost tax-credit or grant - (05/24/10)
     
  1647. Abbott buys Piramal Generic unit to become number one in India - (05/24/10)
     
  1648. HIV Gene Therapy VRX496 & Vaccine Therapy: VIRxSYS Presents Results from Multiple Studies at the 13th ASGCT Annual Meeting - (05/24/10)
     
  1649. Visceral Fat Has Link to Brain Volume - (05/21/10)
     
  1650. High Hepatitis C, Liver Cancer Rate In Queens, NYC: Russians & Asians - (05/21/10)
     
  1651. Illinois HIV/AIDS advocacy groups seek tax increase to fund essential ADAP state programs - (05/20/10)
     
  1652. Boehringer Ingelheim's sexual desire drug for women hits the spot - (05/20/10)
     
  1653. India's top 25 drugmakers' profits soared 180% last year - (05/20/10)
     
  1654. Demonstration Against French Government for HCV Cutbacks - (05/20/10)
     
  1655. India's top 25 drugmakers' profits soared 180% last year - (05/19/10)
     
  1656. Ranbaxy Recalling Some Batches Of Three Drugs In Europe - (05/19/10)
     
  1657. US branded drug prices rose 9.7% in 2009, says study - (05/19/10)
     
  1658. Vitamin D & Metabolics - (05/19/10)
     
  1659. New vitamin D recommendations for older men and women - (05/18/10)
     
  1660. Generic 3TC+d4T Fixed Dose Tablets FDA Approved - (05/18/10)
     
  1661. Decreased Kidney Function Predicts Death Risk in General Population - (05/18/10)
     
  1662. FDA Approval of Generic abacavir sulfate tablets, 300 mg - (05/17/10)
     
  1663. Diabetes Docs Skeptical of FDA Drug Safety Policy, FDA's Demand for Extensive CVD Safety Data on New Drugs - (05/17/10)
     
  1664. Glitazone Prevents Diabetes: Beta Cell Function Preserved with Glitazone Rx - (05/17/10)
     
  1665. Latest Hepatitis C Figures Show Year On Year Increase, UK - (05/17/10)
     
  1666. Amgen looks for second FDA approval for denosumab - (05/17/10)
     
  1667. More M&A as big pharma struggles to innovate sufficiently - (05/17/10)
     
  1668. HIV Increasingly Part of Primary Care - (05/17/10)
     
  1669. Vertex, Worth $7.5B, Eagerly Awaits Final Proof that Hepatitis C Drug Works- phase 3 trials - (05/17/10)
     
  1670. Vertex Hepatitis Drug Seen Successful, But Numbers Are Key: Phase 3 ADVANCE and ILLUMINATE trials in treatment-naive patients fully enrolled - (05/13/10)
     
  1671. Vertex Telaprevir Starting FDA Approval This Summer - (05/13/10)
     
  1672. Second fixed-dose triple antihypertensive under review in US - (05/13/10)
     
  1673. Walgreens won't sell over-the-counter genetic test after FDA raises questions - (05/13/10)
     
  1674. National AIDS Fund Announces Major Grants, Enabling More Than 35 Community-Based Organizations to Help Improve Access to HIV Care in their Communities - Press Release - (05/13/10)
     
  1675. Alzheimer's Genes Do Not Predict Risk: Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease in JAMA - (05/13/10)
     
  1676. New Alzheimer Genes Fail for Risk Prediction - (05/13/10)
     
  1677. Nuts Improve CVD Risk. Let's get nuts! Eating almonds, walnuts, pecans, and other nuts improves lipid levels - (05/12/10)
     
  1678. ADAP Crisis Task Force Reaches Agreements with Three Pharmaceutical Companies to Assist Struggling ADAPs; Additional Federal and State Funding Required - (05/12/10)
     
  1679. Alzheimer's Genes Do Not Predict Risk: Reaching the Limits of Genome-wide Significance in Alzheimer Disease- Back to the Environment. Editorial in JAMA - (05/12/10)
     
  1680. Heinz Family Philanthropies, Welvista and Abbott Announce Solution to Help Patients on State ADAPs - (05/12/10)
     
  1681. BP Variation Linked to CVD, cerebrovascular disease - (05/12/10)
     
  1682. Benefits of Proton Pump Inhibitors May Not Justify the Risks for Many Users - editorial - (05/12/10)
     
  1683. LESS IS MORE: Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women - (05/12/10)
     
  1684. Benefits of Proton Pump Inhibitors May Not Justify the Risks for Many Users - editorial - (05/12/10)
     
  1685. Hypoglycemia-Induced Blood Pressure Elevation in Patients With Diabetes - (05/12/10)
     
  1686. New NRTI Apricitabine Development Stopped - (05/12/10)
     
  1687. Nuts Improve Lipids/CVD Risk - (05/12/10)
     
  1688. Start-Up Pathway Genetics May Sell Genetic Tests in Walgreen's Stores - (05/12/10)
     
  1689. Merck and The ADAP Crisis Task Force Announce Key Initiatives to Help Provide Funding Relief to AIDS Drug Assistance Programs (ADAPs) across the U.S. - (05/06/10)
     
  1690. DDW: Fatty Acids May Protect Against Ulcerative Colitis - (05/05/10)
     
  1691. DDW: Treatment for HCV Can Work for IV Drug Users on opiod substitution - (05/05/10)
     
  1692. Deal watch: GSK invests in targeting microRNA for the treatment of hepatitis C - (05/03/10)
     
  1693. FDA Announcement: New Kaletra (lopinavir/ritonavir) Tablets and Oral Solution once daily dosing regimen in certain adult patients - (05/03/10)
     
  1694. Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy A Randomized Controlled Trial - (05/03/10)
     
  1695. Vitamin E (and pioglitazone) Tops for NASH Therapy - (04/29/10)
     
  1696. FDA Approval for Once-Daily Dosing of Kaletra (lopinavir/ritonavir) for Treatment-Experienced Patients - (04/29/10)
     
  1697. JUPITER: Rosuvastatin benefits elderly patients, but editorialists question role for CRP - (04/29/10)
     
  1698. Gilead Finalizes Selection of Bioequivalent Formulation for the Fixed-Dose Regimen of Truvada(R) and Tibotec Pharmaceuticals' TMC278 - (04/27/10)
     
  1699. Europe's regulators back expanded use of Crestor - (04/27/10)
     
  1700. New Weight Loss Pill - Hydrogel Diminishes Hunger - (04/26/10)
     
  1701. Zinc Linked to Prostate Cancer Survival. What are Good Zinc Food Sources? - (04/26/10)
     
  1702. Immuron Completes Coral HIV Phase 2 Trial - (04/26/10)
     
  1703. Insulin Resistance May Underlie Metabolic Syndrome - (04/26/10)
     
  1704. Airborne Fungus Potentially Deadly - (04/26/10)
     
  1705. Health Department Highlights Health Risks of Unprotected Anal Sex among Heterosexual Women in New York City - (04/23/10)
     
  1706. Mylan Announces Approval Under PEPFAR for Generic Version of Videx(R) EC HIV Treatment - (04/23/10)
     
  1707. Gilead Provides Update on Development of Fixed-Dose Regimen of Truvada(R) and Tibotec Pharmaceuticals' TMC278 - Pivotal Phase III Studies of TMC278 Met Primary Objective - (04/23/10)
     
  1708. BMS' NS5A Experimental compound potent against hepatitis C - "at least 3 drugs required to prevent resistance" - (04/23/10)
     
  1709. FDA Announces Draft Revised Guidance on Transparency and Advisory Committees - (04/21/10)
     
  1710. World pharma sales trends - "will hit $1.1 trillion by 2014" - (04/21/10)
     
  1711. 'Warehoused' Hepatitis C Patients May Boost Merck, J&J, Vertex - (04/21/10)
     
  1712. FDA Updates Product Labeling for Sustiva (Efavirenz) - (04/21/10)
     
  1713. Generic Tenofovir Gets FDA Approval - (04/15/10)
     
  1714. J&J takes stake in Swiss personalised medicine firm - (04/15/10)
     
  1715. HHS Grants $267M for Health IT Centers - (04/15/10)
     
  1716. Fruits and Veggies Have Small Effect on Cancer Risk - (04/15/10)
     
  1717. Hepatitis C infection doubles kidney cancer risk - (04/15/10)
     
  1718. New England Journal of Medicine Publishes PROVE 3 Trial Showing Telaprevir-Based Regimens Significantly Increased Sustained Viral Response (SVR) Rates in Patients Who Did Not Achieve SVR with Prior HCV Therapy - (04/15/10)
     
  1719. New Regenerative Diabetes Therapy: stimulates the growth of new insulin producing islet cells in the pancreas - (04/15/10)
     
  1720. Celibate Lady Gaga says: 'Don't have sex' - (04/15/10)
     
  1721. Gilead Initiates Phase III Clinical Program Evaluating Single-Tablet, Once-Daily "Quad" Regimen for HIV - (04/15/10)
     
  1722. Diet Rich in Fruits, Veggies & Omega 3 Reduce Alzheimers & CVD Risk - (04/14/10)
     
  1723. Virco Acquires LAB TRACKER HIV Electronic Medical Record Software System - (04/14/10)
     
  1724. New Long-Acting Disbetes Drugs - Amylin, Lilly's Byetta May Have Cancer Risk, FDA Says - (04/14/10)
     
  1725. Generics 75% of Scripts; US pharma sales growth returned in 2009: study - (04/06/10)
     
  1726. Canadian payers "reject over 50% of new drugs each year" - (04/06/10)
     
  1727. HIV clinic in East Orange offers incentives to poor patients to take medication - (04/06/10)
     
  1728. Start HAART Immediately Upon Diagnosis - San Francisco To Unveil New Public Health Policy for HIV/AIDS Treatment - (04/05/10)
     
  1729. 'start HAART as soon as found to be infected' - SF Endorses New Policy for Treatment of H.I.V. - (04/05/10)
     
  1730. GEOVAX LABS GRANTED ALLOWANCE BY FDA TO START PHASE 1 CLINICAL TRIAL FOR HIV/AIDS THERAPEUTIC VACCINE - attached press release - (04/05/10)
     
  1731. C-Reactive Protein May Predict Brain Changes - (04/03/10)
     
  1732. GSK signs Isis RNA Interference deal, wins EU nod for Duodart - (04/03/10)
     
  1733. HIV Drugs Inhibit Virus Linked To Prostate Cancer, Chronic Fatigue Syndrome - (04/03/10)
     
  1734. CDC Expands HIV Testing Program for African-Americans, MSM, Latinos - (04/03/10)
     
  1735. Antisense Drug ISIS-11 for HCV Therapy & GSK Deal with ISIS Pharmaceuticals; microRNA therapy research for HCV - (04/03/10)
     
  1736. RNA Interference: Stem cell therapy to tackle HIV - (04/03/10)
     
  1737. GEOVAX LABS GRANTED ALLOWANCE BY FDA TO START PHASE 1 CLINICAL TRIAL FOR HIV/AIDS THERAPEUTIC VACCINE - attached press release - (04/03/10)
     
  1738. Presidio Pharmaceuticals, Inc. to Present at the Canaccord Adams' Hepatitis C Conference - (03/31/10)
     
  1739. FDA Warning on Unpastuerized, Raw Milk, March 26 2010 - (03/31/10)
     
  1740. Wash DC Mayor Fenty Releases New Study on HIV Infection Rates & Men Who Have Sex with Men in DC - (03/31/10)
     
  1741. HCV Therapy Fails in Many Urban Patients - (03/31/10)
     
  1742. High Uric Acid Linked to Gout in Women - (03/31/10)
     
  1743. A Little Bit of Chocolate May Help Keep BP Low - (03/31/10)
     
  1744. FDA approves Salix' Xifaxan for liver failure disorder encephalopathy - (03/28/10)
     
  1745. House Enacts Healthcare Reconciliation Bill - (03/26/10)
     
  1746. South Carolina Proposes To Eliminate HIV ADAP & Prevention Funds: Hundreds protest HIV funding - (03/26/10)
     
  1747. Indian Spice Curcumin May Prevent Liver Damage - (03/25/10)
     
  1748. Victory for pharma as bill keeps biogeneric pathway blocked - (03/24/10)
     
  1749. TB prevalence more common among HIV patients and aged individuals - (03/24/10)
     
  1750. "It is the law of the land" - Obama signs health reform bill - (03/24/10)
     
  1751. HIV patients 'at increased community acquired MRSA infection risk' - (03/24/10)
     
  1752. MEDICARE EXPANDS COVERAGE FOR TREATING FACIAL LIPODYSTROPHY SYNDROME IN PEOPLE LIVING WITH HIV - (03/24/10)
     
  1753. Upcoming FDA Advisory Committee Meeting on Egrifta (tesamorelin acetate) to reduce excess visceral abdominal fat in HIV-related lipodystrophy - (03/23/10)
     
  1754. Omega-3 Fatty Acid Protects Against Polyps - (03/23/10)
     
  1755. US House passes Obama health reform bill - (03/22/10)
     
  1756. House Passes Historic Healthcare Reform - (03/22/10)
     
  1757. ViiV Healthcare Calls for Initial Grant Proposals to the Positive Action for Children Fund - (03/22/10)
     
  1758. Scientists Honored With Discoverers Award for Development of Innovative HIV Medicine Maraviroc - (03/20/10)
     
  1759. State budget could cut AIDS drugs in county jails Alameda County may be forced to pay for expensive program. - (03/20/10)
     
  1760. Insurer targeted HIV patients to drop coverage - (03/19/10)
     
  1761. ViiV Healthcare Responds to Growing ADAP Patient Waiting Lists - (03/19/10)
     
  1762. Statin Rx Cost-Effective Based on C-Reactive Proteins - (03/19/10)
     
  1763. Intensive Statin Tx Cuts CVEs in Kidney Disease Patients - (03/19/10)
     
  1764. Close Lipid and BP Control Fail in Diabetes - (03/15/10)
     
  1765. FDA Announces Review of ACCORD Data - (03/15/10)
     
  1766. Plavix Response Reduced for Patients With CYP2C19 Gene Difference - (03/15/10)
     
  1767. FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine) - (03/15/10)
     
  1768. Intelence (etravirine) label revised to includenew drug-drug interaction information - (03/15/10)
     
  1769. FDA Drug Safety Communication: Ongoing safety review of oral bisphosphonates and atypical subtrochanteric femur fractures - (03/12/10)
     
  1770. Quantity vs. Quality: Long-Term Use of Bone-Building Osteoporosis Drugs May Affect Quality and Structural Integrity of Bone - (03/12/10)
     
  1771. Long-term use of bisphosphonates may increase risk of atypical fractures: studies - (03/12/10)
     
  1772. Hiding place for HIV revealed - The AIDS virus escapes treatment inside progenitor blood cells. - (03/09/10)
     
  1773. Osteoporosis Drugs, Like Fosamax May Increase Risk of Broken Bones in Some Women Long-term Use of Popular Class of Osteoporosis Drugs May Have Opposite Effect for Some Women, Experts Say - (03/09/10)
     
  1774. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs - pdf of full article attached - (03/09/10)
     
  1775. March 10 is National Women and Girls with HIV/AIDS Awareness Day - (03/09/10)
     
  1776. HbA1c More Predictive than Glucose - (03/05/10)
     
  1777. House of Rep Resolution on HIV Aging - (02/28/10)
     
  1778. Cardiology Groups Stand by Embattled Diabetes Drug Rosiglitazone - (02/25/10)
     
  1779. SQV/RTV Safety Alert: FDA NEWS RELEASE - (02/24/10)
     
  1780. FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms - (02/24/10)
     
  1781. Former Schering CEO Hassan Sees More Consolidation Deals Among Drugmakers - (02/17/10)
     
  1782. Certain Syringes More Likely To Spread Hepatitis C Virus Among Drug Users - (02/17/10)
     
  1783. Merck & Co. announces 4Q results, job cuts - (02/17/10)
     
  1784. EPO FDA Alert: FDA backs REMS plan for Amgen and J&J's anaemia drugs - (02/17/10)
     
  1785. Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication - (02/17/10)
     
  1786. Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets - HIV Access Programs in the United States - (02/12/10)
     
  1787. AIDS in America Forgotten - what's new - Rome Burns As the Emperor Fiddles - (02/12/10)
     
  1788. Ending Statins May Not End Associated Muscle Pains - (02/12/10)
     
  1789. FDA approves new tablet formulation of Norvir (ritonavir) - (02/11/10)
     
  1790. FDA Approves New Norvir Tablet for Use - from Abbott - (02/11/10)
     
  1791. GSK's Andrew Witty, Ally for the Poor in an Unlikely Corner - (02/09/10)
     
  1792. Florida AIDS insurance program runs short of cash - (02/09/10)
     
  1793. Gilead Quad Pill Can Overtake Atripla, Milligan Says - (02/09/10)
     
  1794. Syringe Access Fund Awards Nearly $2 Million In Grants For Syringe Exchange And Related Public Policy Improvement - (02/09/10)
     
  1795. AstraZeneca's Crestor approved in US for prevention of cardiovascular disease - (02/09/10)
     
  1796. Public Health Spending to Hit Milestone - (02/08/10)
     
  1797. Price rises "will drive US drug spend to $457.8 billion by 2019" - (02/08/10)
     
  1798. Telaprevir Update- FDA filing second half of 2010 - (02/05/10)
     
  1799. Congressmen seek accounting of AIDS fraud complaints - (02/05/10)
     
  1800. Probe sought into how D.C. funds AIDS groups - (02/05/10)
     
  1801. Telaprevir Update- FDA filing second half of 2010 - (02/05/10)
     
  1802. GSK CoPay Cards Include Pfizer Drugs - (02/05/10)
     
  1803. Prezista (darunavir) labeling changes reflect 96 week study data - (02/04/10)
     
  1804. Follow the Money: AIDS Funding and AIDS Deaths in the Bloomberg Years - pdf attached - (02/04/10)
     
  1805. Ford Foundation Commits $250,000 to Support HIV/AIDS Services in Haiti - (02/04/10)
     
  1806. Is There an AIDS Funding Scandal in NYC: Increased Death Rates for Women of Color in Outer Boroughs. Women With AIDS In NYC: Killing Them Softly - (02/04/10)
     
  1807. David Ho Update: The Man Who Could Beat AIDS - (02/04/10)
     
  1808. MRI Reveals Risk for Kidney Failure in Diabetic Patients - (02/04/10)
     
  1809. GSK to announce more than 3,000 job cuts - (02/04/10)
     
  1810. HIV (global/domestic) & Hepatitis in Budget - (02/04/10)
     
  1811. New Members of PACHA-Presidential Advisory Council on AIDS - (02/04/10)
     
  1812. U.S. Food and Drug Administration Approves Labeling Update for PREZISTA(R) To Include 96-Week Data in HIV-1 Infected Adult Patients - (01/29/10)
     
  1813. The Earthquake in Haiti - Dispatch from Port-au-Prince: "The GHESKIO staff saw trauma patients and handed out antiretroviral drugs to patients with AIDS." - (01/29/10)
     
  1814. New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas - (01/29/10)
     
  1815. Achillion Pharma At A Glance: new HCV drugs - (01/28/10)
     
  1816. Novo Nordisk gets US approval for New Type2 Diabetes Drug Victoza but with warning - (01/28/10)
     
  1817. Gilead revenues soar thanks to Tamiflu royalties - (01/28/10)
     
  1818. Multiple Benefits Seen for Exercise in Seniors - (01/28/10)
     
  1819. Theratechnologies says FDA delays tesamorelin review date - (01/27/10)
     
  1820. Abbott Submits New HIV Test to FDA for Expedited Review - (01/27/10)
     
  1821. Updated Abbott Statement: To Help Respond to Growing Health Crisis, Abbott Increases Aid to $2.5 Million for Haiti Relief and Recovery Efforts - (01/26/10)
     
  1822. Haiti Donations to ACTG Site - (01/21/10)
     
  1823. GSK contributes to Haiti relief efforts - (01/20/10)
     
  1824. GSK Poor Countries New Programs - (01/20/10)
     
  1825. Pfizer to expand presence in emerging markets - (01/20/10)
     
  1826. Fish Oils May Slow Genetic Aging - (01/20/10)
     
  1827. How GlaxoSmithKline chief has changed the agenda for big pharma - (01/20/10)
     
  1828. Merck & Co pulls HIV drug filing plans after trial failure - (01/20/10)
     
  1829. Herpes Therapy Doesn't Bar HIV Transmission - (01/20/10)
     
  1830. AIDS Denialism and Public Health Practice - (01/19/10)
     
  1831. AIDS ERADICATION SCIENTIFIC UPDATE FROM THE ST. MARTIN MEETING in SF Feb 4 2010 - (01/19/10)
     
  1832. ACTG: Tragedy in Haiti and at GHESKIO - (01/17/10)
     
  1833. ACTG Haiti Update - (01/17/10)
     
  1834. HIV Drug Resistance Set to Rise? Publication Pdf attached - (01/15/10)
     
  1835. Economic Burden of Diabetes Tops $200B - (01/15/10)
     
  1836. Wave of Mutant HIV May Undo Years of Drug Progress, Study Says - (01/15/10)
     
  1837. Study: Vitamin D could help fight hepatitis C, Improve Peg/RBV Response - (01/15/10)
     
  1838. Cardiac CT angiography points to preclinical atherosclerosis in HIV+ men - (01/15/10)
     
  1839. Atripla (Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate) Product Label Updated - updated label pdf attached - (01/15/10)
     
  1840. BMS Disaster Relief in Haiti - (01/15/10)
     
  1841. Abbott to Provide $1 Million in Funding, Products to Help Address Health Needs in Haiti - (01/14/10)
     
  1842. AIDS TREATMENT DATA NETWORK AND HOUSING WORKS JOIN FORCES - (01/10/10)
     
  1843. Ginkgo Biloba Did Not Slow Cognitive Decline - (01/06/10)
     
  1844. HIV Drug Resistance A Problem in South Africa - (01/06/10)
     
  1845. Clinical Care in the Aging Century- Announcing "Care of the Aging Patient: From Evidence to Action" - (01/06/10)
     
  1846. Ginkgo Doesn't Stop Cognitive Decline - (01/06/10)
     
  1847. Change of Status of the Botswana TDF2 Study of Pre-Exposure Prophylaxis for HIV Prevention - (01/06/10)
     
  1848. Harvard, Hopkins Stiffen Rules on Faculty Ties to Industry - (01/06/10)
     
  1849. Top Boston Hospitals Limit Docs' Relationships with Industry - (01/06/10)
     
  1850. Generic FDC 3TC/NVP/AZT FDA Approved - (01/06/10)
     
  1851. Trimeris Sale Stops - (12/29/09)
     
  1852. Zinc Fingers Disrupts CCR5/HIV Entry; Sangamo and the University of Pennsylvania started a clinical trial in February. - (12/29/09)
     
  1853. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis - (12/28/09)
     
  1854. C-reactive protein and cardiovascular risk: more fuel to the fire - Comment - (12/28/09)
     
  1855. Largest-ever meta-analysis finds CRP is unlikely to be causal for CVD - (12/28/09)
     
  1856. Telaprevir Development: Beating the odds (of new drug development) - (12/28/09)
     
  1857. WHO to phase out HIV drug Stavudine, warns Indian users - (12/28/09)
     
  1858. Bush insider (Scott Evertz AIDS Czar) recounts how ideology trumped science on US AIDS policy - (12/23/09)
     
  1859. More Evidence on Low Vitamin D Levels Fuels Push to Revise Recommended Intake - (12/21/09)
     
  1860. Rabies Vaccine Protects Against Monkey Version of HIV - (12/21/09)
     
  1861. GlaxoSmithKline's Revolade recommended for thrombocytopaenia in EU - (12/21/09)
     
  1862. HIV Testing Campaign for African-Americans in Florida: A leader in HIV prevention among minority communities - (12/16/09)
     
  1863. FDA advisory panel votes in favor of broadened rosuvastatin indication for CVD primary prevention, elevated CRP - (12/16/09)
     
  1864. FDA Panel Backs Statin for Primary Prevention - (12/16/09)
     
  1865. US Senate votes down pharma imports plan - (12/16/09)
     
  1866. UK drug prices now lowest in Europe, says Health Dept - (12/16/09)
     
  1867. Merck Appoints Dr. Michael Rosenblatt As Executive Vice President & Chief Medical Officer - (12/16/09)
     
  1868. Sanofi Pasteur Commercializing MRSA Vaccine - (12/16/09)
     
  1869. Manto Tshabalala-Msimang, South African Who Oversaw Discredited AIDS Policy, Dies at 69 - (12/16/09)
     
  1870. Joint Scottish Funding Opens Newest Hep C Clinic In Glasgow - (12/16/09)
     
  1871. Some Pediatric H1N1 Vaccine Recalled - (12/16/09)
     
  1872. Prominent Gay, AIDS Activist Dennis DeLeon Dies at 61 - (12/16/09)
     
  1873. Patients withdrawn from Elan Alzheimer's trial after nine deaths - (12/16/09)
     
  1874. OraSure Technologies Receives CE Mark for OraQuick(R) Rapid HCV Antibody Test - (12/15/09)
     
  1875. Exercise Helps Patients Beat Colorectal Cancer - (12/15/09)
     
  1876. Tea, Coffee Seem to Protect Against Diabetes - (12/15/09)
     
  1877. CT Scans May Deliver Higher-than-Expected Radiation Doses - (12/15/09)
     
  1878. Dennis deLeon, AIDS Activist, Dies at 61 - (12/15/09)
     
  1879. Tibotec Virco Virology BVBA Acquires LAB TRACKER(TM) HIV Electronic Medical Record Software System from Ground Zero Software - (12/15/09)
     
  1880. HUMAN GENOME SCIENCES ANNOUNCES SUBMISSION OF MARKETING AUTHORIZATION APPLICATION TO EMEA FOR JOULFERON® (ZALBIN™) - (12/15/09)
     
  1881. Boehringer Ingelheim: Announcing Mind Body HAART Web site - (12/15/09)
     
  1882. ADAP Cuts - (12/15/09)
     
  1883. HCV Treatment for Approx 500,000 HCV+ People on Opiates, either heroin or methadone - (12/14/09)
     
  1884. Anti-HIV microbicide gel PRO 2000 fails in new study results - (12/14/09)
     
  1885. Congressman Treating His HCV - (12/14/09)
     
  1886. FDA Public Health Advisory: Availability of Tamiflu for Oral Suspension - (12/14/09)
     
  1887. AIDS Funding Misspent/Scandal in Wash DC - (12/14/09)
     
  1888. UK Government HCV Report: Increase In Hepatitis C Diagnoses For 2008, UK - (12/14/09)
     
  1889. GlaxoSmithKline looks to expand in emerging markets - (12/11/09)
     
  1890. NIAID Trial of 2009 H1N1 Influenza Vaccine Enrolling HIV-Positive Adults - (12/11/09)
     
  1891. Bodybuilders See Kidney Damage With Steroids - pdf attached of full published report - (12/11/09)
     
  1892. Breaking With Past, South Africa Issues Broad AIDS Policy - (12/09/09)
     
  1893. Obama Is Criticized on Global AIDS Program - (12/09/09)
     
  1894. After Setbacks, Small Successes for Gene Therapy - (12/09/09)
     
  1895. U.S. Rep. Hank Johnson battling hepatitis C; news reporter misstates HCV information - (12/08/09)
     
  1896. UCLA study: Stem cells can target and kill HIV-infected cells - (12/08/09)
     
  1897. New Initiative: "Positive Charge" to Help Address Barriers and Provide Support to People Living with HIV/AIDS - Funded by BMS - (12/08/09)
     
  1898. GlaxoSmithKline to reduce drug prices in emerging markets - (12/08/09)
     
  1899. Norvir (Ritonavir) Product Label Updated - (12/05/09)
     
  1900. Etravirine Label Updated With 48-Week Data - (12/05/09)
     
  1901. Projecting the Future Diabetes Population Size and Related Costs for the U.S.: costs projected to triple over 25 yrs - (12/03/09)
     
  1902. HIV-positive men at high risk for anal cancer - (12/03/09)
     
  1903. Future of Maine's Needle Exchange Programs in Doubt - (12/03/09)
     
  1904. Should drug companies conduct their own clinical trials? - (see full text of 3 BMJ articles below following this summary report. - (12/03/09)
     
  1905. Metabolic Syndrome Problematic After Liver Transplant - (12/03/09)
     
  1906. International collaborative research projects to decipher the biology behind the ageing process - (12/03/09)
     
  1907. New Parasitic Disease Among HIV-Infected Gay Men - (12/03/09)
     
  1908. New Initiative: "Positive Charge" to Help Address Barriers and Provide Support to People Living with HIV/AIDS: BMS Funds National AIDS Fund ProjectChina city Beijing government opens gay bar to fight AIDS - (12/03/09)
     
  1909. New Initiative: "Positive Charge" to Help Address Barriers and Provide Support to People Living with HIV/AIDS: BMS Funds National AIDS Fund Project - (12/03/09)
     
  1910. The International AIDS Society Announces Washington, DC, as Site of the XIX International AIDS Conference in July 2012, Removal of Entry Restrictions on People Living with HIV by the U.S. Allows for Return of Conference after 22-Year Absence - (12/03/09)
     
  1911. FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus - (12/03/09)
     
  1912. Drug companies to be hit by rising tax rates: report - (12/03/09)
     
  1913. Funding crisis "may force Euro biopharma out of R&D" - (12/03/09)
     
  1914. Valproate Sodium and related products (valproic acid and divalproex sodium): Risk of Birth Defects - (12/03/09)
     
  1915. Thai HIV Vaccine Study, Moving Forward in HIV Vaccine Development - Perspective - (12/03/09)
     
  1916. Vitamin D: A potential role in cardiovascular disease prevention - (12/03/09)
     
  1917. Boehringer Ingelheim: Announcing Mind Body HAART Web site - (12/03/09)
     
  1918. Lexiva (fosamprenavir calcium) - Dear Healthcare Professional Letter - (12/03/09)
     
  1919. Exploring a Low-Acid Diet for Bone Health - (11/25/09)
     
  1920. Zuma buries ghost of Mbeki's Aids denial in South Africa - (11/25/09)
     
  1921. Antidepressants/Sedatives-Three Drug Classes Associated with Falls in the Elderly - (11/25/09)
     
  1922. "Needle exchange is AIDS prevention that works", The Needle Nexus, NY Times - (11/25/09)
     
  1923. One in Four Teen Girls Have STDs Almost 20 percent get infected within one year of starting to have sex, CDC report says - (11/25/09)
     
  1924. Silent Epidemic of Viral Hepatitis May Lead to Boom in Serious Liver Disease - (11/20/09)
     
  1925. Drug Makers Raise Prices in Face of Health Care Reform - (11/20/09)
     
  1926. Seeking a Shorter Path to New Drugs - (11/20/09)
     
  1927. BMS signs billion-dollar pact with Alder for inflammatory drug - (11/20/09)
     
  1928. Merck and Schering-Plough Receive Approvals From U.S. Federal Trade Commission, Swiss Competition Commission and Canadian Competition Bureau for Merger - (11/06/09)
     
  1929. GlaxoSmithKline, Pfizer Establish ViiV Healthcare To tackle the increasingly diverse and complex needs of people living with HIV/AIDS worldwide CEO hopes to overtake Gilead, sees Selzentry as key driver - (11/06/09)
     
  1930. Older H1N1 Patients Most Likely to Die - (11/06/09)
     
  1931. IDSA: Opt-Out Tests for HIV Would Extend 610,000 Lives - (11/06/09)
     
  1932. Larger Merck says merger will actually increase R&D efficiency - (11/06/09)
     
  1933. CDC Urges Officials to Get H1N1 Vaccine to Those Most Vulnerable - (11/06/09)
     
  1934. 3TC/Tenofovir FDC Generic FDA Approved - (11/06/09)
     
  1935. Hearing Loss Study Focuses On AIDS Patients: "people with HIV may be aging prematurely. May play a role in hearing" - (11/06/09)
     
  1936. HIV+ African-Americans in SF Sicker, Benign Neglect: Research Shows Neighborhoods Where AIDS Treatments Lag - (11/06/09)
     
  1937. Merck's New Integrase Inhibitor Isentress & Daria Hazuda: The long path to developing an AIDS drug - (11/06/09)
     
  1938. Merck's New Integrase Inhibitor Isentress & Daria Hazuda: The long path to developing an AIDS drug - (11/06/09)
     
  1939. Johnson & Johnson to cut up to 8400 jobs - (11/06/09)
     
  1940. Merck & Co., Schering-Plough to complete merger Tuesday - (11/06/09)
     
  1941. New GSK/Pfizer Company: ViiV Heathcare - Video of Management - (11/06/09)
     
  1942. IMS Health to be sold for $5.2 billion - (11/06/09)
     
  1943. Another Kind of AIDS Crisis: Aging HIV, New York Magazine Article - (11/06/09)
     
  1944. Gout and Metabolic Disease Go Hand in Hand - (10/27/09)
     
  1945. States With The Most And Least H1N1 Vaccine Per 1,000 Residents - (10/27/09)
     
  1946. Vaccine Shipment Status State by State - (10/27/09)
     
  1947. Companies struggling to get H1N1 vaccine to US - (10/27/09)
     
  1948. Swine Flu Vaccine Scarcity Stirs Anger in U.S. Communities - (10/27/09)
     
  1949. Avoiding Guillan-Barre Syndrome Following Swine Origin Pandemic H1N1 2009 Influenza Vaccination - CORRESPONDENCE - (10/26/09)
     
  1950. Flu Shot Locator State by State - (10/26/09)
     
  1951. FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients, Settings - (10/25/09)
     
  1952. H1N1 Vaccine IS Available - (10/23/09)
     
  1953. Pelosi's effort to protect AIDS funds fails - (10/23/09)
     
  1954. Ryan White Pennsylvania Funding - (10/23/09)
     
  1955. Ryan White Care Act Gets Through Congress - (10/23/09)
     
  1956. HHS to Create a National Resource Center for Lesbian, Gay, Bisexual and Transgender Elders - (10/23/09)
     
  1957. D.C. officials respond to HIV/AIDS criticism - (10/20/09)
     
  1958. Manufacturers Come Up Short in Expected H1N1 Vaccine Production - (10/18/09)
     
  1959. Investigation: Earmarked AIDS funds lack oversight Dollars went to organizations cited for false documentation - (10/18/09)
     
  1960. Wash DC AIDS Service Organization Investigation: - (10/18/09)
     
  1961. Washington DC HIV ASO $$ Inquiry - (10/18/09)
     
  1962. Wash DC: Troubled groups get millions while well-regarded ones like Women's Collective teeter - (10/18/09)
     
  1963. Proposed US biogenerics pathway "would scarcely be used" - (10/17/09)
     
  1964. New Pfizer up and running on day one, R&D cuts expected - (10/17/09)
     
  1965. Oakland doctor Robert Scott devoted to care of HIV/AIDS patients dies at 65 - (10/17/09)
     
  1966. Pfizer completes Wyeth acquisition; may reduce research budget - (10/17/09)
     
  1967. H1N1 in HIV+ Pregnancy: recommendations for antiviral therapy with Tamiflu; NIH Launches New Study - (10/17/09)
     
  1968. A fish tale with merit: Omega-3 PUFAs underrated for heart failure; for prevention - (10/17/09)
     
  1969. FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys - (10/17/09)
     
  1970. FDA Approves GARDASIL® for Use in Boys and Young Men Merck Announces Programs to Enhance Vaccine Access - (10/17/09)
     
  1971. FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys - (10/17/09)
     
  1972. White House HIV Town Hall Meetings in LA & SF Oct 16, 18 - (10/17/09)
     
  1973. Pitt researchers find candidates for new HIV nef drugs - (10/16/09)
     
  1974. Fuzeon Sales - (10/16/09)
     
  1975. New NeuroAIDS Drug Study NeuroAIDS is Target of Federal Grant to Children's Hospital - (10/16/09)
     
  1976. Dr Robert Scott, Bay Area founder of AIDS Project dies - (10/13/09)
     
  1977. Teenager who died after having HPV vaccine had a malignant chest tumour - (10/12/09)
     
  1978. HPV Vaccine 'Not Cost Effective' for Boys - Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States - pdf attached - (10/12/09)
     
  1979. US Military HIV Vaccine Research Group Response - (10/12/09)
     
  1980. Data Call Into Question Thai HIV Vaccine Study Results - (10/12/09)
     
  1981. The HIV Vaccine and Science by Press Release - (10/12/09)
     
  1982. Unrevealed Analysis Weakens Claim of AIDS Vaccine "Success" - (10/12/09)
     
  1983. ADAP Waiting Lists Increasing: ADAP Watch from NASTAD - (10/09/09)
     
  1984. FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting HIV Therapy for the First Time - Pfizer Press Release - (10/09/09)
     
  1985. FDA Panel Backs Wider Use Of Pfizer HIV Drug Selzentry - Dow Jones - (10/09/09)
     
  1986. GlaxoSmithKline provides update on government orders for influenza A (H1N1) vaccine - (10/08/09)
     
  1987. FLORIDA: More than 1,800 Broward General Patients May Have Been Exposed to Blood-Borne Infection, nurse reused medical equipment intended for one-time use. - (10/08/09)
     
  1988. Pharma "Outcome Gauantees" - Drug Deals Tie Prices to How Well Patients Do - (10/08/09)
     
  1989. H1N1 Vaccine Deliveries Begin Early Doses to Arrive This Week - (10/07/09)
     
  1990. WHO says H1N1 vaccine safe, urges mass take-up - (10/07/09)
     
  1991. Boehringer Ingelheim Launches Co-Pay Rebate Program for Viramune - (10/07/09)
     
  1992. European regulators approve GSK's swine flu vaccine Pandemrix - (10/06/09)
     
  1993. Bundling Heart Meds Lowers Rates of MI and Stroke - (10/06/09)
     
  1994. FDA panel backs Schering-Plough cancer drug - (10/06/09)
     
  1995. Second-Generation Female Condom is Now Available in the United States; FC2 Female Condom Will Cost 30 Percent Less than Predecessor - (10/05/09)
     
  1996. Swine Flu Could Create Hospital Bed Shortage Report finds demand could exceed supply in 15 states - (10/05/09)
     
  1997. Swine Flu Spread Prompts Move on Vaccine - (10/05/09)
     
  1998. Health official: "Unlikely" that Cervarix caused death of girl in UK - (10/01/09)
     
  1999. Biologic Drugs Generics - (10/01/09)
     
  2000. Selective serotonin reuptake inhibitors and congenital malformations - Editorial - (10/01/09)
     
  2001. HIV Treatment Numbers Climb in Undeveloped Countries - (10/01/09)
     
  2002. Number of People Getting Lifesaving HIV Drugs Rises in Developing World - (10/01/09)
     
  2003. Vertex Raises $155M Through Debt Financing for Hepatitis C Drug in Europe - (10/01/09)
     
  2004. Federal Circuit Rules for Roche in HIV Test Kit Dispute with Stanford - (10/01/09)
     
  2005. FDA needs more time to complete review on GSK's Cervarix - (09/30/09)
     
  2006. EMEA recommends approval of GlaxoSmithKline's and Novartis' influenza A (H1N1) vaccines - (09/30/09)
     
  2007. Biomarker Predicts Prostate Cancer Mortality - (09/29/09)
     
  2008. HIV Vaccine Success May Take Decade to Unravel Why It Works - (09/29/09)
     
  2009. SSRIs in Pregnancy Hike Risk of Heart Defects for Babies - (09/29/09)
     
  2010. HIV Vaccine Reduces Infection Risk - (09/26/09)
     
  2011. GSK to reduce funding for CMEs - (09/25/09)
     
  2012. Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2 - (09/25/09)
     
  2013. For First Time, AIDS Vaccine Shows Some Success in Trials: the vaccine was 31.2 percent effective - (09/25/09)
     
  2014. Rockefeller virologists and MIT tissue engineers receive $5.8 million NIH grant to study hepatitis - (09/25/09)
     
  2015. Merck Gives $500 Million of Vaccine to Poorer Nations - (09/25/09)
     
  2016. Merck and QIAGEN Collaborate to Accelerate Access (Donate for Free) to Cervical Cancer Vaccination and Screening in Developing Countries - (09/25/09)
     
  2017. GlaxoSmithKline reported to be considering 5-percent stake in Dr. Reddy's - (09/21/09)
     
  2018. European Union Commission Approves Expanded Use of ISENTRESS (raltegravir), from MSD, in Adult Patients with HIV-1 Infection - (09/21/09)
     
  2019. September 18, 2009 Marks the Second Observance of National HIV/AIDS and Aging Awareness Day: 50% increase in HIV+ Individuals Over 50 Yrs Old in New York State - (09/21/09)
     
  2020. NY Prisons- HIV & HCV- New Health Dept Oversight - (09/21/09)
     
  2021. CDC Spells Out Process to Get Pandemic Vaccine to Patients - (09/21/09)
     
  2022. US patients "having major problems with mail-order pharmacy" - (09/21/09)
     
  2023. Black Men in Florida 5 Times Higher HIV Rate - (09/18/09)
     
  2024. Abbott Receives European Approval for Once-Daily Dosing of Kaletra (lopinavir/ritonavir) Tablet New Approval Expands Dosing Options for Adult HIV-Infected Patients New to Antiretroviral Therapy - Abbott Press Release - (09/18/09)
     
  2025. Insurer to Pay $10M for Rescission Based on HIV - (09/18/09)
     
  2026. FDA Approves Vaccines for 2009 H1N1 Influenza Virus Approval Provides Important Tool to Fight Pandemic - (09/17/09)
     
  2027. H1N1 Vaccines Safe, Immunogenic in Single Dose - (09/14/09)
     
  2028. Pandemic Influenza Vaccine Policy - Considering the Early Evidence EDITORIAL - (09/14/09)
     
  2029. Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine - Preliminary Report - (09/14/09)
     
  2030. Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine - Preliminary Report - (09/14/09)
     
  2031. Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infection in Two Summer Campers Receiving Prophylaxis --- North Carolina, 2009 - (09/14/09)
     
  2032. FDA Advisory Committee Recommends Approval for Use of GARDASIL(R) in Boys and Men - (09/14/09)
     
  2033. FDA panel backs Glaxo cervical cancer vaccine - (09/11/09)
     
  2034. FDA Panel Backs Gardasil for Use by Men - (09/11/09)
     
  2035. New Alzheimer's Gene Discovery Sparks Hope for Treatments - (09/11/09)
     
  2036. NY State DOH & NYC's St Vincent's Hospital Doctors Start Statewide Emergency Room Post-Exposure Prophylaxis Program Online - (09/11/09)
     
  2037. FDA staff post review of GlaxoSmithKline's Cervarix ahead of meeting - (09/11/09)
     
  2038. FDA reviewers: Merck & Co.'s Gardasil effective against genital warts in males - (09/11/09)
     
  2039. Patient with severe influenza A (H1N1) improves after treatment with intravenous Relenza: report - (09/11/09)
     
  2040. CDC: HIV & H1N1 - (09/11/09)
     
  2041. China's Sinovac to offer cheaper H1N1 flu shot - (09/06/09)
     
  2042. Novartis Says Swine Flu Vaccine Works Quickly - (09/06/09)
     
  2043. CDC Swine Flu Update Swine Flu Remains Mild as Vaccine Advances - (09/06/09)
     
  2044. 2 new antibodies found to cripple HIV - (09/06/09)
     
  2045. NY State may tighten review of inmate HIV/hepatitis care - (09/06/09)
     
  2046. Generic FDC EFV/3TC/TDF Approved by FDA - (09/06/09)
     
  2047. Potent HIV Antibodies Spark Vaccine Hopes - (09/06/09)
     
  2048. PTC THERAPEUTICS ANNOUNCES CNS DRUG DISCOVERY COLLABORATION WITH ROCHE - (09/04/09)
     
  2049. Justice Department Announces Largest Health Care Fraud Settlement in its History: Pfizer To Pay $2.3 Billion For Fraudulent Marketing - (09/04/09)
     
  2050. HIV-AIDS rate is increasing across Florida: HIV/AIDS is at a 'critical' level for men in Florida, a new study has found. - (09/04/09)
     
  2051. HIV-positives advised to get swine flu vaccine - (09/04/09)
     
  2052. China approves H1N1 vaccine - (09/04/09)
     
  2053. H1N1 Antivirals Access/HIV Guidance - (09/04/09)
     
  2054. Takeda starting cardiovascular trial on diabetes drug SYR-322 - (08/29/09)
     
  2055. 49 CU-Boulder students have flu; school says it's "probable" H1N1 & at Ohio Universities - (08/29/09)
     
  2056. Swine Flu Preparation, Projections for Autumn - (08/29/09)
     
  2057. FDA Update: New Intelence labeling: severe skin and hypersensitivity reactions - (08/28/09)
     
  2058. HHS Study for HIV+ Women of Color Quality of HIV Care - (08/28/09)
     
  2059. Circumcision no defense against HIV in gay men - (08/28/09)
     
  2060. Intelence (etravirine) Package Insert Update-Additional Information inserted this week - (08/26/09)
     
  2061. US pharma slammed over Obama "deal gone sour" - (08/26/09)
     
  2062. Swine flu (Update) roundup: Vaccine testing on track. Expected Flu Season in the Fall - (08/26/09)
     
  2063. Disparities in cancer care reflect hospital resources, U-M study finds - (08/26/09)
     
  2064. Gardasil Safe-FDA/CDC. Gardasil Vaccine Safety: Information from FDA And CDC on the Safety of Gardasil Vaccine - (08/20/09)
     
  2065. California Slashes & Redistributes SF & LA AIDS Funding: cuts for San Francisco near $4M - (08/19/09)
     
  2066. AHF - Groups to file complaints against 16 porn companies - (08/19/09)
     
  2067. Study on Vaccine for Cervical Cancer Finds Benefits Despite Some Risks - (08/18/09)
     
  2068. GSK Pandemic (H1N1) 2009 influenza Vaccine Studies update - (08/16/09)
     
  2069. CDC ADVISORY PANEL RECOMMENDS H1N1 VACCINE PRIORITY LIST - (08/16/09)
     
  2070. An HIV-Blocking Gel for Women: New 'Molecular Condom' Meant to Prevent AIDS Transmission - (08/14/09)
     
  2071. Protesters seek cheaper (HCV) drugs at HIV/AIDS meeting - (08/14/09)
     
  2072. Preventing Alzheimer's: Early Language Abilities May Protect Memory Decades Later - (08/12/09)
     
  2073. Generic 3TC Approved - (08/12/09)
     
  2074. Rapid Tests Miss Mark for Pandemic H1N1 Flu - treat empirically.... Evaluation of Rapid Influenza Diagnostic Tests for Detection of Novel Influenza A (H1N1) Virus --- United States, 2009 - (08/12/09)
     
  2075. Pandemic H1N1 vaccine development 'on track,' WHO vaccine head says - (08/12/09)
     
  2076. Medication, Masks, and Clean Hands Effective Against Flu - (08/12/09)
     
  2077. President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines for Patients with Drug-Resistant HIV in Developing Countries - (08/07/09)
     
  2078. Generic Reyataz-r/Truvada & Rifabutin Deal by Clinton/Pfizer/Generic Cos - (08/07/09)
     
  2079. Alzheimer's Linked to Cholesterol Level in Middle Age - (08/06/09)
     
  2080. Pursuing Salmon: It's Gotta Be Wild - (08/06/09)
     
  2081. Case Made for Broad Use of Omega-3 Fatty Acids - (08/05/09)
     
  2082. New BMS/Astra Zeneca Diabetes Drug FDA Approved - (08/04/09)
     
  2083. Legislators Challenge California Governor Over 'Crippling, Cascading' AIDS Cuts - (08/04/09)
     
  2084. Vitamin D deficiency common in U.S. children - (08/04/09)
     
  2085. FDA Approves Colchicine for Acute Gout, Mediterranean Fever - (08/01/09)
     
  2086. Nearing Telaprevir Endgame, Vertex Bulks up War Chest - (08/01/09)
     
  2087. FDA APPROVES TYVASO (TREPROSTINIL) INHALATION SOLUTION FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION - press release - (08/01/09)
     
  2088. Advocates fear spike in HIV due to CA budget cuts - (08/01/09)
     
  2089. FDA Warns Consumers Not to Use Body Building Products Marketed as Containing Steroids or Steroid-Like Substances - (07/30/09)
     
  2090. Cytoplasmic Talk Of Retroviruses, Such As HIV, Helps Them Spread From Cell To Cell - (07/30/09)
     
  2091. FDA says it is continuing with probe into Generics Mylan plant - (07/30/09)
     
  2092. House Bill Lifts Ban On Needle Exchanges - (07/29/09)
     
  2093. IDEAL Study Published-Pegasys v PegIntron - (07/29/09)
     
  2094. AIDS Can Sicken, Kill, Chimpanzees After All, Researchers Find - (07/29/09)
     
  2095. Vets affected by VA hospital errors to file claims - (07/29/09)
     
  2096. Generic d4T/3TC/NVP Fixed Dose Gets FDA Approval - (07/18/09)
     
  2097. Teen AIDS Rate Doubles in Past 10 Yrs CDC Reports - (07/18/09)
     
  2098. FDA Approves Generic Trizivir - (07/17/09)
     
  2099. NY Mt Kisco hospital warns of possible hepatitis exposures, Case Expands From Denver Hospital - (07/17/09)
     
  2100. Surgical Tech's Hep C Case Expands To New York - (07/17/09)
     
  2101. A Phase III Alzheimer's Drug Increase Levels of Beta Amyloid in the Brain - But Still Provides Benefits - (07/17/09)
     
  2102. Alzheimer's Doctors Rethink Disease After Mice Study - (07/17/09)
     
  2103. Preventing Alzheimer's: Early Language Abilities May Protect Memory Decades Later - (07/17/09)
     
  2104. Obama Pick to Head NIH Dr Francis Collins Draws Praise and Some Concern - (07/17/09)
     
  2105. Condoms Reduce Genital Herpes Risk - (07/16/09)
     
  2106. New Surgeon General Dr. Benjamin's AIDS Experience: brother died of AIDS - (07/16/09)
     
  2107. Biologics Patent Protection: Biotech Industry May Be Poised To Score Victory In House - (07/16/09)
     
  2108. Fish Oil Fails to Slow Alzheimer's Decline But Improved Cognitive Impairment - (07/15/09)
     
  2109. Dementia and marital status at midlife and late life - Editorials - (07/15/09)
     
  2110. GlaxoSmithKline agrees royalty-free licensing deal for HIV drug - (07/15/09)
     
  2111. Glaxo investing $97 mln in AIDS drugs for Africa - (07/15/09)
     
  2112. US commits an additional $884 million for influenza A (H1N1) vaccine - (07/15/09)
     
  2113. International development minister urges firms to pool HIV patents: "give up HIV drug patients in poor countries" - (07/14/09)
     
  2114. Comparative trial of Merck & Co., Schering-Plough's Zetia and Abbott's Niaspan halted early - (07/10/09)
     
  2115. Obama Warns of Return of Swine Flu in the Fall - (07/10/09)
     
  2116. HHS Flu Preparedness Summit July 9 2009 - (07/10/09)
     
  2117. New Lab Test Offers Better Prediction of HIV Microbicide Safety - (07/10/09)
     
  2118. Police: 26 arrested in AIDS protest at Wash DC Capitol - (07/10/09)
     
  2119. FDA Performance Goals for Approving Drugs and Biologics EDITORIAL - (07/09/09)
     
  2120. Antibody-Producing System Early Target of HIV - (07/09/09)
     
  2121. TherapyEdge and RightToCare Successfully Launch the New TherapyEdge Down Referral Software Patient Management System in Africa - (07/09/09)
     
  2122. US Department of Justice says drug patent settlements, delaying generics may be illegal - (07/09/09)
     
  2123. - (07/09/09)
     
  2124. WHO: Drug Resistance Expected in H1N1 Pandemic - (07/09/09)
     
  2125. Tamiflu resistant H1N1 from Hong Kong more worrying than earlier findings - (07/09/09)
     
  2126. Drug-Resistant Flu Strain Turns Up in Denmark but Doesn't Last Long - (07/09/09)
     
  2127. Tamiflu Transmitted resistant H1N1 from Hong Kong more worrying than earlier findings - (07/09/09)
     
  2128. Abbott Wins Ruling Tossing AIDS-Drug Norvir Monopoly Claims - (07/08/09)
     
  2129. European Commission approves statement on lipid improvement for Viramune® label - (07/08/09)
     
  2130. Muscle/myopathy Injury from Statins Can Hide Behind Normal Lab Tests - (07/08/09)
     
  2131. From Haiti, a surprise: good news about AIDS - (07/07/09)
     
  2132. Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy - (07/04/09)
     
  2133. Evidence That Proton-Pump Inhibitor Therapy Induces the Symptoms it Is Used to Treat EDITORIAL - (07/04/09)
     
  2134. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy - (07/04/09)
     
  2135. GSK spends £23.2 million to bag B-MS products in Middle East - (07/03/09)
     
  2136. Roche to Sell Tamiflu to Developing Countries at Lower Prices - (07/03/09)
     
  2137. 4.7% Pakistanis infected with hepatitis C - (07/03/09)
     
  2138. HIV-thrombocytopenia therapy infusion fraud: Miami Physician Sentenced to 97 Months in Prison for Role in $10 Million Medicare Fraud Scheme - (07/02/09)
     
  2139. Sanofi to Seek Advice on How to Further Study Lantus: Studies Finding Lantus Associated With Increased Risk For Cancers - (07/02/09)
     
  2140. HHS Proposal would remove ban on HIV foreigners' entry - (07/02/09)
     
  2141. FDA Panel Recommends Ban on 2 Popular Painkillers Vicodin, Percocet - (07/02/09)
     
  2142. FDA Advises Lower Dosage for Popular Painkiller Acetominophen - (07/02/09)
     
  2143. Acetominophen Painkiller Restrictions Urged Because of Threat of Liver Damage - (07/02/09)
     
  2144. FDA Panel Backs 'Black Box' Warning for Acetaminophen Prescription Combos - (07/02/09)
     
  2145. HIV-positive man's prison sentence shines light on Iowa law: may stimulate national discussion on criminal codes - (07/02/09)
     
  2146. Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection - (07/02/09)
     
  2147. Institute of Medicine report lists top priorities for comparative effectiveness research: will HIV ARTs be affected in the future - (07/02/09)
     
  2148. Oral Interferon-Alpha Lozenges Study - Amarillo, CytoPharm Intiates Enrollment For Hepatitis-C Study - (07/02/09)
     
  2149. Are Markers of Inflammation More Strongly Associated with Risk for Fatal Than for Nonfatal Vascular Events? - (07/02/09)
     
  2150. FDA: Boxed Warning on Serious Mental Health Events to be Required for Chantix and Zyban, Smoking Cessation Drugs - (07/02/09)
     
  2151. US FDA questions cancer link with Sanofi's Lantus - (07/02/09)
     
  2152. Diabetics urged to stay on popular insulin Lantus - (07/02/09)
     
  2153. FDA Notice: Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics) - Black Box warning - (07/02/09)
     
  2154. President & CDC urge All Americans Get HIV test as a way to halt AIDS - (06/30/09)
     
  2155. OraSure to conduct more testing on hepatitis C product - (06/30/09)
     
  2156. President & CDC urge All Americans Get HIV test as a way to halt AIDS - (06/30/09)
     
  2157. OraSure to conduct more testing on hepatitis C product - (06/30/09)
     
  2158. Stanford Professor Bob Shafer Settles with ABL in HIV Database Legal Spat; Pursues Patent Reexams - (06/27/09)
     
  2159. Massachusetts Health agency urges routine HIV screening - (06/27/09)
     
  2160. Progress Is Reported in Bronx 'Routine' H.I.V. Testing Campaign - (06/27/09)
     
  2161. FDA DDI Label Updates - (06/21/09)
     
  2162. Antioxidant Supplements Blunt Exercise-Induced Improvement of Insulin Sensitivity - (06/19/09)
     
  2163. Metformin May Help Improve Erectile Function - (06/18/09)
     
  2164. 2009 is the era of pharma merger mania - (06/18/09)
     
  2165. VA officials grilled over botched colonoscopies - (06/18/09)
     
  2166. L.A. County backtracks on reports of porn HIV cases - (06/18/09)
     
  2167. Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development - (06/18/09)
     
  2168. Arizona loses federal aid, limits HIV drugs for ADAP - (06/17/09)
     
  2169. Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer's disease - (06/17/09)
     
  2170. GSK signs deal with Dr Reddys for access to emerging markets - (06/17/09)
     
  2171. Psoriasis Linked to Comorbidities and Vascular Disease - (06/17/09)
     
  2172. California Compromises Restores Some AIDS Budget Cuts - (06/17/09)
     
  2173. AIDS Non-Profits Cut in San Jose - (06/17/09)
     
  2174. North Carolina Case Management Funding Threatened - (06/17/09)
     
  2175. Arizona loses federal aid, limits HIV drugs for ADAP - (06/16/09)
     
  2176. Depression and Insomnia May Be Genetically Linked - (06/16/09)
     
  2177. Novartis Hopeful of H1N1 Flu Vaccine by Autumn - (06/16/09)
     
  2178. New HIV Movie 'Safe Sex' Joe Sonnabend: Daryl Wein's documentary focuses on three men who made a difference as the AIDS crisis broke in the '80s. - (06/16/09)
     
  2179. Insomnia Linked to Premature Death in Men - (06/16/09)
     
  2180. IAS 2012 AIDS Meeting in Wash DC Demands Lift of U.S. Ban on HIV-Infected Visitors - (06/12/09)
     
  2181. Diabetes Control Improved Heart Function - (06/12/09)
     
  2182. Tight Glucose Control Did Not Appear to Increase Mortality Risk - (06/12/09)
     
  2183. Serostim Prescription Fraud - Man Gets 52 Months Jail - (06/12/09)
     
  2184. Arizona cuts ADAP Funds - (06/12/09)
     
  2185. Sacramento protest to draw attention to AIDS/HIV cuts - (06/12/09)
     
  2186. Study Links Gay Marriage Bans to Rise in HIV Rate - (06/10/09)
     
  2187. Analysis of Subjects with Moderately Severe Diabetic Neuropathy Shows Statistically Significant Improvement in Multiple Quantitative Neurological Endpoints - (06/10/09)
     
  2188. Less Sleep May Mean Higher Blood Pressure - (06/10/09)
     
  2189. ADA: Diagnose Diabetes with A1c Test - (06/09/09)
     
  2190. 'Shock And Kill' Research Gives New Hope For HIV-1 Eradication - (06/08/09)
     
  2191. Hopes of HIV cure revived with 'shock and kill' technique that rids body of dormant viruses - (06/08/09)
     
  2192. EU-funded research sheds light on 'shock-and-kill' eradication strategy against HIV-1 - (06/08/09)
     
  2193. Oral Sex and HIV Risk - CDC Report - (06/08/09)
     
  2194. Dallas to cut $325K for HIV/AIDS - (06/08/09)
     
  2195. As Treatment for HIV/AIDS Changes, So Does Role for Specialized Clinics - (06/08/09)
     
  2196. Calif. man sentenced in NH for HIV drug Serostim conspiracy - (06/08/09)
     
  2197. AIDS 2009 State & ADAP Budget Cuts from NASTAD Reports - (06/08/09)
     
  2198. HIV-positive man arrested for forced, unprotected sex and charged with attempted murder - (06/05/09)
     
  2199. NIH Will Use Stimulus Funds to Test Feasibility of 'Universal' HIV Testing - (06/04/09)
     
  2200. Despite Strings, NIH Will Focus Money on Science - (06/04/09)
     
  2201. New FDA Transparency Task Force: US public to have "a seat at FDA table" - (06/04/09)
     
  2202. The UK's appalling failure to tackle HIV Editorial - (06/04/09)
     
  2203. Theratechnologies Files a New Drug Application for Tesamorelin With the US Food and Drug Administration - (06/04/09)
     
  2204. New Portable Low Cost CD4 Test: Melbourne HIV test could help millions - (06/04/09)
     
  2205. Low-Fat Chocolate Milk Aids Muscle Recovery as effective as commercial sports drinks - (06/04/09)
     
  2206. GSK's New Drug Concept, New HIV Protease-like Reyataz - (06/04/09)
     
  2207. California $80M Proposed AIDS Cuts - (06/04/09)
     
  2208. HIV Budget Cuts in New York - Albany, give them shelter: HIV-infected New Yorkers pay too much for rent - (06/03/09)
     
  2209. $600M Black Clergy HIV Bill in Congress: Across Tampa Bay, black churches speak out on HIV and AIDS - (06/03/09)
     
  2210. DDW: Fatty Liver Can Lead to Liver Cancer, Cleveland Clinic reports at DDW - (06/03/09)
     
  2211. GSK Acquisition 'may improve metabolic properties of drugs' - (06/03/09)
     
  2212. Indiana removes gay white men from HIV/AIDS funding priorities - African American/Hispanic MSM & Heterosexual African-American Women Prioritized - (06/03/09)
     
  2213. California $80M Proposed AIDS Cuts - (06/03/09)
     
  2214. California HIV Budget Cut 'Recession Patients', 'many patients come in after going months without medical attention' - (06/02/09)
     
  2215. Sanofi receives H1N1 strain and gears up for production - (06/02/09)
     
  2216. Virco BVBA signs Hepatitis C licensing agreement with Siemens Healthcare Diagnostics Inc. - (06/02/09)
     
  2217. UK trade office may check GSK and Pfizer HIV joint-venture - (06/02/09)
     
  2218. Frisco man gets 45 years for hiding HIV infection from sex partners - (06/02/09)
     
  2219. Women Angry- Texan gets 45 years for spreading HIV - (06/02/09)
     
  2220. Flu Antivirals Stockpiles, Treatment for Prevention and Infection  - (06/02/09)
     
  2221. 4 NYC deaths linked to swine flu - (06/01/09)
     
  2222. CDC Update: Prepares for Swine Flu Surge in Fall - Swine Flu Still Hot in Northeast but Easing in Most of U.S. - (06/01/09)
     
  2223. The FDA as a Public Health Agency: Margaret A. Hamburg, M.D., and Joshua M. Sharfstein, M.D. - (06/01/09)
     
  2224. FDA Issues Proposed Ad Guidelines For Drugs, Medical Devices - (06/01/09)
     
  2225. Cuts to California AIDS budget remain in flux - (06/01/09)
     
  2226. Sanofi to Pay $95.5 Million, Settle False-Claims Case - (06/01/09)
     
  2227. FDA Document: FDA proposes guidelines for presenting drug risk details in promotional materials - (06/01/09)
     
  2228. California AIDS Budget Cuts- Emergency Meeting of the LA County Commission on HIV - (06/01/09)
     
  2229. GARDASIL® is First Cervical Cancer Vaccine to Receive WHO Pre-qualification - (05/29/09)
     
  2230. AIDS Cuts Proposed for California - (05/28/09)
     
  2231. Merck Gets High Court Hearing on Investor Vioxx Suit - (05/28/09)
     
  2232. Merck Serono Launches Thyroid Disorder Awareness Campaign: Millions at risk as thyroid disorders remain undiagnosed - But Serono USA refuses community request for tesamorelin early access program - (05/28/09)
     
  2233. "Attacking Addiction: Cure in a Cocktail?", New Drug Therapy Approach with 'Prometa' - (05/28/09)
     
  2234. Feds target Detroit area as HIV-Medicare fraud rises - (05/28/09)
     
  2235. WHO chief warns H1N1 swine flu likely to worsen - (05/28/09)
     
  2236. New vaginal ring may help block HIV & STIs - (05/26/09)
     
  2237. Cream with green tea extract hinders HIV transmission: study - (05/26/09)
     
  2238. Black Women Contract HIV/AIDS Mostly Through Heterosexual Activity - (05/26/09)
     
  2239. Koronis Pharmaceuticals' Scientific Advisory Board Confirms KP-1461 Clinical Drug Activity, HIV Ablation - (05/22/09)
     
  2240. In India, 40 Million HBV+ & 25 Million HCV+ - (05/22/09)
     
  2241. Mexican Response to H1N1 'Could Have Been Faster'; will this virus return as a panemic? - (05/22/09)
     
  2242. J&J looks to end Remicade pact with S-P after Merck merger - (05/22/09)
     
  2243. U.S. Says Older People Appear Safer From New Flu Strain - (05/22/09)
     
  2244. California lawyer sentenced in Serostim diversion scheme - (05/22/09)
     
  2245. Natalie Cole receives new kidney - (05/22/09)
     
  2246. HIV Biotech Meeting in Atlanta - (05/22/09)
     
  2247. Self-Monitoring HIV Viral Load Device in Development - (05/22/09)
     
  2248. Flu-like Illness May Herald CA-MRSA Pneumonia - (05/22/09)
     
  2249. Pfizer expands generics through major deals with Indian firms - (05/22/09)
     
  2250. Statement by Friends & Family of Rodger McFarlane on his Death - (05/21/09)
     
  2251. HIV-positive man sues assisted living facility after being kicked out - (05/20/09)
     
  2252. Quadrivalent HPV Vaccine Gardasil Reduces Persistent Anogenital HPV Infection in Men Who Have Sex With Men: Presented at IPV - (05/20/09)
     
  2253. New York City DOH Commissioner Tom Frieden Is Obama Pick for C.D.C. Director - (05/20/09)
     
  2254. New York City DOH Commissioner Tom Frieden Is Obama Pick for C.D.C. Director - (05/18/09)
     
  2255. Pfizer Provides Free Drugs for Unemployed Through MAINTAIN Program - (05/18/09)
     
  2256. Australian Online HIV predator's accusers go public - (05/18/09)
     
  2257. Aussie HIV+ man catches prey on web - (05/18/09)
     
  2258. Obama budget short on AIDS funding - (05/14/09)
     
  2259. HHS Ryan White Funding Award Announced - (05/14/09)
     
  2260. Medicare Trust Fund to Run Dry in 2017 - (05/14/09)
     
  2261. Vitamin D3 May Protect Against Nonmelanoma Skin Cancer - (05/14/09)
     
  2262. Emergency Room's offer HIV tests in bid for prevention - (05/14/09)
     
  2263. Scientific Evidence Supports WHO's Action To Declare H1N1 Flu Pandemic As 'Imminent' - (05/13/09)
     
  2264. Drugmakers in coalition to save $2 trillion for US health reform - (05/13/09)
     
  2265. With Health Care Groups at the Table, Analysts Urge Caution on Industry Promises: health industry pledge $2 Trillion Cut - (05/13/09)
     
  2266. Health Reform Battle- Idustry/Obama. Obama's Push for Health Care Cuts Faces Daunting Odds - (05/13/09)
     
  2267. Government + Industry??? Health Care Reform: What's in It for Patients? - (05/13/09)
     
  2268. Health Reform: Public vs Private Health Plan - (05/13/09)
     
  2269. Doctors Revolt - (05/13/09)
     
  2270. Media comment on medicines may constitute advertising, says EU Court - (05/13/09)
     
  2271. GSK gets 16% stake in South Africa's Aspen - (05/13/09)
     
  2272. Bid to name Rio de Janeiro's HIV carriers online sparks row - (05/13/09)
     
  2273. HIV Among Blacks Near Epidemic Levels, Advocates Say - (05/13/09)
     
  2274. Lancet article critical of Gates giving - (05/12/09)
     
  2275. New Gardasil Data Presented at International Papillomavirus Conference (IPC) in Sweden Merck Press Announcement - (05/12/09)
     
  2276. Medical journal scolds Gates Foundation: Gates Response - (05/12/09)
     
  2277. What has the Gates Foundation done for global health? Lancet EDITORIAL - (05/12/09)
     
  2278. The Bill & Melinda Gates Foundation's grant-making programme for global health - (05/12/09)
     
  2279. CDC Update: Novel Influenza A (H1N1) Virus Infections --- Worldwide, May 6, 2009 - (05/11/09)
     
  2280. AIDS Budget from Obama-Disappoints Advocates Obama seeks $107 million boost in domestic AIDS spending - (05/11/09)
     
  2281. Obama Budget Bans Federal Funding For Needle Exchange, Breaking Campaign Pledge - (05/11/09)
     
  2282. Cervarix & Gardasil New Studies Reported at the International Papillomavirus Conference at Malmo, Sweden - (05/11/09)
     
  2283. HIV case brings 25-year sentence for Having Sex with Man Without Disclosing HIV Status - (05/07/09)
     
  2284. WHO head indicates full flu pandemic to be declared - (05/07/09)
     
  2285. New York State Proposes Universal Health Care Plan - (05/07/09)
     
  2286. Obama announces $63 Billion global health effort - (05/07/09)
     
  2287. Obama administration seeks $63B for world health - Why? For Peace.... - (05/07/09)
     
  2288. Swine influenza: how much of a global threat? The Lancet Editorial - (05/07/09)
     
  2289. Swine influenza: how much of a global threat? The Lancet Editorial - (05/07/09)
     
  2290. Swine Flu Reaches Three Continents With 'Less Severe' Illness - (05/04/09)
     
  2291. Latest updates on the influenza A (H1N1) outbreak - (05/04/09)
     
  2292. CDC HIV & SWINE FLU UPDATE - (05/04/09)
     
  2293. Crowley addresses AIDS activists - (05/01/09)
     
  2294. Bristol-Myers Squibb Announces Call for Entries for the 2009 REYATAZ® (atazanavir sulfate) "Fight HIV Your Way" Contest - (04/29/09)
     
  2295. U.S. Declares Public Health Emergency Over Swine Flu - NYC, USA, Global News - (04/28/09)
     
  2296. FDA OKs Anti-Inflammatory Drug Simponi for Rheumatoid Arthritis - (04/28/09)
     
  2297. New Swine Flu Feared To Be Weaponized Strain - (04/28/09)
     
  2298. Atripla Co-Pay Assistance Program - (04/27/09)
     
  2299. Virco Lab, Inc. Enters Into Collaboration with SmartGene, Inc. Enhancing HIV Resistance Test Services for Laboratories and Physicians - (04/22/09)
     
  2300. Miami VA tests find 7 cases of hepatitis C, 1 HIV - (04/21/09)
     
  2301. Action Urged on Routine HIV Testing; IDSA/ACP Urge Routine HIV Testing & Universal Opt-Out, Access to Skilled Providers, Comprehensive Care & Subscriptions Coverage, Comprehensive Sex Education (condoms available), Broader coverage and reimbursement for care by federally supported healthcare programs and elimination of requirements for a separate informed consent for HIV testing - (04/21/09)
     
  2302. GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business - (04/21/09)
     
  2303. Glaxo to buy Stiefel Labs for up to $3.6 bln - (04/21/09)
     
  2304. Tennessee VA: 3 patients HIV-positive after exposure to faulty equipment - (04/21/09)
     
  2305. Osteoporosis Drug Teriparatide Speeds Fracture Healing - (04/20/09)
     
  2306. New GSK-Pfizer HIV Merged Company - (04/20/09)
     
  2307. Glaxo, Pfizer in HIV drug deal - (04/20/09)
     
  2308. HIV deal shows need for new pharmaceutical models- GSK Gets Maraviroc - (04/20/09)
     
  2309. Gilead Initiates Phase II Clinical Trial of Integrase-Based, Single-Tablet, Once-Daily Regimen for the Treatment of HIV - (04/20/09)
     
  2310. Polyunsaturated Fats Help the Heart - (04/20/09)
     
  2311. FDA Sprout Recall Due to Potential Contamination with Listeria - (04/17/09)
     
  2312. Medical Groups Seek Boost in Pay for DEXA - (04/17/09)
     
  2313. Access to Osteoporosis Testing for Americans in Jeopardy - (04/17/09)
     
  2314. Ardea HIV NNRTI May Treat Gout to An HIV Drug. Or A Gout Drug? Or Both. . . - (04/17/09)
     
  2315. Stuart James McDonald pleads not guilty to HIV sex attacks - (04/17/09)
     
  2316. Ignoring Addiction in Prison/Jails Increases HIV & HCV Infections - (04/17/09)
     
  2317. HIV/AIDS: South struggles against rising problem. Not enough funding, doctors, education to fight growing problem - (04/17/09)
     
  2318. Dendreon prostate cancer immunotherapy vaccine improves survival; the company develops immunotherapies for cancers - (04/17/09)
     
  2319. HIV/AIDS Complacency in USA - (04/17/09)
     
  2320. Obama Administration & HIV & Blacks - (04/17/09)
     
  2321. Statins Cut Stroke Risk by One-Fifth in Meta-Analysis - (04/17/09)
     
  2322. A Policy Cocktail for Fighting HIV: 3 approaches - PrEP, universal testing/immediate ART, 'cure'/functional cure research - (04/17/09)
     
  2323. GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company - (04/17/09)
     
  2324. Community Update: Creation of a new company dedicated to the discovery and delivery of treatments for HIV a collaboration between GSK and Pfizer - (04/17/09)
     
  2325. GlaxoSmithKline and Pfizer Inc announced innovative agreement that they would create a 'new-world HIV focused specialist' company ('Newco') - (04/17/09)
     
  2326. Link Between Atrial Fibrillation, Bisphosphonates Still Cloudy - (04/17/09)
     
  2327. Preventing Colon Cancer, Screening Recommendations by New York City Department of Health and Mental Hygiene - (04/17/09)
     
  2328. FDA Labeling changes for Kaletra reflecting new QT/QTC interval and PR interval prolongation information - (04/10/09)
     
  2329. Insulin Resistance Linked to Fat & Protein Intake - Insulin Resistance Linked to Protein 'Signature' - (04/10/09)
     
  2330. Awareness Campaign On HIV/AIDS Begins U.S. to Spend $45 Million Over 5 Years - (04/10/09)
     
  2331. PEPFAR Cut AIDS Death by 10%, 1.2 Million in Africa - (04/08/09)
     
  2332. VA patient tests HIV-positive after clinic mistake - (04/08/09)
     
  2333. US cancer drug R&D "at record levels" - 861 new cancer drugs in development stage - (04/08/09)
     
  2334. Routine HIV testing recommended for women - (04/08/09)
     
  2335. More debate urged after historic HIV murder verdict for HIV+ Who Transmitted HIV by Sex To Multiple Women Who Died From HIV - (04/07/09)
     
  2336. The bed bugs bite, but they won't spread disease (HIV), report says - (04/07/09)
     
  2337. Rejection painful for gay men with HIV - (04/07/09)
     
  2338. AASLD Practice Guidelines: Diagnosis, management, and treatment of hepatitis C: An update, pdf attached - (04/06/09)
     
  2339. Fauci: Why there is no AIDS vaccine- "it is possible that an HIV vaccine alone will never fully prevent HIV infection the way smallpox or polio vaccines can" - (04/03/09)
     
  2340. Tentaive approval of generic nevirapine tablets, 200 mg - (04/03/09)
     
  2341. Leading HIV Experts Convene to Tackle the Challenge of Late Presentation in Europe - (04/03/09)
     
  2342. Hughes Backs Institute at Epicenter of HIV and Resistant TB in Durban, South Africa - (04/03/09)
     
  2343. ImQuest Presents Data on the Anti-Hepatitis B Virus Activity of Pyrimidinediones at the 13th ISVHLD Meeting in Washington D.C. - (04/01/09)
     
  2344. Tentative approval emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg - (04/01/09)
     
  2345. HCV Prison-Provider Telemedicine: Ironwood Calif Prison hosts Hepatitis C conference - (04/01/09)
     
  2346. Expand Medicaid to HIV+ with Low Income ETHA Bill Introduced - (04/01/09)
     
  2347. Expand Medicaid to HIV+ with Low Income ETHA Bill Introduced - (03/30/09)
     
  2348. HIV/TB Report from WHO: HIV/TB coinfection rates higher than expected - (03/27/09)
     
  2349. GSK puts 800 patents in 'pool', expands trials transparency - (03/27/09)
     
  2350. Glaxo to buy stake in S.Africa's Aspen -sources - (03/27/09)
     
  2351. HIV Medicaid Drug co-payments in Corzine budget draw fire - (03/27/09)
     
  2352. Prescription Financial Assistance Program - (03/24/09)
     
  2353. D.C. AIDS Crisis is Scandalous: What the Mayor Won't Tell You About D.C. - (03/24/09)
     
  2354. The Challenges of Microbicides, How HIV prevention has defied science - (03/24/09)
     
  2355. FDA Approved First DNA Test for Two Types of Human Papillomavirus - (03/17/09)
     
  2356. Gilead Expands Into Heart Disease As HIVers Age: Gilead Sciences relies on CV Therapeutics, other deals to expand - (03/17/09)
     
  2357. HIV/AIDS Rate in D.C. Hits 3% - (03/17/09)
     
  2358. Where Is New Drug Development Going To Come From: 'Stem Cells and the Truth About Medical Innovation' - (03/17/09)
     
  2359. 2 Miami-Dade doctors, 2 assistants convicted of Medicare fraud - (03/17/09)
     
  2360. Tentative approval of stavudine and lamivudine fixed dose combination tablets - (03/17/09)
     
  2361. Idaho Man Charged -- Again -- With Knowingly Spreading HIV - (03/16/09)
     
  2362. Drug-Industry Shakeout Hits Small Firms Hard - (03/13/09)
     
  2363. FDA Tentative approval of lopinavir/ritonavir Tablets , 200 mg/50 mg - (03/13/09)
     
  2364. Gilead Sciences Agrees to Acquire CV Therapeutics for $20.00 Per Share - (03/13/09)
     
  2365. Norwegian activists call for repeal of HIV law that criminalizes sexual HIV transmission - (03/13/09)
     
  2366. Merck to Buy Schering-Plough for $41.1 Billion - (03/10/09)
     
  2367. New York State of Denial: HIV & Women of Color in NYC - Natl Women & Girls HIV Awareness Day - (03/10/09)
     
  2368. Senate Rejects Omnibus Spending Bill Amendment on Ryan White Funding Allocation - (03/10/09)
     
  2369. Text Messages Aid HIV Patients in Rural Areas - (03/10/09)
     
  2370. HIV EXPERTS PROPOSE NEW APPROACH TO ERADICATE HIV IN LATEST ISSUE OF SCIENCE - (03/09/09)
     
  2371. Vertex beats out Big Pharma to acquire ViroChem for $375M - (03/09/09)
     
  2372. Man found guilty in HIV sex assault case - (03/04/09)
     
  2373. Switzerland: Geneva Court of Justice accepts 'Swiss statement', quashes HIV exposure conviction - (03/04/09)
     
  2374. Tentative approval of stavudine, lamivudine and nevirapine fixed dose combination tablets - (03/04/09)
     
  2375. HIV, AIDS pose serious economic/social risk to South Asia: World Bank Report - (03/04/09)
     
  2376. AIDS drugs' success fuels a new apathy among teens/young adults: New AIDS Cases Highest in South Florida - (03/04/09)
     
  2377. Older people face greater HIV infection risks due to Viagra: WHO study - (03/04/09)
     
  2378. HIV/AIDS mortality rates show no improvement in Mexico: 'lack of patient adherence' - (03/04/09)
     
  2379. Obama picks top advisor to head HIV/AIDS efforts - Office of National AIDS Policy (ONAP) - (03/02/09)
     
  2380. FDA/Justice Dept Investigates Generic Drug Maker For 'Faking Generic Drug Test', Including AIDS PEPFAR Drugs - (03/02/09)
     
  2381. Big Drug Makers May Seek to Fill Holes in Roster By Buying Other Companies - (02/27/09)
     
  2382. Mylan's Matrix Receives WHO Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor - (02/27/09)
     
  2383. Ranbaxy facility in India falsified data, claims FDA - (02/27/09)
     
  2384. Congress' AIDS Funding Criticized: Flat Funding for HIV Prevention/Treatment, Obama Disappoints? - (02/27/09)
     
  2385. Bristol-Myers Squibb donates $1.17m to hepatitis C projects - (02/25/09)
     
  2386. Drug giant GlaxoSmithKline pledges cheap medicine for world's poor - (02/25/09)
     
  2387. Pfizer's future tied to biotechnology New outlook coincides with last month's deal to acquire Wyeth - (02/25/09)
     
  2388. Pfizer to list payments to doctors, researchers, Other Drugmakers Disclose To - (02/25/09)
     
  2389. GSK lays out plans to seriously tackle disease in developing world - (02/25/09)
     
  2390. Stimulus Bill Gives $1.1 Billion for Comparative Effectiveness Research - (02/25/09)
     
  2391. Reusing Syringes Causes HBV Outbreak in India - (02/25/09)
     
  2392. Panacos Provides Corporate and Strategic Update - (02/25/09)
     
  2393. Stimulus Money Goes To South Carolina budget plans to prevent HIV/health care cuts - (02/25/09)
     
  2394. Vertex founder Josh Boger to retire as president, CEO - (02/07/09)
     
  2395. Young Black MSM - Risky Behavior Increases HIV Risk: 69% had unprotected anal intercourse- new CDC study - (02/07/09)
     
  2396. Issentress Receives Traditional Approval from the FDA - (02/05/09)
     
  2397. AIDS Group opposes NYC health official Thomas Frieden for CDC job But Others Support Him - (02/05/09)
     
  2398. Bristol-Myers Squibb shares climb on takeover rumours - (02/04/09)
     
  2399. FTC takes drugmakers to court over AndroGel agreement - (02/04/09)
     
  2400. GSK on the brink of announcing thousands of job cuts? - (02/04/09)
     
  2401. The global financial crisis: an acute threat to health COMMENT - (02/04/09)
     
  2402. Controversy over PEPFAR, Mark Dybul, and Who Should Replace Him: After Departure, No Leader for U.S. AIDS Program - (02/04/09)
     
  2403. Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock - (02/03/09)
     
  2404. EMEA: D.A.D. Study Expands - (02/03/09)
     
  2405. Gilead Reports on HIV & HCV Pipeline - (01/29/09)
     
  2406. Stem Cell Research Cleared by FDA: Geron trial approval marks new era for stem cell research - (01/27/09)
     
  2407. Hidden HIV epidemic amongst MSM in Eastern Europe and Central Asia - (01/26/09)
     
  2408. 100,000 unaware in UK they have hepatitis C, poll suggests - (01/26/09)
     
  2409. In Wyeth, Pfizer Saw Drug Pipeline: biologics, vaccines - (01/26/09)
     
  2410. Pfizer to buy Wyeth for $68 billion Cash-and-stock deal will keep Pfizer the No. 1 drugmaker. Company announces sharp drop in profit. - (01/26/09)
     
  2411. Pfizer in Talks to Buy Wyeth - (01/23/09)
     
  2412. Online STI Sex Partner Notification Service - (01/22/09)
     
  2413. Myriad Pharmaceuticals Acquires Novel HIV Drug, Bevirimat, a First-in-Class Maturation Inhibitor, Represents a New Class of HIV Drugs - (01/22/09)
     
  2414. Panacos Says It Is Developing 2nd Generation HIV Maturation Inhibitors - (01/21/09)
     
  2415. Myriad Pharmaceuticals Acquires Novel HIV Drug, Bevirimat - (01/21/09)
     
  2416. HIV testing available, but care scarce: economic slowdown may affect routine HIV testing programs - (01/21/09)
     
  2417. Progressives Hope U.S. Shifts Global Social and HIV/AIDS Policies - (01/21/09)
     
  2418. NIAID Honors AIDS Activist Martin Delaney - (01/20/09)
     
  2419. Parexel adjusts guidance after default by biopharma client - (01/20/09)
     
  2420. Former FDA officer attacks US plans for comparative effectiveness in Congress Stimulus Bill - (01/20/09)
     
  2421. Project to study Hispanic HIV issues in 7 Counties in Florida - (01/20/09)
     
  2422. Healthcare to Reap $160 Billion from Proposed Stimulus Plan - (01/20/09)
     
  2423. PEPFAR, Bush's legacy: An unlikely champion - (01/17/09)
     
  2424. Idenix About To Announce Outlicensing of HIV NNRTI IDX899 - (01/15/09)
     
  2425. New HIV Target Identified for Possible ART Drug Development: Mutant host cell protein sequesters critical HIV-1 element - (01/15/09)
     
  2426. Demand for cholesterol, diabetes, hypertension drugs will be flat in 2009 - (01/14/09)
     
  2427. Hepatitis C action plan 'delayed' in UK - (01/14/09)
     
  2428. Bristol Myers Squibb: strengthening the hepatitis C pipeline - (01/14/09)
     
  2429. Pfizer Plans to Lay Off Researchers - (01/13/09)
     
  2430. Sexually transmitted disease rates soar: CDC - (01/13/09)
     
  2431. 9 Possible Pharma Deals for '09 - (01/13/09)
     
  2432. Gilead to Start Advanced Trial of First Four-in-One AIDS Drug - (01/13/09)
     
  2433. 9 Possible Pharma Deals for '09 - (01/13/09)
     
  2434. Gilead to Start Advanced Trial of First Four-in-One AIDS Drug - (01/13/09)
     
  2435. AIDS battle burnishes Bush's legacy in Africa: critics and praises - (01/12/09)
     
  2436. Daschle Makes Case for Appointment to HHS Post - (01/09/09)
     
  2437. Big Pharma Mergers/Acquisitions Outlook: Glaxo CEO sees more bolt-on acquisitions in 2009 - (01/09/09)
     
  2438. Biotechs feel the pain, strapped for cash, Big Pharma Presence - (01/09/09)
     
  2439. Health group says local hepatitis C rate 'alarming' in at-risk residents: HCV testing by Western Colorado AIDS Project - (01/09/09)
     
  2440. HIV-Positive Surgeon Allowed Back into Operating Room - (01/09/09)
     
  2441. AFGHANISTAN: HIV-positive patients to get ARV therapy for first time - (01/09/09)
     
  2442. New HIV Capsid Assembly Inhibitor Development - (01/07/09)
     
  2443. Reissued patent on Lipitor boosts Pfizer - (01/07/09)
     
  2444. Ziagen 300 mg scored tablet facilitates pediatric treatment of infection with HIV - (01/06/09)
     
  2445. New 75 mg Prezista tablet and corresponding pediatric dosing information approved - (01/06/09)
     
  2446. Approval of Generic abacavir sulfate and lamivudine fixed-dose combination - (01/06/09)
     
  2447. German govt "to force drugmakers to sell through wholesalers" - (01/05/09)
     
  2448. What Lies Behind the Fall in the HIV Population in India? - (01/05/09)
     
  2449. Pfizer eyes merger deal with large rival - (01/05/09)
     
  2450. Generic d4T Capsules & Oral Solution Approved - (01/02/09)
     
  2451. GAO Report Examines Effect of Part D Expense Cap on Ryan White Grantees - (12/23/08)
     
  2452. In Young Men, HPV Vaccine Prevents Conditions That Lead to Cancer - (12/22/08)
     
  2453. Glaxo, Dynavax To Develop Immuno-Inflammatory Disease Treatments - (12/18/08)
     
  2454. Researchers Successfully Used the 454 Sequencing System for Sensitive Detection of HIV Tropism - (12/18/08)
     
  2455. Glaxo, Dynavax To Develop Immuno-Inflammatory Disease Treatments - (12/18/08)
     
  2456. HPV Vaccine Gardasil May Help Boys, Men - (12/18/08)
     
  2457. Bristol-Myers Plans Additional Layoffs - (12/18/08)
     
  2458. HIV infects women through healthy tissue: U.S. study - (12/18/08)
     
  2459. MAN FAKED HIV TEST RESULTS SO THAT HE COULD HAVE UNPROTECTED SEX WITH HIS GIRLFRIEND ... IT TURNS OUT HE WAS POSITIVE!!! - (12/16/08)
     
  2460. Criminalization of Non-Disclosure of HIV Status: Should Nebraska require partners to be informed if you have HIV? - (12/16/08)
     
  2461. Generic Efavirenz for Peds FDA Approved - (12/16/08)
     
  2462. New Roche Dual Target HIV-1 Test Approved for Use in European Union - (12/16/08)
     
  2463. EU to ease curbs on Rx drug info to patients - (12/16/08)
     
  2464. Drug price controls may shorten lives: report - (12/16/08)
     
  2465. Sanofi-Aventis And Bristol-Myers Squibb Prevail Before The U.S. Court Of Appeals For The Federal Circuit In The U.S Plavix(R) Patent Infringement Case - (12/15/08)
     
  2466. Expand AIDS testing- Routine HIV Testing EDITORIAL - (12/15/08)
     
  2467. Homosexuality needs to be curbed as it spreads HIV/AIDS: Centre to HC - (12/09/08)
     
  2468. Roche Chief Warns of a Likely Shakeout Among Drugmakers - (12/09/08)
     
  2469. Malaria Vaccine Candidate Advancing in Africa Data in infants and young children - (12/09/08)
     
  2470. Discovery of virus in lemur could shed light on AIDS - (12/03/08)
     
  2471. HIV Diagnoses Among Gay Men Continues to Rise in UK - (12/03/08)
     
  2472. Bone Finding May Point to Hope for Osteoporosis - (12/02/08)
     
  2473. New anti-inflammatory compound promising in ACS - (12/02/08)
     
  2474. AIDS patients (who are "sexually aggressive") in Indonesia's easternmost province may get microchips - (12/02/08)
     
  2475. Statement on Fuzeon Access in South Korea from Roche - (12/02/08)
     
  2476. Kenya Govt launches male cut as HIV preventive measure - (12/02/08)
     
  2477. Advocates Urge Obama Administration To Develop U.S. HIV/AIDS Strategy - (12/02/08)
     
  2478. Drug addiction causes 65 pct of Russian HIV cases: agency - (12/02/08)
     
  2479. 15M People suffering from hepatitis B & C in Pakistan: Experts - (12/02/08)
     
  2480. National AIDS Strategy: AIDS groups appeal to Obama for help in fighting HIV/AIDS - (12/02/08)
     
  2481. Swiss vote on radical medicalization of heroin rules - (12/02/08)
     
  2482. Prostate cancer radiotherapy safe for HIV patients - (12/02/08)
     
  2483. Obama Addresses World AIDS Day - (12/02/08)
     
  2484. Sen Clinton On World AIDS Day Dec 1 2008 - (12/02/08)
     
  2485. Houston's HIV infection rate nearly twice national average - (12/02/08)
     
  2486. Lawsuit says Ind. teen with HIV bullied at school - (11/24/08)
     
  2487. Man knowingly transmitted HIV, police say - (11/24/08)
     
  2488. Rapid HCV Test from OraSure Technologies - (11/24/08)
     
  2489. No let-up for pharma as Congressional health panel changes leadership: Waxman Replaced Dingell as Chair of US House Energy & Commerce (healthcare) Committee - (11/24/08)
     
  2490. Chile's Lapse in Notification Leaves HIV-Positive Unaware - (11/24/08)
     
  2491. Gilead sees future in HIV, hepatitis C - (11/21/08)
     
  2492. CALL FOR NOMINATIONS: IRMA (Intl Rectal Microbicide Advocates) Steering Committee - (11/21/08)
     
  2493. Cancer Rates Doubled in HIV+ - (11/21/08)
     
  2494. Approval for Obama's new Health Sec Tom Daschle, but row brews over lobbying - (11/21/08)
     
  2495. Merck's HPV Vaccine Gardasil Demonstrates Efficacy In Males In Late-stage Study - (11/17/08)
     
  2496. Fighting AIDS at Home: A PEPFAR plan for America's inner cities; address the growing HIV/AIDS pandemic in the United States - (11/17/08)
     
  2497. Men are being warned they could be "gambling with their lives" if they buy fake medicines online. - (11/13/08)
     
  2498. Recession threat means Big Pharma "must speed up transformation plans" - (11/13/08)
     
  2499. H.I.V. Scare Unnerves a St. Louis High School - (11/10/08)
     
  2500. HIV vaccine failure explained? Failed vaccine makes immune cells easier to infect in culture. - (11/10/08)
     
  2501. Souped-up immune cells catch even disguised HIV - New Vaccine Approach - (11/10/08)
     
  2502. FDA cracks down on labeling, initiates trial result reporting - (11/10/08)
     
  2503. High rate of HIV cases is 'wake-up call' for Phila. - (10/31/08)
     
  2504. Credit crunch hurting pharma and biotech R&D badly - (10/31/08)
     
  2505. Global Financial Crisis Could Harm HIV/AIDS Funding, Piot Says - (10/31/08)
     
  2506. Theratechnologies and EMD Serono Announce Collaboration and Licensing Agreement for Tesamorelin in the United States - (10/31/08)
     
  2507. Steady growth for global pharma sales but US will slow - IMS - (10/31/08)
     
  2508. High & Increasing Suicide Rates Among White Baby Boomers 40-64 - (10/22/08)
     
  2509. Diabetes may cause first fall in life expectancy for 200 years - (10/21/08)
     
  2510. More Alzheimer's Risk for Hispanics, Studies Suggest - (10/21/08)
     
  2511. Compulsive Behavior-- malfunctioning dopamine system - (10/20/08)
     
  2512. HIV infections up sharply among Hong Kong gay men - (10/20/08)
     
  2513. Medicaid Spending Will Join Medicare in Out Running the Economy in Years Ahead - (10/20/08)
     
  2514. National Latino AIDS Awareness Day - (10/16/08)
     
  2515. Scientists (Fauci) bleak about AIDS vaccine prospects...and HIV/Global Funding - (10/15/08)
     
  2516. US justice dept withdraws motion against Ranbaxy - (10/15/08)
     
  2517. Mild glucose abnormalities in pregnancy linked to postpartum diabetes risk - (10/10/08)
     
  2518. National Latino AIDS Awareness Day - (10/07/08)
     
  2519. California to Cover Cost of Screening for H.I.V. - (10/06/08)
     
  2520. Nobel prize for viral discoveries; French researchers win Nobel for HIV discovery, Gallo not mentioned - (10/06/08)
     
  2521. Statin drugs and amyotrophic lateral sclerosis - (10/02/08)
     
  2522. Big Pharma, Pfizer, GSK Refocus, Big Pharma prunes R&D as times get tough - (10/01/08)
     
  2523. Maraviroc & Raltegravir Win Best Pharmaceuticals 2008: Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments - (09/27/08)
     
  2524. Pharma Companies Agree to Sunshine Act: disclosing doctor payments, grants - (09/26/08)
     
  2525. Schering-Plough slashes US workforce by 20% - (09/26/08)
     
  2526. Schering-Plough slashes US workforce by 20% - (09/23/08)
     
  2527. New York City Report Finds Reduced HIV/AIDS-Related Deaths, Increased Condom Distribution in FY 2008 - (09/22/08)
     
  2528. CDC: Double U.S. HIV prevention budget - (09/18/08)
     
  2529. CDC Needs Additional $4.8B To Reduce Annual Number of New Infections, Officials Say - (09/18/08)
     
  2530. A New York City dialysis center was shut down by the state Health department after one patient tested positive for hepatitis C. - (09/18/08)
     
  2531. Brazil to make generic version of key AIDS drug Efavirenz - (09/18/08)
     
  2532. OraSure AIDS Test Has High Rate of Error, Report Says (Update1) - (09/08/08)
     
  2533. FDA Approves First Hepatitis B Viral Load Quantification Test - (09/08/08)
     
  2534. Brazil Rejects Gilead Patent On HIV Drug - (09/04/08)
     
  2535. GSK's Commitment to R&D - (09/03/08)
     
  2536. Gilead may shoot past big firms' buyout hunts - (09/03/08)
     
  2537. Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes - (08/29/08)
     
  2538. The Inflammatory Debate: Is it the Virus, the Drugs, or the Host? - (08/28/08)
     
  2539. AMBRILIA PROVIDES UPDATE ON PPL-100 PARTNERSHIP WITH MERCK & CO, INC. - (08/15/08)
     
  2540. Compulsory licensing "a last mechanism," says Thai Health Minister - (08/11/08)
     
  2541. FDA looks to avoid conflict of interest on advisory panels - (08/05/08)
     
  2542. AIDS hitting Asian gays at high rates - - (08/04/08)
     
  2543. NATALIE COLE - COLE BEATING HEPATITIS - (08/04/08)
     
  2544. No More drug Company detailing, New Congressional Bill - (08/04/08)
     
  2545. US Congress slams FDA for off-label promotion control failures - (08/04/08)
     
  2546. Global AIDS deaths down 10% in 2007: (from Jules: HIV in the USA Needs More Attention: prevention, among minorities -Blacks & Latinos, HCV/HIV coinfection, Aging with HIV & its complication, early testing) - (08/04/08)
     
  2547. FDA says Salmonella strain found on Mexican farm - (08/01/08)
     
  2548. Exercise Pill Makes Mice More Fit - (08/01/08)
     
  2549. PEPFAR/Bush Press EDITORIALS - (08/01/08)
     
  2550. AIDS patients, Abbott agree to settle lawsuit - (07/31/08)
     
  2551. India: govt to be country's sole buyer of patented drugs? - (07/28/08)
     
  2552. India: govt to be country's sole buyer of patented drugs? - (07/28/08)
     
  2553. Biotech/ Pharma Update: Summer Slump for China Biotech News - (07/28/08)
     
  2554. Gregg Allman Recovers from Hepatitis C Treatments - (07/28/08)
     
  2555. HIV/AIDS in Latin America and the Caribbean Editorial - (07/28/08)
     
  2556. African American Council On Liver Awareness Convenes In Washington D.C. - (07/25/08)
     
  2557. $50 Billion PEPFAR Bill Passed by Senate; Senate poised to lift ban on visitors with AIDS - (07/25/08)
     
  2558. African Gene That protected Against Malaria Increases Risk by 40% for Contracting HIV - (07/25/08)
     
  2559. Trimeris/Fuzeon/TRI-1144 Sales of Trimeris' HIV drug drop 34% - (07/25/08)
     
  2560. Broccoli Consumption May Prevent or Reduce Risk of Protate Cancer - (07/17/08)
     
  2561. FDA, European Medicines Agency to Consider Additional Test Results When Assessing New Drug Safety -Collaborative effort by FDA and EMEA expected to yield additional safety data - (07/16/08)
     
  2562. Did HIV Generic Drug Maker Falsify Data? - (07/15/08)
     
  2563. Lawsuit Filed for HCV Testing/Care in California Prisons - (07/09/08)
     
  2564. Boehringer Ingelheim denied Nevirapine drug patent in India - (07/07/08)
     
  2565. Drug Makers Say FDA Safety Focus Is Slowing New-Medicine Pipeline - (07/03/08)
     
  2566. Post-Exercise Caffeine Helps Muscles Refuel - (07/03/08)
     
  2567. Diabetes drugs need cardiovascular risk studies, says FDA panel - (07/03/08)
     
  2568. New HIV/AIDS Cases up among people over 50 in Atlanta & Florida - (07/01/08)
     
  2569. Delhi NGO opposes patent for Roche's HIV drug - (07/01/08)
     
  2570. Push in Bronx for Routine H.I.V. Test for All - (06/24/08)
     
  2571. Senate Leaders Reach 'Tentative' Agreement on Legislation To Reauthorize PEPFAR, AP/Google.com Reports - (06/24/08)
     
  2572. Latino leaders, health officials say HIV, AIDS are crisis in communities - (06/24/08)
     
  2573. GSK tops new ethical ranking for investors - (06/16/08)
     
  2574. Vertex Sells Royalty Rights to HIV Inhibitors for $160 Million to Fund Telaprevir Development - (06/10/08)
     
  2575. Pfizer turns up defense of smoking cessation drug - (06/10/08)
     
  2576. Utah AIDS Foundation Rejects Federal Prevention Funding Over Condoms Ads: sees link between dull ads and rise in Utah HIV rate - (06/04/08)
     
  2577. Good Medicine for Thailand - (05/30/08)
     
  2578. S.F. AIDS funding likely spared budget knife - (05/29/08)
     
  2579. Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases - (05/29/08)
     
  2580. Pfizer to disclose grants to increase transparency - (05/20/08)
     
  2581. Vitamin D Associated with Breast Cancer - (05/20/08)
     
  2582. The Scottish Government is to spend 43m tackling Hepatitis C over the next three years. - (05/20/08)
     
  2583. 35-year sentence for HIV-positive spitter worries some - (05/20/08)
     
  2584. Parents Refusing Vaccines For Their Kids - (05/15/08)
     
  2585. Pakistan National Hepatitis Control Program - (05/15/08)
     
  2586. CDC Gerberding 'More Money Needed for African-American HIV Prevention' - (05/15/08)
     
  2587. GSK Responds to This Article: Glaxo 'downplayed' warning on heart-attack risk from Aids drug - (05/15/08)
     
  2588. EU urges pharma to act on drug counterfeiting and piracy - (05/15/08)
     
  2589. HIV exceptionalism is dead-and the writing is on the wall for UNAIDS. - (05/15/08)
     
  2590. Transplant Recipients Die Due to Rare Virus in Donor - (05/15/08)
     
  2591. Texas Appeals Court Overturns Vioxx $32 Million Verdict Against Merck - (05/15/08)
     
  2592. Las Vegas Health District Identifies 77 Potential Clinic Associated Infections - (05/08/08)
     
  2593. Is medical-marijuana use reason to deny someone a liver organ transplant? - (05/06/08)
     
  2594. Pharma Strategizes To Meet Future Challenges - (05/06/08)
     
  2595. Merck & BMS Continue Streamlining - (05/06/08)
     
  2596. GSK CEO puts focus on emerging markets for future growth - (05/02/08)
     
  2597. Magic Johnson teams up to fight AIDS in the Washington DC - (05/02/08)
     
  2598. "Magic" and Cookie Johnson: Their New Fight Against HIV/AIDS - (05/02/08)
     
  2599. 1 in 40 in Wash DC Have HIV/AIDS: AIDS Warriors in Wash DC - (05/02/08)
     
  2600. US patients' drug payments fall as generics use soars - (04/22/08)
     
  2601. Central obesity and increased risk of dementia more than three decades later - (04/18/08)
     
  2602. When Drug Costs Soar Beyond Reach Editorial - (04/16/08)
     
  2603. The Health Insurance Mafia OPINION - (04/16/08)
     
  2604. Co-Payments Soar for Drugs With High Prices - (04/16/08)
     
  2605. Amy Patick, Agouron/Nelfinavir Virologist Resurfaces at HCV Biotech - (04/15/08)
     
  2606. Brazil may reject Gilead's AIDS drug patent - (04/15/08)
     
  2607. Walking and primary prevention: a meta-analysis of prospective cohort studies - (04/14/08)
     
  2608. Pfizer Statement on Exubera Labeling Update in the United States - (04/11/08)
     
  2609. Exubera Runs Into More Woes - Wall St Jnl - (04/11/08)
     
  2610. Abbott: No Lung-Cancer Signals In Inhaled-Insulin Trials - (04/11/08)
     
  2611. US probes Roche, Novartis drugs on rare central nervous system disorder PML - (04/11/08)
     
  2612. Clinics pay up, avoid facing angry patients; No-shows at Las Vegas hearing leave many in audience frustrated - (04/09/08)
     
  2613. ADAP Waiting Lists Nearly Eliminated, Kaiser Family Foundation, NASTAD Survey Says; Challenges Remain - (04/09/08)
     
  2614. Government of Canada Funds Peer Support Network for People Living With Hepatitis C Virus - (04/09/08)
     
  2615. Roche Diagnostics Expands Availability of HCV Immunoassay - (04/08/08)
     
  2616. Sen. Coburn Says He Might Block PEPFAR Reauthorization Bills; House Approved PEPFAR - (04/08/08)
     
  2617. US court ends early generic Actos hope for Alphapharm - (04/08/08)
     
  2618. Schering Plans Cuts of $1.5 Billion by 2012 - (04/03/08)
     
  2619. More unsanitary procedures documented in Las Vegas Endoscopy Clinic - (04/02/08)
     
  2620. Study Is Setback for Some RNA-Based Drugs - (04/02/08)
     
  2621. Abacavir Controversy: SF Chronicle article - (04/02/08)
     
  2622. AIDS Lobby Group (AHF) and CDC Clash on Meaning of New HIV Numbers - (04/01/08)
     
  2623. Thai Public Health Minister faces impeachment campaign - (04/01/08)
     
  2624. Fixed Dose Calcium Blocker+Ace Inhibitor Reduces Blood Pressure. ACCOMPLISH study proves to be a win-win for Novartis - (04/01/08)
     
  2625. Tight FDA deadlines increase drug safety concerns; FDA Defends Itself - (03/28/08)
     
  2626. Greg Allman: HEPATITIS C RECOVERY PROMPTS ALLMAN TO POSTPONE SHOWS - (03/28/08)
     
  2627. FDA Drug-Review Deadlines and Safety Problems - (03/27/08)
     
  2628. Indian clinics uncover high rate of hepatitis C - (03/26/08)
     
  2629. Sharp Debate Over HIV Vaccine Failure Scientists Can't Agree on Future of HIV Research - (03/26/08)
     
  2630. U.S. agency Fauci vows to back AIDS study - (03/26/08)
     
  2631. AIDS Vaccine Testing at Crossroads After Little Progress in 25 Years, Scientists Urge Return to Basic Research - (03/26/08)
     
  2632. AIDS Group Calls for End of Federal Funds for Vaccine - (03/26/08)
     
  2633. Indian clinics uncover high rate of hepatitis C - (03/25/08)
     
  2634. Roche closer to launching anaemia drug onto US market? - (03/20/08)
     
  2635. Incyte to Outlicense CCR5 Antagonist - (03/17/08)
     
  2636. HCV In Las Vegas- PUBLIC HEALTH CRISIS: Lawyers: 100 fear infection - (03/16/08)
     
  2637. Nationally Representative CDC Study Finds 1 in 4 Teenage Girls Has a Sexually Transmitted Disease - (03/14/08)
     
  2638. New Data Reveal 7th Consecutive Syphilis Increase in the U.S. and Opportunities to Improve STD Screening and Prevention for Gay and Bisexual Men - (03/14/08)
     
  2639. Thai Ministry to Recommend Ignoring Patents on Cancer Drugs - (03/12/08)
     
  2640. Microbicide Developer Receives License for Novel: HIV Microbicide Candidate from Merck - (03/12/08)
     
  2641. Promising data for GSK's Cervarix and Merck & Co's Gardasil - (03/12/08)
     
  2642. Thailand to maintain patent override policy - (03/12/08)
     
  2643. Rift Over AIDS Treatment for Mother-To-Child Transmission Lingers in South Africa, NVP+AZT vs One Drug therapy and Affordability - (03/12/08)
     
  2644. Pharma "shooting itself in the foot" over reputation - (03/10/08)
     
  2645. HIV prevention trials 'hindered by obstacles' - (03/10/08)
     
  2646. HIV & Intl Women's Day Saturday - (03/10/08)
     
  2647. The Balm In Gilead, Inc. Mobilizes the 19th Annual Black Church Week of Prayer for the Healing of AIDS March 2-8, 2008 - (03/07/08)
     
  2648. Op-Ed: Fight AIDS here at home-HIV health crisis among Africn-Americans (again I add HCV/HIV coinfection) - (03/06/08)
     
  2649. Blacks silent as HIV/AIDS attack through their communities - (03/06/08)
     
  2650. Panacos Announces Discovery of Bevirimat Patient Response Predictors - (03/04/08)
     
  2651. Generic Efavirenz & d4T FDA Approved - (03/04/08)
     
  2652. Cases of HIV predicted to rise by 75% in Australia - (03/04/08)
     
  2653. Slow Growth Seen in Hepatitis C Market - (03/03/08)
     
  2654. Pfizer to appeal Dutch Lipitor patent ruling - (03/03/08)
     
  2655. Las Vegas Endoscopy center closed by the city today - (03/03/08)
     
  2656. Clinic accused of reusing syringes sued - (03/03/08)
     
  2657. Americans and the Caribbean HIV Explosion - (03/03/08)
     
  2658. 10 million Pakistanis suffering from hepatitis - (03/03/08)
     
  2659. EU approves Novartis combo diabetes drug Eucreas - (02/27/08)
     
  2660. Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco - (02/20/08)
     
  2661. FDA guidance for off-label use criticised - (02/20/08)
     
  2662. Microbicide Carraguard Study Fails - (02/20/08)
     
  2663. Glaxo Cuts Price of HIV Drugs For World's Poorest Countries - (02/20/08)
     
  2664. NIAID Scientists Identify New Cellular Receptor for HIV - (02/15/08)
     
  2665. HIV vaccine may never be found, warns leading scientist Dr David Baltimore - (02/15/08)
     
  2666. Viramune (nevirapine) Extended Release Once Daily Study - (02/15/08)
     
  2667. Tentative Approval of Generic Atazanavir Sulfate Capsules - (02/15/08)
     
  2668. FDA Approves Generic AZT 300mg Tablets - (02/15/08)
     
  2669. WHO narrows down second-line ARV options - (02/15/08)
     
  2670. UNAIDS & WHO 'Correct' Swiss on Unrotected Sex - (02/04/08)
     
  2671. Merck Aids Vaccine Failure Signals Doom for African, U.S. HIV Vaccine Projects - (02/01/08)
     
  2672. NEJM Reviewer leaked Avandia study to drug firm - (02/01/08)
     
  2673. Raltegravir Launched in UK - (01/30/08)
     
  2674. HIV Infection in the United States Household Population Aged 18-49 Years: Results from 1999-2006 - (01/30/08)
     
  2675. Pfizer Licenses Maraviroc for Vaginal Microbicide Research - (01/30/08)
     
  2676. Fuzeon Drug Sales Fall in 4Q Fuzeon HIV Drug Sales Fall During the 4th-Quarter on Lagging U.S., Canadian Markets - (01/30/08)
     
  2677. Abbott's Kaletra and Aluvia (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA - (01/29/08)
     
  2678. Lipid Sciences Announces Positive HIV Program Results - (01/29/08)
     
  2679. 3 Articles on Viread Patent Rejection News - (01/25/08)
     
  2680. Merck signs deal for Fosamax authorized generic - (01/14/08)
     
  2681. Arthritis Drug May Improve Alzheimer's Amgen, Wyeth Arthritis Treatment Eases Alzheimer's - (01/14/08)
     
  2682. Pfizer Gets Favorable Celebrex Court Ruling Judge Calls Celebrex Evidence Unreliable - (01/11/08)
     
  2683. Study Finds Possible Targets for AIDS Drugs - (01/11/08)
     
  2684. NYC HIV-Death Rate Hit All-Time Low in '06 - (01/09/08)
     
  2685. Pharma industry must change R&D model for drug company success, says Tufts director - (01/09/08)
     
  2686. Where have all the new drug's gone: Industry's medicine cabinet running empty on compounds - (01/09/08)
     
  2687. Roche Engages in Four Additional AIDS Technology Transfers to Strengthen Local Manufacturing in World's Poorest Countries - (01/09/08)
     
  2688. Global Battle on AIDS, Bush Creates Legacy - (01/07/08)
     
  2689. Minn. Department of Health to Fund HIV/AIDS Education - (01/07/08)
     
  2690. Sri Lanka clamps down on drug multinationals reps - (01/04/08)
     
  2691. Canadian court rules against Pfizer in Lipitor patent case - (01/04/08)
     
  2692. Oral bisphosphonates may cut risk of jaw necrosis - (01/04/08)
     
  2693. High case rates make D.C. the nation's HIV/AIDS capital - (01/02/08)
     
  2694. Putting (Global AIDS) a Plague in Perspective - (01/02/08)
     
  2695. New HIV Cases Drop but Rise in Young Gay Men & Black/Latino MSM - (01/02/08)
     
  2696. India gets $100 million to fight AIDS - (12/27/07)
     
  2697. D.C. to Fund Needle - Exchange Programs - (12/27/07)
     
  2698. New Jersey First State to Require HIV Testing for Mom & Baby - (12/27/07)
     
  2699. EU and pharma pact challenges status quo of drug discovery: funds 2 billion euros for biomedical research - (12/20/07)
     
  2700. H&M Links with Rihanna, Jade Jagger in AIDS Fight - (12/20/07)
     
  2701. Data About Zetia Risks Was Not Fully Revealed - (12/20/07)
     
  2702. GSK and Santaris Pharma enter global R&D alliance to discover, develop and commercialise RNA antagonists as novel antivirals - (12/20/07)
     
  2703. FDA Warning: nonoxynol 9 & Abstinence - (12/19/07)
     
  2704. EU Approval for ATRIPLA once-a-day HIV pill BBC Story - (12/18/07)
     
  2705. New study suggests why vaccines directed against cancer, HIV don't work - (12/18/07)
     
  2706. GSK presents details of well-stocked neuroscience pipeline - (12/17/07)
     
  2707. Pharmaceutical rep licensing bill survives first D.C. Council vote - (12/17/07)
     
  2708. GSK's Cervarix cancer vaccine US launch delayed by FDA review - (12/17/07)
     
  2709. 7.5 million hepatitis C patients in Pakistan - (12/17/07)
     
  2710. AIDS rising again EDITORIAL - (12/12/07)
     
  2711. Trimeris says target of Novartis suit - (12/11/07)
     
  2712. Pfizer first MNC to get HIV drug patent in India - (12/11/07)
     
  2713. GSK drops claims on two ARTs Abacavir/Trizivir - (12/11/07)
     
  2714. Huckabee's AIDS Comments Alarm Ryan White's Mother - (12/11/07)
     
  2715. Naval Academy ex-chaplain sentenced to 2 years Catholic priest who is HIV-positive guilty in sex scandal - (12/10/07)
     
  2716. Controversy, Drug-patient Info in Europe - (12/10/07)
     
  2717. Uganda: HIV Patients Find Hope in Antiretroviral Drugs - (12/10/07)
     
  2718. Bristol-Myers to trim jobs, factories - (12/05/07)
     
  2719. AIDS on the home front: Domestic Issues Neglected - (12/04/07)
     
  2720. Domestic Figures on H.I.V. Rate Expected to Rise - (12/04/07)
     
  2721. Mass. urges more HIV/AIDS testing in minority areas; Over 50% of HIV+ in Mass. Are Minorities - (12/04/07)
     
  2722. In a Progressive State New Jersey, a City Where Gay Life Hangs by a Thread - (12/04/07)
     
  2723. CDC Rapid HIV Testing in Outreach and Other Community Settings --- United States, 2004-2006 - (12/04/07)
     
  2724. FDA Considers Easing Curbs on Drug Makers Off-Label Marketing - (12/04/07)
     
  2725. AIDS Activists Riled by CDC Refusal to Release Infection Data - (12/04/07)
     
  2726. One-Third of HIV-Infected Gay Men Have Unsafe Sex: CDC - (12/04/07)
     
  2727. Living With HIV, Dying Of Cancer - (12/04/07)
     
  2728. GSK's omega-3 based triglycerides drug - (11/28/07)
     
  2729. UK Sex Health 'Crisis'-HIV Rates High - (11/28/07)
     
  2730. Former Soviet Union sees most new HIV infections-report - (11/28/07)
     
  2731. Woman Sues Ex-Fiance's Parents for Reportedly Hiding Their Son's HIV - (11/28/07)
     
  2732. Proposed Label Changes for flu Drugs Tamiflu & Relenza - (11/28/07)
     
  2733. Study shows how some AIDS vaccines may harm - (11/16/07)
     
  2734. Brazil & Pharma on Drug Patents - (11/16/07)
     
  2735. R. Scott Hitt, 49; early activist for AIDS/HIV patients - (11/15/07)
     
  2736. The Impact of HIV in Central America: The United Nations Report - (11/15/07)
     
  2737. Merck Study Volunteers to be told who got HIV vaccine - (11/15/07)
     
  2738. Merck Study Volunteers to be told who got HIV vaccine - (11/15/07)
     
  2739. Long Island Doctor reused needles, put patients at risk - (11/15/07)
     
  2740. Merck AIDS Failure Hurts HIV Vaccine Research, U.S. Effort - (11/15/07)
     
  2741. Doctor reused syringes while injecting patients with anesthetics - (11/15/07)
     
  2742. HIV vaccine trials suspended in South Africa - (11/15/07)
     
  2743. Dr Scott Hitt Prominent AIDS Activist Dies in Calif. - (11/09/07)
     
  2744. Merck to Pay $4.85 Billion to Resolve Vioxx Claims - (11/09/07)
     
  2745. Abbott's new combination drug Simcor shines in trial to target good and bad cholesterol - (11/07/07)
     
  2746. FDA approval rate slows: who's to blame? - (11/07/07)
     
  2747. Valeant Pharmaceuticals to Sell Infergen - (11/02/07)
     
  2748. Pharmasset Appoints Michael Rogers as Chief Development Officer, leaves GSK - (11/02/07)
     
  2749. Abbott's m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award - (10/22/07)
     
  2750. Schering's Hepatitis C Data Dull Vertex's Shine - (10/19/07)
     
  2751. Prostate cancer treatment raises osteoporosis risk - (10/16/07)
     
  2752. Statins may slow lung decline, could become new COPD treatment - (10/16/07)
     
  2753. Pfizer to network with 30,000 US doctors with Sermo, online doctor website - (10/16/07)
     
  2754. Prostate cancer treatment raises osteoporosis risk - (10/16/07)
     
  2755. Statins may slow lung decline, could become new COPD treatment - (10/16/07)
     
  2756. Pfizer to network with 30,000 US doctors with Sermo, online doctor website - (10/16/07)
     
  2757. Marianne Faithful: I have Hepatitis C - (10/11/07)
     
  2758. Pfizer names new R&D head and launches a biotech centre - (10/10/07)
     
  2759. Uganda opens first HIV drug plant - (10/10/07)
     
  2760. Global AIDS challenge: prevention + treatment - (10/10/07)
     
  2761. Kenya: Country Needs New Aids Plan: marriage, sexual networking - (10/10/07)
     
  2762. GSK names new CEO Witty as Garnier replacement - (10/10/07)
     
  2763. BI's Aptivus wins full US approval; SPRING Trial for Women tests TDM - (10/10/07)
     
  2764. Ethiopia: Study Finds HIV Infection Rate in Ethiopia Rose By 26 Percent; universal ART access plan - (10/10/07)
     
  2765. New concerns raised over Merck's Gardasil - (10/10/07)
     
  2766. AstraZeneca, GSK and Roche set up UK stem cell initiative - (10/03/07)
     
  2767. BMS pays out $515 million to US Govt to settle marketing practice probe - (10/02/07)
     
  2768. Idenix Will Focus on HIV & HCV Pipeline - (10/01/07)
     
  2769. 'Condoms HIV Infected' Shock at Mozambique archbishop condom claim - (10/01/07)
     
  2770. Idenix Laying Off 100, Amends Novartis Deal - (09/28/07)
     
  2771. Shock for Novartis as osteoarthritis drug Prexige 'not approvable' - (09/27/07)
     
  2772. AZ to move prostate drug into late-stage trials - (09/26/07)
     
  2773. Congress finally passes bill to give FDA sweeping powers - (09/24/07)
     
  2774. Galvus superior to Actos with regard to weight, says Novartis - (09/24/07)
     
  2775. The Forgotten H.I.V. Test: CDC recommended Emergency Room HIV test - (09/24/07)
     
  2776. GlaxoSmithKline's Cervarix vaccine gets European green light - (09/24/07)
     
  2777. All sides welcome FDA reauthorisations, with reservations - (09/24/07)
     
  2778. HIV Vaccine Studies Delayed Due to Merck Stoppage; South African HIV trial suffers setback - (09/24/07)
     
  2779. Rival Cholesterol Drug programs - (09/24/07)
     
  2780. Report: Medicare overbilling rampant in South Florida HIV claims - (09/20/07)
     
  2781. J&J unit gets rights to two of Isis' diabetes compounds - (09/14/07)
     
  2782. Anita Roddick, 64; Founder Of Activist Cosmetics Firm, Diagnosed Late with HCV - (09/13/07)
     
  2783. 420 jobs to go as Pfizer stops manufacturing at Sandwich - (09/12/07)
     
  2784. NEW HIV DIAGNOSES RISING IN NEW YORK CITY AMONG YOUNG MEN WHO HAVE SEX WITH MEN - (09/12/07)
     
  2785. HCV+ Body Shop Founder Anita Roddick Dies - (09/11/07)
     
  2786. Make HIV testing normal and routine - (09/10/07)
     
  2787. HIV+ 2-year-old barred from pool: Local activists join protest at Alabama resort that banned HIV-positive toddler - (09/05/07)
     
  2788. NIH $19M Grant to Understand How HIV Hijacks Cells - (08/31/07)
     
  2789. California Reversing HIV Sperm Washing Ban - (08/30/07)
     
  2790. Liver cancer trial halted early as Bayer/Onyx' Nexavar shines - (08/28/07)
     
  2791. bioLytical Announces Provision of INSTI(TM), 60-Second Rapid HIV Test, to Ontario Government - (08/27/07)
     
  2792. Abuse, prosecutions reverse USA rocketing painkiller sales - (08/22/07)
     
  2793. Washing After Sex May Raise HIV Risk- in Uganda Study - (08/21/07)
     
  2794. Sex Now Primary Cause Of China HIV Spread: Report - (08/20/07)
     
  2795. FDA backs Novartis' once-yearly osteoporosis drug for Reclast - (08/20/07)
     
  2796. US rejects bid by Pfizer to get vital Lipitor patent reissued - (08/20/07)
     
  2797. Progen's liver cancer drug closer to orphan status - (08/16/07)
     
  2798. Abbott gets US FDA nod for RealTime HIV-1 viral load test - (08/13/07)
     
  2799. Viropharma HCV Drug/Drug Development Concerns - (08/13/07)
     
  2800. Low-cost AZT/3TC/NVP generic Fixed Dose Combination gets OK - (08/09/07)
     
  2801. False Positive HIV Test Boxer Tommy Morrison Says Error in H.I.V. Test Hurt Career - (08/02/07)
     
  2802. 10 Million Hepatitis Positive in Pakistan - (08/02/07)
     
  2803. Libya Frees Nurses - (08/02/07)
     
  2804. House Judiciary Committee Approves Bill That Would Alter HIV Testing Requirements for Prison Inmates - (08/02/07)
     
  2805. EU launches public consultation on future of pharma - (08/02/07)
     
  2806. EU backs Pfizer HIV drug Maraviroc facing U.S. delay - (07/20/07)
     
  2807. Pfizer's new HIV medicine nears European market - (07/20/07)
     
  2808. Dr. Charles Farthing, Director for Scientific Affairs in HIV, Merck & Co. Inc. - (07/17/07)
     
  2809. Ferd Eggan, 60; ally for those with HIV, AIDS Dies of Liver Cancer - (07/12/07)
     
  2810. Cervical cancer vaccine Gardasil to be reimbursed in France - (07/12/07)
     
  2811. Libya to decide HIV medics' fate - (07/12/07)
     
  2812. Experts Reduce Estimate of India's HIV Population by Half - (07/11/07)
     
  2813. Libya court upholds death sentence on medics - (07/11/07)
     
  2814. Pfizer Wins Lipitor Patent Case - (07/11/07)
     
  2815. Many young 18-24 years old 'still ignorant about HIV' - (07/06/07)
     
  2816. House Ends Wash DC 9-Year Ban on Needle-Exchange Funding - (07/02/07)
     
  2817. Increased Money for Global HIV/Health Perhaps - (07/02/07)
     
  2818. HIV Prevalence Not Increased by War-Torn Africa? - (07/02/07)
     
  2819. FDA/Maraviroc: Concerns Over Drug Safety, Patents Weigh on Big Pharma - (06/25/07)
     
  2820. 'HEP C' MD'S NEW 'VICTIMS' - (06/25/07)
     
  2821. USA warned by CDC about the growing burden of diabetes - (06/25/07)
     
  2822. EU Approves Schering-Plough's Hepatitis C Treatment For Patients Co-infected With HIV - (06/25/07)
     
  2823. FDA Approves First Drug for Treating Fibromyalgia - (06/25/07)
     
  2824. HCV/HBV/HIV New drug Technology: removal of the lipid coatings from lipid-enveloped viruses - (06/25/07)
     
  2825. Cardiovascular risk calculators of questionable value in type 2 diabetes - (06/22/07)
     
  2826. NNRTI Gel Shows Safety as a Topical Anti-HIV Microbicide in Animal Tests - (06/22/07)
     
  2827. HIV patients with TB may benefit from longer therapy - (06/22/07)
     
  2828. Gout/Uric acid may boost cardiovascular mortality - (06/22/07)
     
  2829. Drop in diabetes mortality not seen in women - (06/22/07)
     
  2830. Colgate says fake toothpaste a low health risk - (06/22/07)
     
  2831. Roche establishes Viracept Patient Registries in the interest of patient care - (06/22/07)
     
  2832. Roche to do more studies as EMEA suspends Viracept licence - (06/22/07)
     
  2833. 3 NYC Hepatitis Cases Linked to M.D. - (06/21/07)
     
  2834. City-based institute to evaluate HIV drug resistance across Asia - (06/21/07)
     
  2835. Sanofi and BMS win Plavix case but analysts unsure of a merger - (06/21/07)
     
  2836. Libya Court hears Bulgarian Nuses' appeal in HIV cases - (06/21/07)
     
  2837. Libya sets July 11 for HIV nurses ruling - (06/21/07)
     
  2838. Signs "encouraging" on Libya HIV nurses, but no deal yet - (06/21/07)
     
  2839. Abbott Receives CE Marking For PCR Test For Monitoring Hepatitis B Viral Load In Patients - (06/21/07)
     
  2840. Hepatitis C spreads among drug abusers in Iceland - (06/19/07)
     
  2841. Libya to Pronounce Final Verdicts on Bulgarian Nurses HIV Case June 20 - (06/19/07)
     
  2842. FDA and EMEA keen to expand cooperation arrangement - (06/19/07)
     
  2843. US legislators slam FDA/industry PDUFA meetings - (06/19/07)
     
  2844. FDA OKs Gilead's Letairis for pulmonary arterial hypertension - (06/19/07)
     
  2845. Gilead Sciences moving in new direction - (06/15/07)
     
  2846. Boehringer tests HIV drug Aptivus in racially-diverse trial - (06/15/07)
     
  2847. Man with HIV gets life term for sex - (06/14/07)
     
  2848. Pfizer to roll out Maraviroc in July; South Africa availability - (06/11/07)
     
  2849. Alzheimer's Cases May Quadruple by 2050 - (06/11/07)
     
  2850. Roche recalls Viracept in Europe due to chemical impurities - (06/07/07)
     
  2851. Risks Of Glaxo Diabetes Drug Still Unclear: FDA - (06/07/07)
     
  2852. Avandia to Carry Stronger Warning Label: Congress hearing - (06/07/07)
     
  2853. Fireworks fly as lawmakers weigh up Avandia case - (06/07/07)
     
  2854. Puerto Rico's AIDS Care in Disarray Over Funds - (06/06/07)
     
  2855. Porn Industry Dropped Condom Policy - (06/06/07)
     
  2856. OraSure Applauds $35 Million in CDC Funding to Support Increased HIV Testing and Prevention - (06/04/07)
     
  2857. WHO/UNAIDS Recommend Doctor Initiated Routine Testing For HIV - (06/04/07)
     
  2858. Merck & Co horrified as Brazil breaks patent on AIDS drug - (05/30/07)
     
  2859. Hepatitis C rises among young people in Mass. - (05/30/07)
     
  2860. Pfizer Launches Online Initiative Disclosing Its U.S. Post-Marketing Commitments - (05/30/07)
     
  2861. Bill Clinton brokers deal for lower AIDS drug prices - (05/30/07)
     
  2862. Roche Transfer Saquinavir Technology to African Generic Companies - (05/30/07)
     
  2863. Abbott Fund Increases Commitment to Fight Against HIV/AIDS in Tanzania, Opening Country's First Corporate Foundation Office - (05/30/07)
     
  2864. Senate Approves New Power for F.D.A. on Drugs - (05/24/07)
     
  2865. Ryan White Grant helps only 93 on South Carolina HIV/AIDS waiting list - (05/24/07)
     
  2866. Senate backs bill giving FDA more powers on drug safety - (05/24/07)
     
  2867. Avexa secures CCR5 inhibitor HIV program with TargetDrug - (05/24/07)
     
  2868. Plan to track HIV+ Visitors to Sydney, Site of World AIDS Conference - (05/24/07)
     
  2869. Syphilis rise in gay, bisexual men causes worry - (05/24/07)
     
  2870. Vermonters urged to get tested for hepatitis C - (05/24/07)
     
  2871. Highly Sensitive and Accurate Roche HIV-1 Test Approved by FDA - (05/24/07)
     
  2872. Abbott's HIV-1 Viral Load Test Approved by FDA for Use on New m2000(TM) Molecular Diagnostics Instrument - (05/24/07)
     
  2873. New Jersey Law Would Mandate HIV Test for Mothers and Newborns - (05/24/07)
     
  2874. Patient in Puerto Rico Stops HAART to Protest ADAP Wait List - (05/24/07)
     
  2875. Pfizer says parallel trade leads to fake drugs in supply chain - (05/24/07)
     
  2876. Spanish Doctor Convicted for Infecting HCV in People with Dirty Needles - (05/24/07)
     
  2877. Thailand: Abbott Makes New Offer of $1000 Per Person for HIV/AIDS Drug - (05/24/07)
     
  2878. Plan to track HIV-positive migrants visiting Australia, site of 2007 Intl AIDS Conference - (05/24/07)
     
  2879. Health Canada Approves Reyataz (atazanavir sulfate) 300 mg Single Capsule Formulation in Combination Therapy for Adults with HIV-1 Infection - (05/24/07)
     
  2880. Viramune Price Cut in Developing World - (05/21/07)
     
  2881. UK and Wales Fail on HCV Policy - (05/21/07)
     
  2882. Thailand and Brazil look to co-operate on healthcare - (05/21/07)
     
  2883. Ex-Serono executives acquitted in USA of bribing doctors - (05/04/07)
     
  2884. Brazil Threatens To Break Efavirenz Drug Patent - (05/04/07)
     
  2885. Merck & Co., Inc. Statement on Brazilian Government's Decision To Issue Compulsory License for Efavirenz (STOCRIN) - (05/04/07)
     
  2886. Abbott, activists tangle: Drug giant's chief defends response to Thailand patent break - (05/04/07)
     
  2887. 33% with HIV in UK don't know they're infected - (05/04/07)
     
  2888. Pfizer Foundation's ConnectHIV Initiative Provides $7.5 Million in Grants To Community-Based AIDS Service Organizations Across 10 States - (05/02/07)
     
  2889. Australia NSW report predicts rise in liver, stomach cancer - (05/02/07)
     
  2890. A Better Blood Test for Prostate Cancer - (04/26/07)
     
  2891. Abbott Announces FDA Approval of a New Coated Niaspan Tablet for HDL - (04/25/07)
     
  2892. FDA Panel urged to OK Pfizer HIV drug - (04/25/07)
     
  2893. Abbott Announces FDA Approval of a New Coated Niaspan Tablet for HDL - (04/24/07)
     
  2894. Abbott Submits New Drug Application for Combination Niaspan/Simvastatin Tablet - (04/24/07)
     
  2895. Merck's Januvia launches in UK - (04/20/07)
     
  2896. Broadway Actress/HIV Advocate, Sheryl Lee Ralph, Unveils Winning Photographs in Contest Communicating Personal Experiences with HIV/AIDS Through Photography - (04/20/07)
     
  2897. HRT linked to higher ovarian cancer risk - (04/19/07)
     
  2898. Sanofi gets first US licence for avian flu vaccines - (04/19/07)
     
  2899. Medicare drug price bill stalls in US Senate - (04/19/07)
     
  2900. Abbott Agrees with WHO Director-General to Expand Access to Kaletra/Aluvia (lopinavir/ritonavir) - (04/09/07)
     
  2901. New AIDS Drug (Darunavir) Helps Patients Immune to Other Medications - (04/05/07)
     
  2902. China Approves Schering-Plough's Pegintron for Hepatitis B - (04/05/07)
     
  2903. Two New Studies Back Vitamin D for Cancer Prevention - (04/02/07)
     
  2904. Tampering with Combivir Tablet Containers, Misbranding Abacavir as Combivir: Notice from GlaxoSmithKline - (04/02/07)
     
  2905. HIV in Asia Doubling Expected From 8.6 Million HIV infections in Asia hit economy - (04/02/07)
     
  2906. Early HIV Treatment Bill Reintroduced in Senate: Medicaid expansion to include HIV - (04/02/07)
     
  2907. Combination Diabetes Therapy Approved: Januivia + Metformin - (04/02/07)
     
  2908. Hepatitis Awareness Campaign in Abu Dhabi - (03/30/07)
     
  2909. NJ eyes mandatory HIV testing for moms, newborns - (03/30/07)
     
  2910. NJ eyes mandatory HIV testing for moms, newborns - (03/27/07)
     
  2911. Illinois Gov.'s Plan to Help HIV/AIDS Community: Universal coverage - (03/21/07)
     
  2912. NIH Announces Phase III Clinical Trial of Creatine for Parkinson's Disease - (03/21/07)
     
  2913. Decline in NIH Research Federal Funding: Bob Siliciano testifies to Congress - (03/21/07)
     
  2914. Roche-Trimeris Change TRI-1144 Deal - (03/21/07)
     
  2915. CDC: Fruits & Vegetables Consumption Too Low, Unhealthy - (03/21/07)
     
  2916. NY Court Waives Ryan White Care Act 75% Medical Spending Requirement - (03/21/07)
     
  2917. ADAP Waiting Lists - (03/21/07)
     
  2918. Revisions to Ryan White Program Result in Loss of HIV/AIDS Funding for Minority Services in Austin, Texas, Region - (03/21/07)
     
  2919. A letter to America's heterosexuals by Larry Kramer - (03/21/07)
     
  2920. Roche Gives Workers Flu Drug in Case of Pandemic - (03/16/07)
     
  2921. Magic Johnson Visits South Carolina - (03/16/07)
     
  2922. Bill Would Require Prisons To Provide HIV Counseling, Prevention Education, Condoms - (03/12/07)
     
  2923. FDA Approves Generic ddI Oral Solution - (03/12/07)
     
  2924. Single Genetic Defect Causes Early Heart Disease - (03/08/07)
     
  2925. Few Latinos advised to get tested for HIV, study says - (03/08/07)
     
  2926. Single Genetic Defect Causes Early Heart Disease - (03/08/07)
     
  2927. Few Latinos advised to get tested for HIV, study says - (03/08/07)
     
  2928. Few Latinos advised to get tested for HIV, study says - (03/06/07)
     
  2929. Novartis Challenges Indian Drug Patent Law - (03/06/07)
     
  2930. 2 New Drugs for HIV - (02/29/07)
     
  2931. FDA Demands More Diabetes Drug Glavus Data - (02/27/07)
     
  2932. Reinfection 'the main cause' of drug-resistant TB - (02/27/07)
     
  2933. Barriers to Male Circumcision HIV Prevention - (02/27/07)
     
  2934. J&J unit's HIV drug Prezista gets conditional OK in Europe - (02/22/07)
     
  2935. Kelly Osbourne's HIV revelation - (02/22/07)
     
  2936. Breakthrough for Can-Fite: CF102 Found to be Active Against Liver Cancer, Hepatitis B Virus in Pre-Clinical Studies - (02/22/07)
     
  2937. Are we spending too much on HIV? - (02/22/07)
     
  2938. Tommy Morrison Says He's Not HIV+ After all, Attempting Comeback - (02/22/07)
     
  2939. GSK Reports Increased Fractures Among women Taking Rosiglitazone - (02/22/07)
     
  2940. Hepatitis Meds May Be Linked To Drug Resistant HIV Canadian Health Agency Warns - (02/22/07)
     
  2941. Merck Integrase/Pfizer CCR5 & New HIV Drugs Spark Care Revolution - (02/15/07)
     
  2942. 20 anti-Aids gel trial participants test positive; activists call to re-start study - (02/15/07)
     
  2943. 20 anti-Aids gel trial participants test positive; activists call to re-start study - (02/14/07)
     
  2944. Two New Studies Back Vitamin D for Cancer Prevention - (02/14/07)
     
  2945. HIV Spreading Rapidly in Malaysia - (02/14/07)
     
  2946. Push for mandatory cervical cancer vaccine in NY - (02/14/07)
     
  2947. Swedish firm Medivir Licenses HIV ART Drug to Chinese - (02/14/07)
     
  2948. Body Shop founder Roddick has Hepatitis C - (02/14/07)
     
  2949. Polydex Pharmaceuticals reports Phase III trial of Ushercell for HIV Prevention Halted - (02/08/07)
     
  2950. Bush/Congress in Fighting AIDS/Malaria/TB - (02/08/07)
     
  2951. Men's testicles 'HIV hiding spot' - (02/08/07)
     
  2952. Microbicide Research Remains Hopeful - (02/08/07)
     
  2953. Wash DC tries to improve HIV/AIDS initiatives - (02/08/07)
     
  2954. New HCV therapy Targets Mitochondrial Function - (02/08/07)
     
  2955. GRACE Study for Women Looks at Race & Gender in ART - (02/08/07)
     
  2956. GSK Announces Co-Pay Assistance for Lexiva - (02/08/07)
     
  2957. EGYPT: 5 million infected with Hepatitis C - (02/08/07)
     
  2958. Flat NIH funding again in '08; Medicaid/Medicare - (02/08/07)
     
  2959. AstraZeneca Enters HCV, Buys Arrow - (02/01/07)
     
  2960. Studies of AIDS microbicide gels halted, HIV Infections Increased - (02/01/07)
     
  2961. Decreases in plasma selenium linked to cognitive decline in elderly - (02/01/07)
     
  2962. India to create HIV "safe zones" for migrants - (02/01/07)
     
  2963. Caution About Selenium & Recent Study - (02/01/07)
     
  2964. HCM City: 12,000 HIV/AIDS patients receive free treatment - (01/30/07)
     
  2965. Thailand allows copycat AIDS, heart disease drugs - (01/30/07)
     
  2966. HIV dementia is common in a sub-Saharan African HIV clinic - (01/30/07)
     
  2967. Pegasys/Copegus Approved in Japan - (01/26/07)
     
  2968. HIV testing offered in the ER at Hopkins - (01/26/07)
     
  2969. Criticism of Suit Against Pfizer Over Viagra - (01/25/07)
     
  2970. Young women 'complacent over HIV' - (01/24/07)
     
  2971. Pharmasset Appoints Michelle Berrey as Chief Medical Officer and William Symonds as Vice President, Clinical Pharmacology - (01/24/07)
     
  2972. Pfizer to shed 10,000 jobs as earnings fall back 15% - (01/23/07)
     
  2973. Gardasil and Cervarix go head-to-head - (01/22/07)
     
  2974. Cancer Rates Down, But Liver Cancer Rates UP - (01/22/07)
     
  2975. Study links gum disease, cancer - (01/22/07)
     
  2976. GE Is Near Deal for Abbott Unit - (01/22/07)
     
  2977. Roche Diagnostics Submits Hepatitis C Viral Load Monitoring Test to FDA - (01/16/07)
     
  2978. US House passes drug price bill to negotiate on Medicare prescriptions, but Bush pledges veto - (01/16/07)
     
  2979. Statins link to Parkinson's? - (01/16/07)
     
  2980. US Senate warned of threat to R&D by negotiating Medicare drug pricing - (01/16/07)
     
  2981. Pfizer Overhaul Continues - (01/16/07)
     
  2982. Ireland Department of Health plan to combat Hepatitis C - (01/16/07)
     
  2983. Algae Microbicide gel in Brazil - (01/16/07)
     
  2984. Vaccines Purchase Plan Proposal for Developing World from Group of 8 Nations - (01/12/07)
     
  2985. Diet seen to affect liver cancer risk: study - (01/12/07)
     
  2986. Not one but four biotechnology deals for Pfizer - (01/12/07)
     
  2987. US prescription drug spending growth continues to fall - (01/12/07)
     
  2988. Tenofovir HIV PEP Study Focuses on Enrolling Black MSM - (01/12/07)
     
  2989. Nevirapine for MTCT - (01/12/07)
     
  2990. FDA proposes major hike in drug industry user fees to review drug safety & direct-to-consumer advertising - (01/12/07)
     
  2991. Democrats propose price negotiation plan with drugmakers - (01/09/07)
     
  2992. New HIV & HCV Abbott Viral Load Tests - (01/09/07)
     
  2993. Doug Mayers Leaves Boehringer Ingelheim & Joins Idenix - (01/09/07)
     
  2994. HCV Is Diagnosed late in UK: found with severe liver disease upon diagnosis - (01/09/07)
     
  2995. UK government backs generic statins: pravastatin, simvastatin - (01/05/07)
     
  2996. Chris Lawford says get tested for HCV - (01/05/07)
     
  2997. 'Salvage Therapy' - New AIDS drug offers hope, but too late for one man - (01/05/07)
     
  2998. Diabetes a Nerve Disease? - (01/05/07)
     
  2999. Marsha Martin Leaves Wash DC AIDS Office; HIV/AIDS in DC in Disarray - (01/05/07)
     
  3000. Trana Discovery and Southern Research Institute Collaborate to Discover New Classes of Drugs for the Treatment of HIV - (01/02/07)
     
  3001. HCV Is Diagnosed late in UK: found with severe liver disease upon diagnosis - (01/02/07)
     
  3002. Valeant Sells HIV & Cancer Programs - (01/02/07)
     
  3003. Circumcision Not Solution to HIV - Museveni, Uganda Pres. - (01/02/07)
     
  3004. UK Cervical Cancer Vaccine Program for Schoolgirls - (01/02/07)
     
  3005. NIH Cuts ACTG AIDS research funding - (01/02/07)
     
  3006. Rifts Emerge on Push to End Written Consent for H.I.V. Tests - (01/02/07)
     
  3007. HIV home screening kit launched in UK - (01/02/07)
     
  3008. Major Risk Factors for HCV Besides IV Drug Use, Get Tested for HCV Says Peter Lawford - (01/02/07)
     
  3009. Waiting List for AIDS Drugs Causes Dismay in South Carolina; South Carolina Health Dept requests Additional $3-4 Million - (01/02/07)
     
  3010. Jamaica making progress in fight against HIV/AIDS; 250,000 HIV+ in Caribbean - (01/02/07)
     
  3011. Vytorin Reduces LDL More Than Crestor - (01/02/07)
     
  3012. US drug approvals study 'refutes industry R&D myths' - (01/02/07)
     
  3013. Bristol Says U.S. Inquiry Is Settled, Pays $499 Million Fine - (01/02/07)
     
  3014. Awareness And Testing For Hepatitis C Are Increasing, UK - (01/02/07)
     
  3015. New Microbicide Potential: 'Molecular condom' to combat HIV - (01/02/07)
     
  3016. Bulgaria requests EU help to free Libya nurses - (01/02/07)
     
  3017. US FDA "must improve drug ad policies," says govt agency - (01/02/07)
     
  3018. UK confidence in drugs, devices is high, study finds - (01/02/07)
     
  3019. Study Suggests That Body Composition Is Key Player in Controlling Cancer Risks - (01/02/07)
     
  3020. Bush on AIDS & Malaria in Africa: "The Other War" - (01/02/07)
     
  3021. PEPFAR Recordkeeping Questioned - (01/02/07)
     
  3022. HCV Is Diagnosed late in UK: found with severe liver disease upon diagnosis - (12/22/06)
     
  3023. Nipple piercing & HCV or HBV Infection - (12/22/06)
     
  3024. HCV Is Diagnosed late in UK: found with severe liver disease upon diagnosis - (12/22/06)
     
  3025. Nipple piercing & HCV or HBV Infection - (12/22/06)
     
  3026. Libya Sentences 6 Bulgarian Nuses to Die in H.I.V. Case - (12/20/06)
     
  3027. Theratechnologies Reports Positive Phase 3 Results for TH9507 in HIV associated Lipodystrophy - (12/20/06)
     
  3028. PA-457 Disappointing Study Results - (12/20/06)
     
  3029. Bush Signs New AIDS & Autism Bills - (12/20/06)
     
  3030. Shocking 'lack of evidence' - Medics sentenced to death in Libya - (12/20/06)
     
  3031. Libyan court condemns all accused to death for infecting children with HIV - (12/20/06)
     
  3032. Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV - (12/14/06)
     
  3033. Valeant Pharmaceuticals and Metabasis Therapeutics License Rights to Hepatitis B Compound Pradefovir to Schering-Plough Corporation - (12/14/06)
     
  3034. Offers to pay for circumsion - (12/14/06)
     
  3035. Merck Pipeline: to file three FDA New Drug Applications in 2007 - (12/13/06)
     
  3036. GSK's New Drug for Low Platelets & HCV Therapy - (12/13/06)
     
  3037. New AIDS funds may help bring transportation to rural patients - (12/13/06)
     
  3038. New AIDS funds may help bring transportation to rural patients - (12/13/06)
     
  3039. South Carolina to see more AIDS funding - (12/13/06)
     
  3040. ADAP in South Carolina: Call for $3 Million Emergency Funds - (12/13/06)
     
  3041. Ryan White Funds in Baltimore/Maryland - (12/13/06)
     
  3042. Microbicide Carraguard in Phase III Study - (12/13/06)
     
  3043. Magic Johnson in the Bronx Dec 14 for HIV Testing & Talk - (12/13/06)
     
  3044. Senate Amendments to Ryan White HIV/AIDS Treatment Act (HR 6143) & NIH Bill - (12/12/06)
     
  3045. Gilead Grants Intellectual Property Rights for Tenofovir Topical Gel to the International Partnership for Microbicides and CONRAD - (12/12/06)
     
  3046. FDA plans to widen use of experimental drugs - (12/12/06)
     
  3047. Dr. Oliver Pybus: The Libyan Children were Infected before Arrival of Bulgarian Nurses and Palestinian Doctor: HCV & non-sterile syringes - (12/12/06)
     
  3048. Novartis starts major study of Galvus versus glitazones - (12/11/06)
     
  3049. Pfizer Challenged Due to cancelling of cholesterol drug Torcetrapid Development - (12/11/06)
     
  3050. Deal Paves Way For Approval Of Compromise Ryan White Reauthorization - (12/11/06)
     
  3051. The Ethics and Politics of Compulsory HPV Vaccination - (12/11/06)
     
  3052. Ryan White Act Passes House - (12/11/06)
     
  3053. BMS and Sanofi backed by US court on Plavix - (12/11/06)
     
  3054. HIV Conference in New Orleans & Katrina Affect - (12/11/06)
     
  3055. FDA Proposes Rules Overhaul to Expand Availability of Experimental Drugs The Agency Also Clarifies Permissible Charges to Patients - (12/11/06)
     
  3056. Pfizer Challenged Due to cancelling of cholesterol drug Torcetrapid Development - (12/05/06)
     
  3057. Pfizer Setback opens door for Abbott Niaspan/Somcor Combination Therapy - (12/05/06)
     
  3058. Amid Pfizer cholesterol drug setback, older drug already on market Niaspan/Abbott Drug - (12/05/06)
     
  3059. Maraviroc Holds Promise for Pfizer - (12/05/06)
     
  3060. Rival Cholesterol Drug programs - (12/05/06)
     
  3061. Russia Promises ART to 10,000 in 2007 - (12/04/06)
     
  3062. Taiwan to Double Spending on HIV Prevention After Cases Surged - (12/04/06)
     
  3063. Massachusetts will report HIV carriers by name - (12/04/06)
     
  3064. Trimeris trims down to focus on Fuzeon - (12/04/06)
     
  3065. UK Agency warns of rise in syphilis - (12/04/06)
     
  3066. Migrants 'carry disease burden' in UK - (12/04/06)
     
  3067. FDA Approves Silicone Gel-Filled Breast Implants After In-Depth Evaluation Agency Requiring 10 Years of Patient Follow-Up - (12/04/06)
     
  3068. Routine AIDS Testing Pays Off:Meeting in Wash DC - (12/04/06)
     
  3069. Coffee drinkers show lower diabetes risk - (12/04/06)
     
  3070. Shanghai lauches HIV/AIDS campaign to increase public awareness - (12/04/06)
     
  3071. Clinton Brokers Deal: Children with HIV to receive cheap drugs & starts treatment for kids in India - (12/04/06)
     
  3072. HCV Co-infection in India a deadlier problem for HIV/AIDS infected in state - (12/04/06)
     
  3073. Blacks' HIV Risk Dramatically Higher Than Whites Despite Safer Sex Lives Due to Higher rate of STDs Among Young African-American Adults, Study Reports - (12/04/06)
     
  3074. OLIVE OIL COMPOUND SLOWS HIV SPREAD - (12/04/06)
     
  3075. A fresh start: South Africa's war on HIV/AIDS - (12/04/06)
     
  3076. Merck to cut AIDS drug price in Thailand - (12/04/06)
     
  3077. FDA Approves Silicone Gel-Filled Breast Implants After In-Depth Evaluation Agency Requiring 10 Years of Patient Follow-Up - (11/30/06)
     
  3078. Hepatitis in Kuwait - (11/30/06)
     
  3079. Troubling reports tarnish credibility of US drug agency - (11/30/06)
     
  3080. Cases of HIV infection in UK rise by 8,000 - (11/30/06)
     
  3081. China's HIV/AIDS cases rise nearly 30% - (11/30/06)
     
  3082. Number of People with HIV in Latin America and the Caribbean Rises to 2 Million, Number of People under Treatment and Getting Tested also Increases, Says Report - (11/30/06)
     
  3083. New Low Dose Interferon Drug for HBV Enters Study - (11/30/06)
     
  3084. Hepatitis spreading fast in Pakistan (10% Rate), while government yet to take action - (11/30/06)
     
  3085. Boehringer Ingelheim Licenses HCV Drugs - (11/30/06)
     
  3086. Singapore forms panel to fight HIV - (11/30/06)
     
  3087. Study Shows Americans Ambivalent About HIV/AIDS Crisis - (11/30/06)
     
  3088. India Launches Free HIV treatment for 20,000 children from Nov 30 - (11/30/06)
     
  3089. Indonesia projects 500,000 HIV cases by 2010 - (11/30/06)
     
  3090. HIV Test Plan May Triple New Cases, Swamp Clinics, Doctors Say - (11/30/06)
     
  3091. Light A Virtual Candle to Support HIV on Dec 1 Natl AIDS Day - (11/30/06)
     
  3092. Magic Johnson Campaign Free HIV Testing in LA on Dec 1 World AIDS Day - (11/30/06)
     
  3093. How Quiet Moves by a Publisher Sway Billions in Drug Spending - (11/10/06)
     
  3094. HIV testing effort may hit obstacles - (11/10/06)
     
  3095. Electronic Network to Pool Information About H.I.V. - (11/10/06)
     
  3096. 4th Annual National Latino AIDS Awareness Day - (11/10/06)
     
  3097. Experimental Microbicide To Be Tested on HIV-Positive Women in Thailand - (11/10/06)
     
  3098. New HIV infections in Australia up 41 percent from 2000, study finds - (11/10/06)
     
  3099. Updates on Pandemic Flu Vaccine Trials to be Presented at 44th Annual IDSA Meeting - (11/10/06)
     
  3100. AIDS Activist Jeff Getty Dead at 49 - (11/10/06)
     
  3101. The truth about men! - (11/10/06)
     
  3102. Merck Diabetes Drug Gets FDA Approval - (11/10/06)
     
  3103. Hepatitis drug from Vertex could reap billions - (11/10/06)
     
  3104. China: AIDS Spreads As Authorities Sharpen Their Struggle - (11/10/06)
     
  3105. China opens 206 new methadone clinics in anti-AIDS effort - (11/10/06)
     
  3106. China: AIDS Spreads As Authorities Sharpen Their Struggle - (11/10/06)
     
  3107. FDA APPROVES REYATAZ (atazanavir sulfate) 300 mg SINGLE CAPSULE FORMULATION IN COMBINATION THERAPY FOR ADULTS WITH HIV-1 INFECTION - (11/10/06)
     
  3108. Methadone therapy, needle exchanges leading HIV battle - (11/10/06)
     
  3109. TV Anchor Has HCV, Takes Peg/RBV - (11/10/06)
     
  3110. Gastro experts challenge standard PPI treatment recommendations - (11/10/06)
     
  3111. Some NSAIDs linked to heart disease, EMEA concludes - (11/10/06)
     
  3112. Merck says US will fund Gardasil for uninsured - (11/10/06)
     
  3113. Abbott & Baylor Open Pediatric AIDS Clinic in Malawi - (11/10/06)
     
  3114. ADAP Tragedy in South Carolina: Three Die While on "Waiting List" for AIDS Treatment - (11/10/06)
     
  3115. Abacavir Generic FDA Approved - (11/10/06)
     
  3116. HIV gene therapy study 'shows promise' - (11/10/06)
     
  3117. Magic Johnson keeps up HIV fight - (11/10/06)
     
  3118. $1.7 million more sought to prevent HIV in Chicago - (11/10/06)
     
  3119. Osteoporosis group slams UK guidance on drug treatment - (10/05/06)
     
  3120. CHILE TO LAUNCH MASSIVE HIV/AIDS AWARENESS CAMPAIGN - (10/03/06)
     
  3121. HIV High in Dominican Republic/Prisons - (10/03/06)
     
  3122. Drugmakers "OK to give patients non-promotional info" in Europe - (10/03/06)
     
  3123. NJ moves to end ban on over-the-counter syringes - (10/03/06)
     
  3124. NYC HIV Testing & Identifying HIV+ Up By 63% - (10/03/06)
     
  3125. CHILE TO LAUNCH MASSIVE HIV/AIDS AWARENESS CAMPAIGN - (10/03/06)
     
  3126. HIV High in Dominican Republic/Prisons - (10/03/06)
     
  3127. Drugmakers "OK to give patients non-promotional info" in Europe - (10/03/06)
     
  3128. NJ moves to end ban on over-the-counter syringes - (10/03/06)
     
  3129. NYC HIV Testing & Identifying HIV+ Up By 63% - (10/03/06)
     
  3130. New drug may heal liver - (09/29/06)
     
  3131. Agencies told to streamline care for HIV - (09/29/06)
     
  3132. Aerosmith singer delves into battle with hepatitis C on Peginterferon Therapy - (09/29/06)
     
  3133. Ryan White Care Act Stalls in Senate - (09/29/06)
     
  3134. Lawmakers Argue Over AIDS Funding Bill - (09/29/06)
     
  3135. India to Increase HIV Treatment Centers - (09/29/06)
     
  3136. Ryan White Care Act AIDS funding bill passes House over complaints by big-state senators - (09/29/06)
     
  3137. Money Fight Stalls AIDS Bill in Senate - (09/29/06)
     
  3138. Roche Transfers Invirase Manufacturing Technology to African Generic Companies - (09/25/06)
     
  3139. Generic Co & Gilead Agree to Make Tenofovir - (09/25/06)
     
  3140. Gilead inks licensing pacts with 4 Indian firms - (09/25/06)
     
  3141. FDA Told U.S. Drug System Is Broken Expert Panel Calls For Major Changes - (09/25/06)
     
  3142. GILEAD ANNOUNCES LICENSING AGREEMENTS WITH EIGHT INDIA-BASED COMPANIES FOR MANUFACTURING AND DISTRIBUTION OF GENERIC VERSIONS OF VIREAD IN THE DEVELOPING WORLD - (09/25/06)
     
  3143. Broward County Florida puts income cap on Ryan White services - (09/25/06)
     
  3144. Gardasil gets green light in Europe - (09/25/06)
     
  3145. Needle Exchange Proposed for 6 Cities in NJ - (09/25/06)
     
  3146. NY Times Supports Routine Testing for the AIDS Virus - (09/25/06)
     
  3147. Wash DC HIV Rapid Tests Reveal Infection Rate Double the U.S. Average - (09/21/06)
     
  3148. GSK debuts "flexible" drug pricing in Europe - (09/21/06)
     
  3149. German Merck KGaA to buy Serono in $13.5bn deal (this is a different company than the US Merck) - (09/21/06)
     
  3150. Fish Oils May Be Lifesavers - (09/20/06)
     
  3151. HIV/AIDS crisis among blacks often ignored - (09/19/06)
     
  3152. GSK Provides ARTs to Russia - (09/19/06)
     
  3153. Rep. Barbara Lee moves to provide condoms for prisoners: Lawmaker's intent is to slow HIV spread - (09/19/06)
     
  3154. Glitazones, Study Results - (09/19/06)
     
  3155. Colchicine May Prevent Hepatocellular Carcinoma in Patients With Hepatitis - (09/19/06)
     
  3156. Schering - Plough CEO Cures Host of Ills - (09/19/06)
     
  3157. New Drug Treats Premature Ejaculation - (09/15/06)
     
  3158. Marijuana helps patients stay on medication - (09/15/06)
     
  3159. New Drug Treats Premature Ejaculation - (09/12/06)
     
  3160. H5N1 Vaccines Being Prepared - (09/12/06)
     
  3161. J&J's dapoxetine effective for premature ejaculation - (09/12/06)
     
  3162. HRSA Awards $400,000 Dental Grant - (09/12/06)
     
  3163. NIH Live H5N1 Avian Flu Virus Vaccines Show Protection in Animal Studies - (09/12/06)
     
  3164. BMS CEO Leaves - (09/12/06)
     
  3165. Scientists Rip S. African AIDS Policies - (09/08/06)
     
  3166. Trimeris Extends Research Agreement with Roche Covering Next-Generation HIV Fusion Inhibitors; Research Term Extended for Additional 2 Years Through the End of 2008; TRI-1144 Advancing as the Lead Preclinical Candidate - (09/08/06)
     
  3167. Health care delivery for HIV patients an 'emerging crisis' - (09/08/06)
     
  3168. Mayo Researchers Discover HIV Dependence on a Human Protein; Essential For Infection, Protein Is Potential Therapy Target - (09/08/06)
     
  3169. Pfizer nears Maraviroc HIV FDA application - (09/08/06)
     
  3170. Viagra Increases HIV risk in Seniors - (09/07/06)
     
  3171. Primetime Reports the HIV Epidemic Among Blacks ... A Decade Too Late - (09/07/06)
     
  3172. Fruit and Vegetable Juice Called Alzheimer's Preventive - (09/07/06)
     
  3173. Jitters over Celebrex as more cardiac concerns arise - (09/07/06)
     
  3174. Congress poised to renew Ryan White Act - (09/07/06)
     
  3175. AIDS Money Suddenly at Risk (Ryan White Act) Editorial - (09/07/06)
     
  3176. CALIFORNIA BILL TO STREAMLINE HIV TEST COUNSELING AND TREAT STDS PASSES - (09/07/06)
     
  3177. FDA & Industry Negotiate Fees - (09/07/06)
     
  3178. NIH Funding: End of a Golden Era - (09/07/06)
     
  3179. Ryan White Act May Pass Before Nov Elections - (09/07/06)
     
  3180. Bone mineral density often low in women infected with HIV - (09/07/06)
     
  3181. Merck exonerated by external Vioxx probe - (09/07/06)
     
  3182. HIV among gay men up 8 percent across U.S., CDC says Rise could be tied to increased testing, risky sex - (09/07/06)
     
  3183. HIV, Music Culture, & Black Youth - (09/07/06)
     
  3184. Gardasil hits shelves in Australia - (08/31/06)
     
  3185. Prosecutor seeks death penalty in Libya HIV case - (08/31/06)
     
  3186. Generic d4T Gets FDA Approval - (08/31/06)
     
  3187. Analysis: Time to quit on AIDS vaccine? - (08/23/06)
     
  3188. Sen. Clinton Delays AIDS Law's Renewal, Citing Cut in N.Y. Funds - (08/23/06)
     
  3189. Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States - (08/23/06)
     
  3190. National Black Chamber of Commerce President/CEO Sends Letter to Sen. Clinton Regarding Ryan White HIV/AIDS Act - (08/22/06)
     
  3191. Abbott broadens its HIV treatment access programme - (08/21/06)
     
  3192. Gilead, Merck to Market New AIDS Pill in Poor Nations - (08/11/06)
     
  3193. Mark Dybul is New Global AIDS Coordinator - (08/11/06)
     
  3194. ABBOTT STATEMENT REGARDING NEW INITIATIVES TO EXPAND ACCESS AND AFFORDABILITY TO LOPINAVIR/RITONAVIR IN THE DEVELOPING WORLD - (08/11/06)
     
  3195. Saudi Arabia Begins to Face Hidden AIDS Problem - (08/11/06)
     
  3196. Patient Died in Lipodystrophy Drug Study - (08/11/06)
     
  3197. Court: Wife entitled to husband's sexual history - (08/11/06)
     
  3198. Saudi Arabia Begins to Face Hidden AIDS Problem - (08/08/06)
     
  3199. HIV Drug Holidays Get New Support - (08/07/06)
     
  3200. Interview with J-P Garnier-Chief Executive Officer of GlaxoSmithKline - (08/04/06)
     
  3201. Romania kids with HIV face discrimination - (08/04/06)
     
  3202. TMC-114 Discoverer Arun Ghosh Has New PIs - (08/04/06)
     
  3203. Persistence of HPV Infection Depends on a Patient's Race - (08/04/06)
     
  3204. Gay man jailed for passing on HIV - (08/04/06)
     
  3205. Interview with J-P Garnier-Chief Executive Officer of GlaxoSmithKline - (08/01/06)
     
  3206. Almost 15,000 Canadians don't know they have HIV: report - (08/01/06)
     
  3207. Canada To Compensate HCV-Infected Tainted Blood Victims - (07/31/06)
     
  3208. Unique HIV Clinic in India - (07/31/06)
     
  3209. GSK Calls New Bird Flu Vaccine More Effective - (07/28/06)
     
  3210. HIV: The drug firms' quest for a cure - (07/28/06)
     
  3211. Merson Heads Duke Global AIDS/Health Institute: $350 million goes to Duke for AIDS research - (07/28/06)
     
  3212. Buprenorphine Gets EU Positive Opinion - (07/28/06)
     
  3213. FDA Approves Generic 3TC/AZT/Abacavir Copackaged - (07/27/06)
     
  3214. Annan pushes AIDS drug makers to bring down prices - (07/27/06)
     
  3215. New Real-Time HCV Genotype Test - (07/27/06)
     
  3216. China faces huge task in Hepatitis B fight - (07/27/06)
     
  3217. Duke Names AIDS/HIV Researcher Merson To Lead Global Health Institute - (07/27/06)
     
  3218. GSK gearing up to file pandemic flu vaccine - (07/27/06)
     
  3219. Making HIV Tests Routine Screening for the virus in annual physicals may be the best way to fight AIDS. - (07/27/06)
     
  3220. Making HIV Tests Routine Screening for the virus in annual physicals may be the best way to fight AIDS. - (07/24/06)
     
  3221. In India, HIV Threatens Economy - (07/24/06)
     
  3222. NYC Aids organizations face funding peril - (07/24/06)
     
  3223. 2 Gates AIDS Donations: $287 Million for Vaccine; $900,000 for HIV Training Facility - (07/20/06)
     
  3224. Gardasil cleared for Launch in Canada - (07/19/06)
     
  3225. New Clinton HIV Initiatives: second-line therapies & launches Ethiopa AIDS Program - (07/18/06)
     
  3226. Long-Term Non-Progressors & Personal HIV Stories - (07/17/06)
     
  3227. New Anemia Drug - (07/17/06)
     
  3228. First one-a-day AIDS pill approved - (07/12/06)
     
  3229. Baltimore offers new Acute HIV testing - (07/12/06)
     
  3230. Russia Acknowledges AIDS Drug Shortage - (07/12/06)
     
  3231. Clinton, Gates Join Forces In a Global Effort to Fight AIDS - (07/12/06)
     
  3232. Russia to offer free treatment for HIV/AIDS in 2006 - (07/11/06)
     
  3233. 'Home-Grown' H5N1 Vaccine Trials in UK - (07/11/06)
     
  3234. D.C. to require HIV names reporting - (07/10/06)
     
  3235. Pa. court allows charges for hiding HIV during sex - (07/10/06)
     
  3236. FDA Encourages New Study Designs - (07/10/06)
     
  3237. Entecavir Approved in India - (07/06/06)
     
  3238. Abbott's Tablet Formulation Of Kaletra Receives Marketing Approval From European Commission - (07/06/06)
     
  3239. Liability Is Expanded for Negligent Sexual HIV Infection - (07/06/06)
     
  3240. Liability for HIV infection: Top California State court rules man in lawsuit must tell sexual history to wife - (07/06/06)
     
  3241. Plans to Expand AIDS Testing Alarm Activists - (07/06/06)
     
  3242. GSK licenses OTC erectile dysfunction product - (07/06/06)
     
  3243. Calif. Supreme Court Rules "Constructive'Knowledge" of Having HIV-Infection: man should have known he might have HIV & should inform wife - (07/06/06)
     
  3244. New Anti-Lipid Fixed Combination 'Power Pill' - Abbott and AstraZeneca forge lipid pact - (07/06/06)
     
  3245. Rosiglitazone, pioglitazone equally effective in type 2 diabetes therapy - (07/06/06)
     
  3246. CDC Panel Supports HPV Vaccine for Pre-Teen Girls - (06/30/06)
     
  3247. HPV Vaccine Stirs Economic Debate - (06/30/06)
     
  3248. NYC & Wash DC Order OraSure Rapid HIV Test - (06/29/06)
     
  3249. CDC Says HIV Rapid Testing Program Appears Successful in Identifying Unknown HIV+ Status - (06/29/06)
     
  3250. Generic d4T Receives Tentative Approval from FDA for Outside USA - (06/29/06)
     
  3251. Generic Abacavir Oral Solution Gets FDA Tentative Approval - (06/29/06)
     
  3252. Generic d4T Receives Tentative Approval from FDA for Outside USAoke - (06/29/06)
     
  3253. New Surgeon General's Report Focuses on the Effects of Secondhand Smoke - (06/29/06)
     
  3254. NYC & Wash DC Order OraSure Rapid HIV Test - (06/29/06)
     
  3255. CDC Says HIV Rapid Testing Program Appears Successful in Identifying Unknown HIV+ Status - (06/29/06)
     
  3256. Generic d4T Receives Tentative Approval from FDA for Outside USA - (06/29/06)
     
  3257. Generic Abacavir Oral Solution Gets FDA Tentative Approval - (06/29/06)
     
  3258. Generic d4T Receives Tentative Approval from FDA for Outside USAoke - (06/29/06)
     
  3259. New Surgeon General's Report Focuses on the Effects of Secondhand Smoke - (06/29/06)
     
  3260. Routine HIV Testing in Wash DC: D.C. Estimates Up to 25,000 Residents Have HIV - (06/27/06)
     
  3261. FDA: Tentative approval of lamivudine oral solution - (06/23/06)
     
  3262. The Immune Response Corporation Completes First Stage of Enrollment and Receives Approval for Expansion of Phase II Trial for Investigative HIV Immunotherapy IR103 - (06/21/06)
     
  3263. CCR5 HIV Drugs: discussion of concerns - (06/21/06)
     
  3264. The Immune Response Corporation Completes First Stage of Enrollment and Receives Approval for Expansion of Phase II Trial for Investigative HIV Immunotherapy IR103 - (06/21/06)
     
  3265. CCR5 HIV Drugs: discussion of concerns - (06/21/06)
     
  3266. PUBLIC HEALTH: HIV Testing in China - (06/08/06)
     
  3267. MONKEYS VACCINATED AGAINST SIV SURVIVE LONGER AFTER INFECTION - (06/08/06)
     
  3268. Merck Plans to Study HPV Vaccine in Boys - (06/08/06)
     
  3269. Sanofi-Aventis & partner Merck files cervical cancer vaccine in Europe - (06/08/06)
     
  3270. More on Merck's cervical cancer vaccine approval in USA - (06/08/06)
     
  3271. FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus - (06/08/06)
     
  3272. Moscow Gay Activists Assaulted by Homophobes - (06/08/06)
     
  3273. Number of HIV-infected Women in Russia Growing - (06/08/06)
     
  3274. International AIDS conference opens in Moscow - (06/08/06)
     
  3275. GSK HPV Vaccine Cervarix works on older women too, says GSK - (06/08/06)
     
  3276. Circumcision of Men in UNAIDS HIV prevention study - (06/06/06)
     
  3277. Dual superinfection identified in high-risk HIV-infected patient - (06/06/06)
     
  3278. Genelabs Announces Novartis Collaboration for Development and Commercialization of HCV Non-Nucleoside Drug Candidates - (06/05/06)
     
  3279. NIH Statement on 25th Anniversary of HIV/AIDS - (06/05/06)
     
  3280. U.N. Urges ($22 Billion) Tripling of Funds by '08 to Halt AIDS: UNGASS Week at UN - (06/01/06)
     
  3281. UN AIDS Meeting This Week - (05/31/06)
     
  3282. AIDS Growth Slowing Worldwide, U.N. Report Finds - (05/31/06)
     
  3283. Africa's leaders failing on AIDS - U.N. - (05/31/06)
     
  3284. More adults are dying of AIDS despite better access to drugs, U.N. reports - (05/31/06)
     
  3285. UN Contentious Issues: condoms, IDUs, women - (05/31/06)
     
  3286. AIDS increases among women, Sexual control absent, UN Report - (05/31/06)
     
  3287. Green Tea & Cancer, HIV - (05/31/06)
     
  3288. Hepatitis C care 'fails patients' in the UK - (05/31/06)
     
  3289. Aids experts to review progress at UNGASS - (05/31/06)
     
  3290. 1.8 M Nigerian AIDS Orphans Kenya: No drugs for children with HIV - (05/31/06)
     
  3291. SmarTube Detects Antibodies Within Days After Infection - (05/31/06)
     
  3292. Bush's Talk And Results On AIDS: international AIDS funding & policy - (05/31/06)
     
  3293. Hep A/B Vaccinations Available for MSM in NYC - (05/31/06)
     
  3294. SciClone HCV Drug Zadaxin Fails in Phase III Trial - (05/26/06)
     
  3295. Intermune HCV protease Starts Study in Europe - (05/26/06)
     
  3296. Merck's Zostavax Shingles Vaccine Approved - (05/26/06)
     
  3297. Pre-test Consent/Counseling & Medical Records Controversies in SF & NYC - (05/25/06)
     
  3298. FDA Grants Abacavir Generic Tentative Approval - (05/23/06)
     
  3299. San Francisco Adopts CDC Recommendation to Not Require HIV Testing Consent & Counseling - (05/22/06)
     
  3300. Tenofovir To Prevent HIV Transmission - (05/19/06)
     
  3301. Clarion Call for Condoms in Corrections (Prisons and Jails) - (05/19/06)
     
  3302. FDA Panel Endorses Cervical Cancer Vaccine - (05/19/06)
     
  3303. Roche, Aspen sign deal to boost Tamiflu output - (05/17/06)
     
  3304. Glaxo, Vertex: HIV drug matches Kaletra in study - (05/17/06)
     
  3305. Rights Groups Threaten NYS Suit Over HIV-Medical Data Collection - (05/16/06)
     
  3306. GlaxoSmithKline announces transitional plan to Medicare Part-D enrollees for former patient assistance program enrollees - (05/16/06)
     
  3307. Call by the CDC for routine HIV testing gets mixed response - (05/15/06)
     
  3308. Gilead Patent Filing for Viread in India - (05/15/06)
     
  3309. HPV vaccine nearing approval: political/religious controversy - (05/15/06)
     
  3310. A Queens Doctor Finds Fighting Hepatitis B Is a Frustrating Task - (05/15/06)
     
  3311. 13 Million Suffer From Hep B and C in Pakistan - (05/15/06)
     
  3312. 1st Russian AIDS Conference; Biggest HIV Epidemic in Europe - (05/15/06)
     
  3313. FDA Approves Pfizer Smoking Cessation Drug - (05/15/06)
     
  3314. HIV Generic Drugs-Patent Battles in India - (05/11/06)
     
  3315. New HCV Drug AVI- 406 Early Data - (05/11/06)
     
  3316. Hepatitis Risk for East Asians in New York - (05/11/06)
     
  3317. PFIZER AND MONOGRAM TO MAKE HIV CO-RECEPTOR TROPISM ASSAY AVAILABLE GLOBALLY - (05/10/06)
     
  3318. Rising Syphilis Rate Linked to Gay Men & Success of HAART - (05/10/06)
     
  3319. Committee for Medicinal Products for Human Use Summary of Opinion for Baraclude (entecavir) for HBV treatment - (05/05/06)
     
  3320. Russia to produce anti-HIV drugs next year - (05/05/06)
     
  3321. DSMB RECOMMENDS THAT ALL CLINICAL STUDIES IN MARAVIROC PHASE 3 DEVELOPMENT PROGRAM CONTINUE WITHOUT CHANGE - (05/05/06)
     
  3322. VA biopsies could have infected men with HIV, HCV, and HBV - (05/03/06)
     
  3323. Timing Crucial In Liver Transplants For HIV Patients; HIV Doctors Need Training on Liver Disease & Transplantation - (05/03/06)
     
  3324. Genetic Test to Give Clues on Treatment of Hepatitis C - (04/27/06)
     
  3325. Fosamax Causes 'Bone Death,' Florida Class Suit Says - (04/25/06)
     
  3326. Real & Fake ARVs in Africa - (04/24/06)
     
  3327. Ryan White Care Act Funding Disputes - (04/24/06)
     
  3328. NYC HIV Doctor Writes Bird Flu Book - (04/21/06)
     
  3329. Exposure to Mumps During Air Travel --- United States, April 2006 - (04/21/06)
     
  3330. New Study Examines HAART Effects on HCV - (04/21/06)
     
  3331. Schwarzenegger Signs Bill to Track HIV Cases by Name - (04/21/06)
     
  3332. Gilead Earnings Set For Further Upside On Strong HIV Franchise - (04/21/06)
     
  3333. Abbott Deal expands reach of OraSure's HIV test - (04/21/06)
     
  3334. Valeant Seeks Partner for Pradefovir - (04/14/06)
     
  3335. New Corporate Fund for Intl AIDS - (04/14/06)
     
  3336. New Genetic Diagnostic Tests-Financial Impact - (04/14/06)
     
  3337. OraSure Rapid OTC HIV Test Needs Study - (04/11/06)
     
  3338. India reports rise in HIV infections to 5.2 mln - (04/11/06)
     
  3339. India reports rise in HIV infections to 5.2 mln - (04/11/06)
     
  3340. Does UN Overestimate AIDS Estimates - (04/11/06)
     
  3341. UK Health service hits London gay bars - (04/11/06)
     
  3342. S Africa's Zuma Testimony pushes back Aids battle - (04/11/06)
     
  3343. Abbott Signs Johnson for Health Initiative - (04/11/06)
     
  3344. HIV+ man faces new charges for unprotected sex - (04/11/06)
     
  3345. Alarming 10% of pregnant women infected with HIV/Aids in Santiago, Santo Domingo - (04/11/06)
     
  3346. HIV Monkey Research Stopped by Animal Activists - (04/10/06)
     
  3347. Uganda: HIV vaccine trial starts soon to prevent transmission from infected mothers to their babies through breast feeding - (04/10/06)
     
  3348. HIV funding slashed 13 percent in Palm Beach County - (04/10/06)
     
  3349. Assessing AIDS In some African countries, the toll is lower than what the U.N. told us. EDITORIAL - (04/10/06)
     
  3350. Miami Jackson Memorial Hospital ER & 50 Emergency Rooms Begin HIV testing - (04/07/06)
     
  3351. Man charged for unprotected sex with women - (04/07/06)
     
  3352. California lawmakers OK HIV name tracking - (04/07/06)
     
  3353. San Francisco Sees a Drop in HIV Cases- due to 'sero-sorting' - (04/05/06)
     
  3354. FDA Tentatively Approves a Co-package of Generic AIDS Drugs in Association with the President's Emergency Plan for AIDS Relief - (04/05/06)
     
  3355. FDA Approves First Generic HIV/AIDS Drug in Capsule Form for United States Market - (04/05/06)
     
  3356. Viet Nam spends over 24 million USD on HIV/AIDS control - (04/05/06)
     
  3357. Thorny legal issues in case of HIV in marriage California State's top court to weigh privacy right, liability for harm - (04/05/06)
     
  3358. Study unearths the reasons gay men risk HIV - (04/05/06)
     
  3359. Gilead Won't Tout AIDS Pill As Preventive - (03/30/06)
     
  3360. Women, Hit Hard by AIDS, Need Own UN Agency: Envoy - (03/22/06)
     
  3361. Prevention/Cultural Changes in HIV - (03/22/06)
     
  3362. Romania likely has most cases of HIV/AIDS in SE Europe - (03/15/06)
     
  3363. LA Bathhouses Not Sex Venues, Suit Says - (03/15/06)
     
  3364. GLAXO HOPES FOR PANDEMIC FLU VACCINE BY YEAR'S END - (03/15/06)
     
  3365. An Article in Harper's Ignites a Controversy Over H.I.V. - (03/15/06)
     
  3366. Merck of Germany Seeks Control of Rival Drug Maker - (03/15/06)
     
  3367. Romania likely has most cases of HIV/AIDS in SE Europe - (03/09/06)
     
  3368. Merck Cutting Efavirenz Price 20% in Developing World - (03/08/06)
     
  3369. Mortality higher among HIV-positive patients during illicit drug use - (03/08/06)
     
  3370. Coffee, CYP1A2 Genotype, and Risk of Myocardial Infarction - (03/08/06)
     
  3371. Circumcision not HIV prevention - (03/02/06)
     
  3372. Ryan White Care ACT; Coburn Bill; HCV/HBV Coinfection; SF would lose funding under Coburn CARE Act bill - (03/02/06)
     
  3373. 'There's no govt Aids crisis' in South Africa Pres. Mbeki says - (02/28/06)
     
  3374. Living with HIV, Having Sex Relations - (02/28/06)
     
  3375. Bird Flu's Sweep Worries Health Officials - (02/28/06)
     
  3376. Hepatitis B &C Silent Diseases- Get tested - (02/24/06)
     
  3377. USAID awards $ 2.7m for HIV/AIDS prevention and care program in Pakistan - (02/24/06)
     
  3378. California Changes to HIV Names Reporting - (02/24/06)
     
  3379. Faces of HIV - (02/24/06)
     
  3380. China Issues First Guidelines on HIV: free care/treatment - (02/15/06)
     
  3381. AIDS becomes China's third-deadliest infectious disease - (02/15/06)
     
  3382. BMS Licenses Reyataz to Generic Drug Companies: to be sold cheaply - (02/15/06)
     
  3383. Bird Flu Experts Arrive in Nigeria After Outbreak - (02/10/06)
     
  3384. HIV drug sales lift Gilead profits - (02/01/06)
     
  3385. Tamiflu Gets Additional EU Approval - (02/01/06)
     
  3386. Roche Posts Strong Sales, Operating Profit for 2005 - (02/01/06)
     
  3387. Trimeris Reports 2005 FUZEON Sales Results - (02/01/06)
     
  3388. Expanded HIV testing efforts - would benefit entire county, country - (02/01/06)
     
  3389. Thousands infected with HCV from blood transfusion - (01/30/06)
     
  3390. Thousands infected with HCV from blood transfusion - (01/30/06)
     
  3391. No. of new HIV & AIDS cases in Japan tops 1,000 for 2nd yr in row+ - (01/30/06)
     
  3392. New Estimate in China Finds Fewer AIDS Cases - (01/30/06)
     
  3393. Increased HIV Rates in UK - (01/30/06)
     
  3394. Roche Scientist Becomes Global Point Man On Avian-Flu Drug - (01/26/06)
     
  3395. Three Major Business Initiatives Launched to Fight HIV/AIDS - (01/26/06)
     
  3396. Bristol-Myers Earnings Rise on Lower Costs; Sales Decline - (01/26/06)
     
  3397. Experts warn Beijing of growing AIDS threat - (01/26/06)
     
  3398. Rate of New HIV Cases Continues to Rise in UK UK reports 5,560 new HIV infections in 2005 - (01/26/06)
     
  3399. Sex, Drugs and HIV: No Strangers to Iran - (01/24/06)
     
  3400. Statins and colorectal cancer risk: A new panacea? - (01/24/06)
     
  3401. Libya in talks with Bulgaria over HIV deal - (01/23/06)
     
  3402. Vaccine Research Needed - (01/23/06)
     
  3403. Hepatitis, 'the silent killer,' driven out of the shadows - (01/23/06)
     
  3404. California Approves Tracking HIV by Name - (01/20/06)
     
  3405. Illinois considers requiring HIV tests for newborns - (01/20/06)
     
  3406. Latin America and the Caribbean unite against AIDS - (01/20/06)
     
  3407. Hospital Patient Errors Error Rate Greatest In Hospital Radiology Study Cites Communication Failures - (01/18/06)
     
  3408. Global Fund head says she is 'impressed' with Jamaica's HIV/AIDS programme - (01/12/06)
     
  3409. China to publish updated estimates of AIDS/HIV epidemic soon - (01/11/06)
     
  3410. HIV Partner Notification examined - (01/10/06)
     
  3411. 12,556 HIV positive patients in Iran - (01/10/06)
     
  3412. Delhi's nearly 40% population at risk of contracting HIV/AIDS - (01/10/06)
     
  3413. Schering-Plough Announces PEG-Intron and Rebetol Approved in Japan for Expanded Use in Treating Chronic Hepatitis C - (01/04/06)
     
  3414. Retrial ordered in Libya AIDS case - (01/04/06)
     
  3415. Official: Drug Cos. Lack Vaccine Incentive - (01/04/06)
     
  3416. China $476 Million on AIDS/HIV prevention, control - (01/04/06)
     
  3417. Herpes in pregnancy may raise HIV risk for baby - (01/04/06)
     
  3418. Cuts considered in program for poor with HIV (Medicaid) Ryan White, HIV prevention funds also face budget reductions - (01/04/06)
     
  3419. Teen Daughters of Parents With HIV Have Higher Childbearing Rate - (01/04/06)
     
  3420. Pres Clinton- HIV & China - (01/04/06)
     
  3421. Free treatment in Nigeria is the key to survival - (01/04/06)
     
  3422. 0.3% of adults in Delhi infected with HIV: DSACS - (01/04/06)
     
  3423. Iran's HIV cases top 12,000 - (01/04/06)
     
  3424. Coffee consumption may reduce breast cancer risk - (01/04/06)
     
  3425. Facility Halts Use of Oral HIV Test - (12/21/05)
     
  3426. Nurses On trial for HIV transmission to kids - (12/21/05)
     
  3427. Hospitals ReUsing Single-Use Instruments - (12/14/05)
     
  3428. New Law Regulates Sex Trade & HIV in Tijuana - (12/14/05)
     
  3429. Cost of Sex: The Economy of Desire - (12/14/05)
     
  3430. County: Black community faces AIDS emergency Officials say services for those in need are lacking - (12/08/05)
     
  3431. Merck Seeks FDA Priority Review for Cervical Cancer Vaccine - (12/08/05)
     
  3432. Travellers warned of hepatitis B risk - (12/07/05)
     
  3433. HIV-positive man sentenced to prison for lying about illness to sex partners - (12/07/05)
     
  3434. HIV Funding scandal in Nigeria - (12/07/05)
     
  3435. Tibotec Discontinues Exploratory Trial With TMC125 - (12/03/05)
     
  3436. HIV Could Launch Bird Flu Pandemic - (11/29/05)
     
  3437. India's HIV cases far higher than official numbers - (11/29/05)
     
  3438. HIV in Africa & Caribbean - (11/29/05)
     
  3439. Decaf may raise LDL levels more than regular coffee - (11/29/05)
     
  3440. UK HIV drug resistance increasing - (11/18/05)
     
  3441. Three Sue Calif. Hospital Over Transplants - (11/18/05)
     
  3442. HIV diagnoses fall among blacks in US - CDC - (11/18/05)
     
  3443. Gilead Gets Some Control Over Tamiflu - (11/18/05)
     
  3444. Univ California Irvine Hospital Halts Liver Transplant Program, Organs Refused While patients Die - (11/15/05)
     
  3445. FDA Proposes More Specific Condom Labels - (11/15/05)
     
  3446. AIDS activists remain wary of Serono Distrust comes as Serono pushes new use for treatment - (11/15/05)
     
  3447. HDL cholesterol useful in targeting statin therapy for elderly patients - (11/11/05)
     
  3448. Communication from Roche regarding Tamiflu - (11/11/05)
     
  3449. HDL cholesterol useful in targeting statin therapy for elderly patients - (11/11/05)
     
  3450. Senate OKs HIV Medicaid coverage If House passes, benefits will not be limited to full-blown AIDS - (11/08/05)
     
  3451. Senate Passes $450 Million Smith Medicaid/HIV Treatment Amendment: Early Treatment for HIV Act (ETHA) - (11/07/05)
     
  3452. US OKs generic 3TC for children's use abroad - (11/07/05)
     
  3453. Increase in HIV and Hepatitis C infections among injecting drug users in 2004 and up to half IDU with HIV do not know their HIV status - (11/07/05)
     
  3454. U.S. Weighs Whether to Open an Era of Rapid H.I.V. Detection in the Home - (11/07/05)
     
  3455. Emilio Emini: Wyeth Hires HIV Vaccine Pioneer - (11/07/05)
     
  3456. Senate Passes $450 Million Smith Medicaid/HIV Treatment Amendment: Early Treatment for HIV Act (ETHA) - (11/07/05)
     
  3457. US OKs generic 3TC for children's use abroad - (11/07/05)
     
  3458. Increase in HIV and Hepatitis C infections among injecting drug users in 2004 and up to half IDU with HIV do not know their HIV status - (11/07/05)
     
  3459. U.S. Weighs Whether to Open an Era of Rapid H.I.V. Detection in the Home - (11/07/05)
     
  3460. Emilio Emini: Wyeth Hires HIV Vaccine Pioneer - (11/07/05)
     
  3461. Stem cells could lead new fight against HIV, AIDS - (11/03/05)
     
  3462. - (11/03/05)
     
  3463. Arizona Medicaid Told by Court to Cover Liver Transplant in HCV/HIV Coinfected Woman - (11/02/05)
     
  3464. Pegasys Approved in Taiwan for HBV - (11/02/05)
     
  3465. NY Times Reports on FRAM Study - (11/02/05)
     
  3466. Joseph F. O'Neill, M.D., Former Director of the Office of National AIDS Policy, Joins The Immune Response Corporation as CEO and President - (11/02/05)
     
  3467. Pediatric AIDS Corp in Africa: Baylor College of Medicine & BMS - (11/02/05)
     
  3468. Avian Flu Information - (11/02/05)
     
  3469. Bristol-Myers May End Plans for Oral Diabetes Treatment - (10/28/05)
     
  3470. BMS to launch new hepatitis B drug in China - (10/27/05)
     
  3471. CDC Panel Recommends Hepatitis A Vaccine for Children and Whooping Cough Shots for Adults - (10/27/05)
     
  3472. HIV in India - (10/27/05)
     
  3473. Microbicide Study in Women Begins - (10/25/05)
     
  3474. Merck Profit Rises, but Sales Fall; Schering-Plough Net Surges - (10/25/05)
     
  3475. Grab some eggs, milk, pasta, soup and an HIV test - (10/24/05)
     
  3476. China to Limit HIV Cases to 1.5m by 2010 - (10/24/05)
     
  3477. METHAMPHETAMINE... - (10/24/05)
     
  3478. Over 88,000 HIV cases in Rajasthan - (10/24/05)
     
  3479. Schering-Plough Reports 2005 Third Quarter Financial Results - (10/24/05)
     
  3480. China could have 10 mllion HIV cases by 2010 - (10/24/05)
     
  3481. FDA seeks more safety data for Bristol-Myers/Merck diabetes drug - (10/21/05)
     
  3482. Roche Will Meet With Generic Drugmakers on Tamiflu - (10/21/05)
     
  3483. HIV resistance testing at diagnosis improves survival, cost-effective - (10/21/05)
     
  3484. Erectile Dysfunction Drugs & Risk for Blindness - (10/21/05)
     
  3485. Roche Promises New Plant for Bird Flu Drug - (10/20/05)
     
  3486. Cardiologist says Vioxx plaintiff had risk factors - (10/20/05)
     
  3487. Truvada Drives Gilead Sales - (10/20/05)
     
  3488. HIV-infected women may have hyperinsulinemia, truncal adiposity without PCOS - (10/20/05)
     
  3489. Indian Co. Plans Generic Bird Flu Drug Tamiflu - (10/18/05)
     
  3490. Home Based Rapid HIV Test Kit to be approved by US: pros & cons - (10/18/05)
     
  3491. LeRoy Whitfield, 36, Dies; Wrote of AIDS Battle - (10/18/05)
     
  3492. China Reports 42% Increase in HIV - (10/18/05)
     
  3493. AVIAN FLU: PREVENTING A PANDEMIC - (10/18/05)
     
  3494. HIV in India: SOCIAL VACCINE ONLY REMEDY FOR HIV/AIDS - DR.RAMADOSS - (10/18/05)
     
  3495. Roche says could allow others to produce Tamiflu - (10/18/05)
     
  3496. Scientists say bird flu cases back migration theory - (10/18/05)
     
  3497. Chiron Says Flu Vaccine Production Falls Short - (10/18/05)
     
  3498. China reports over 126,000 HIV cases - (10/14/05)
     
  3499. Professor: Most people with hepatitis C don't know it - (10/11/05)
     
  3500. Bush Plan Shows U.S. Is Not Ready for Deadly Flu - (10/11/05)
     
  3501. DNA vaccine can offer painless jabs - (10/11/05)
     
  3502. Hepatitis: Stalking a Cancer That's Silent and Deadly - (10/11/05)
     
  3503. Fish Intake May Be Good for Cognitive Function - (10/11/05)
     
  3504. HIV in China Rising - (10/07/05)
     
  3505. Governor Signs Historic Bill to Address HIV/AIDS within California's Black Community - (10/07/05)
     
  3506. Abbott, Tanzania open HIV treatment facility - (10/06/05)
     
  3507. Avian (Chicken) Flu 'Epidemic' Expected - (10/06/05)
     
  3508. Buprenorphine Helps Combat Teen Heroin Addiction - (10/06/05)
     
  3509. White House Preparing for Flu Epidemic - (10/06/05)
     
  3510. Condom clears man with HIV From Criminal Nuisance for Having Sex - (10/06/05)
     
  3511. Liver Cancer Up, Other Kinds Improving - (10/06/05)
     
  3512. Brazil says it is close to deal with Abbott on AIDS drug - (10/05/05)
     
  3513. Testing All For HIV Upon Dr Visit - (10/05/05)
     
  3514. National Survey Sharpens Picture of Major Depression Among U.S. Adults - (10/05/05)
     
  3515. Historic Bill, African-Americans & HIV in Cal. - (10/04/05)
     
  3516. Aids virus 'could be weakening' - (10/03/05)
     
  3517. AIDS Said on the Rise Again in Thailand - (10/03/05)
     
  3518. AIDS-Vaccine Test To Be Expanded On Upbeat Results - (10/03/05)
     
  3519. Los Angeles County Investigating Couple After Child Died of AIDS-Related Pneumonia Without Ever Having HIV Test - (09/27/05)
     
  3520. Former Playboy Playmate with HIV makes positive impact - (09/27/05)
     
  3521. FDA Commissioner Quits - (09/27/05)
     
  3522. Leader of the F.D.A. Steps Down After a Short, Turbulent Tenure - (09/27/05)
     
  3523. New FDA Commissioner - (09/27/05)
     
  3524. New FDA Acting Commissioner - (09/27/05)
     
  3525. HIV therapy tied to atypical histoplasmosis manifestation - (09/27/05)
     
  3526. Serono May Pay $700 Million Fines - (09/27/05)
     
  3527. India Co. to Sell Generic Drugs in Canada - (09/27/05)
     
  3528. HIV Denialist's Daughter Dies of HIV - (09/27/05)
     
  3529. Drug firms launch Web site to disclose trials data - (09/27/05)
     
  3530. Teva Announces Tentative FDA Approval of Ribavirin Tablets - (09/20/05)
     
  3531. September is Liver Cancer Awareness Month - (09/20/05)
     
  3532. Aplaviroc phase II halted due to hepatic toxicity; Study continues in treatment-experienced - (09/20/05)
     
  3533. F.D.A. Panel Endorses Inhaled Form of Insulin - (09/08/05)
     
  3534. Can HIV Be Cured: New Strategy Shows Promise In Tackling Dormant HIV - (09/08/05)
     
  3535. Hepatitis B: The Forgotten Virus - (09/08/05)
     
  3536. Brazil Again Seeks to Cut Cost of AIDS Drug - (09/08/05)
     
  3537. HIV Decline in SF by Half: A Good Report on AIDS, and Some Credit the Web - (09/08/05)
     
  3538. Health Mystery in New York: Heart Disease is HIGH - (09/08/05)
     
  3539. NJ Court Rejects Needle-Exchange - (09/08/05)
     
  3540. Dirty Needles Spreading Hepatitis C in Jail in Australia - (09/08/05)
     
  3541. FDA Grants Generic AZT Tentative Approval - (09/08/05)
     
  3542. Tentative FDA Approval of Generic AZT Oral Solution - (09/08/05)
     
  3543. U.S. to Help China Combat Surge in HIV - (09/01/05)
     
  3544. Diabetes often undiagnosed, untreated in heart disease patients - (09/01/05)
     
  3545. Merck may settle some Vioxx cases, NJ trial looms - (09/01/05)
     
  3546. Money for AIDS - (09/01/05)
     
  3547. Rosiglitazone lowers insulin resistance in nondiabetics - (09/01/05)
     
  3548. Novartis offers $4.5 bln to buy up Chiron - (09/01/05)
     
  3549. Roche talking to WHO about large Tamiflu stockpile against avian flu - (08/04/05)
     
  3550. Cervical neoplasia often recurs in women with HIV infection - (08/04/05)
     
  3551. Rosiglitazone Aids Insulin in Diabetes Control & Reduced Blood Pressure - (07/25/05)
     
  3552. Low-dose oral contraceptives increase cardiovascular disease risk - (07/25/05)
     
  3553. Who's Minding NY's Medicaid? - (07/25/05)
     
  3554. Large drop reported in HIV cases in S.F. Feared second wave of infections appears to have crested - (07/25/05)
     
  3555. Potent Burkitt's lymphoma therapy appropriate in HIV patients - (07/25/05)
     
  3556. Gilead quarterly profit up 76 pct on HIV drug sales - (07/25/05)
     
  3557. Low-dose oral contraceptives increase cardiovascular disease risk - (07/13/05)
     
  3558. Urgent Measures Needed to Tackle HIV Epidemic in Moscow - (07/07/05)
     
  3559. NJ Failing to Support Needle Exchange: Playing AIDS Games in New Jersey - (07/07/05)
     
  3560. Intl AIDS: Asian Conference Ongoing Now; Caribbean Update - (07/07/05)
     
  3561. Herpes & Syphilis Among Young IDUs - (06/30/05)
     
  3562. Bristol-Myers Squibb, Baylor College of Medicine to Launch Pediatric AIDS Corps For Africa - (06/28/05)
     
  3563. CT Predicts Heart Attack More Accurately Than Framingham, Conventional Risk Factors - (06/27/05)
     
  3564. Generic Efavirenz Approved by FDA - (06/27/05)
     
  3565. Adult Antisocial Syndromes Common Among Substance Abusers - (06/23/05)
     
  3566. Anal cancer precursors common in homosexual men - (06/23/05)
     
  3567. Sperm Injection on Rise in Europe Clinics - (06/23/05)
     
  3568. Ex-Employee With AIDS Sues McDonald' - (06/23/05)
     
  3569. AIDS Money Must Triple to $22 Billion in 2008 - U.N - (06/23/05)
     
  3570. FLORIDA: "HIV Rate in Blacks Drops, but Still High" - (06/21/05)
     
  3571. GSK Biologicals and IAVI Partner to Develop AIDS Vaccine - (06/21/05)
     
  3572. FLORIDA: "HIV Rate in Blacks Drops, but Still High" - (06/21/05)
     
  3573. GSK Biologicals and IAVI Partner to Develop AIDS Vaccine - (06/21/05)
     
  3574. Foster Kids & AIDS Experiments: ongoing controversy - (06/20/05)
     
  3575. McDonald's Sued for AIDS Discrimination - (06/20/05)
     
  3576. Bristol Myers Squibb Announces New Consumer Advertising Policy - (06/17/05)
     
  3577. Feds: Some AIDS Drug Tests Violated Rules - (06/17/05)
     
  3578. Ex-College Hoopster Helping Africans With HIV/AIDS - (06/17/05)
     
  3579. Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680 - (06/17/05)
     
  3580. Trimeris Announces Appointment of Neil Graham, M.D., as Chief Medical Officer and Senior Vice President of Clinical Development and Medical Affairs - (06/14/05)
     
  3581. Dental Problems from Methamphetamine: Grisly Effect Of One Drug: 'Meth Mouth' - (06/14/05)
     
  3582. More Than a Million in U.S. Lives With HIV: numbers increasing - (06/14/05)
     
  3583. FDA Probes Reports of Blindness With Impotence Drugs Most Incidents Involve Viagra; Some Reported With Cialis - (06/7/05)
     
  3584. Vertex HCV Protease Inhibitor: A new hope for hepatitis therapy - (06/7/05)
     
  3585. New Hepatitis C Drug - (06/7/05)
     
  3586. Red Cross Tainted HCV/HIV Blood "Canadian Red Cross fined for tainted blood scandal" - (06/7/05)
     
  3587. Roche has Europe approval for more potent HIV drug - (06/7/05)
     
  3588. WELL diet more effective than regular low-fat diet in reducing blood pressure - (06/7/05)
     
  3589. UN says goal to reverse AIDS by 2015 won't be met - (06/7/05)
     
  3590. 42% of Americans With HIV Are Undiagnosed - (05/25/05)
     
  3591. Tenofovir Prevention Study Problems AIDS Scientists, Activists Fail to Fully Resolve Rift Over Trials - (05/25/05)
     
  3592. New York Proposes Controversial Measures to Slow the Spread of AIDS - (05/25/05)
     
  3593. Hepatitis C Drug Rocks Virus in Early Test: VX-950, HCV Protease Inhibitor - (05/24/05)
     
  3594. More Seniors Living With HIV - (05/24/05)
     
  3595. Hepatitis C Drug Rocks Virus in Early Test: VX-950, HCV Protease Inhibitor - (05/24/05)
     
  3596. More Seniors Living With HIV - (05/24/05)
     
  3597. AIDS Activists Go After Vitamin Salesman - (05/16/05)
     
  3598. Maverick doctor steps up campaign against AIDS drugs in South Africa - (05/16/05)
     
  3599. LifeStyles(R) Condoms Protecting New York City - (05/05/05)
     
  3600. New Vaginal Microbicide Gel - (05/05/05)
     
  3601. Achillion Announces Receipt of SBIR Grant from National Institutes of Health for New Area of HIV Research - (05/05/05)
     
  3602. VIRxSYS Announces Completion of Phase I Study of VRX496, Novel HIV Gene Therapy, and Plans to Intitiate Phase II Study - (05/05/05)
     
  3603. HIV testing should be offered to all who are sexually active, researchers say - (04/28/05)
     
  3604. HIV Prevention Apathy, Methamphetamine - (04/28/05)
     
  3605. HIV infection, cocaine use linked to early atherosclerosis - (04/28/05)
     
  3606. ATM kinase inhibition may provide new class of HIV inhibitor - (04/28/05)
     
  3607. Breast and uterine cancer reduced in women with AIDS - (04/28/05)
     
  3608. HAART improves prognosis of AIDS-related lymphoma - (04/28/05)
     
  3609. Serono may pay $725m to end probe: Federal investigation targets AIDS treatment - (04/28/05)
     
  3610. US advises firms on better drug safety monitoring - (04/01/05)
     
  3611. U.S. Drug Trials Proposal Unethical, Critics Say - (04/01/05)
     
  3612. Roche, GSK say FDA backs once-monthly bone drug - (04/01/05)
     
  3613. Depression may up risk of dementia in men - (04/01/05)
     
  3614. Exercise helps control type 2 diabetes - (04/01/05)
     
  3615. Light drinking has immediate effects on diabetes, cardiovascular risk factors - (04/01/05)
     
  3616. Willie Nelson pitches in against deadly disease Hep C - (04/01/05)
     
  3617. Cancer In Patients With Hepatitis C - (03/15/05)
     
  3618. Doctors Urge Free HIV Drugs for All - (03/09/05)
     
  3619. Tommy Thompson, Former Secretary of Health & Human Services, Joins Akin Gump as Partner and Deloitte & Touche USA LLP as Senior Advisor - (03/09/05)
     
  3620. US Says Expects to Approve More Generic AIDS Drugs - (03/07/05)
     
  3621. HIV-Positive Men Can Sue Airline: job discrimination - (03/07/05)
     
  3622. U.S. belt tightening could hit AIDS efforts - (03/04/05)
     
  3623. Rapid, multiresistant HIV in New York City still worrisome - (03/04/05)
     
  3624. NY Case-Researchers say Not A Super Virus - (03/04/05)
     
  3625. New HIV Strain Shakes Up New York Gay Community - (02/22/05)
     
  3626. AIDS a Leading Cause of Death in S. Africa - (02/18/05)
     
  3627. Number of reported AIDS cases increases sharply in S. Florida - (02/18/05)
     
  3628. South Africa's Aspen gets U.S. approval for AIDS drugs - (01/26/05)
     
  3629. WHO, Boehringer Back German AIDS Drug Despite Fears - (01/24/05)
     
  3630. Britain's Brown Unveils $10 Billion Plan to Beat AIDS - (01/14/05)
     
  3631. Hepatitis C Seen as Health Threat on Long Island - (01/13/05)
     
  3632. HIV risk high among black men in England who have sex with men - (01/12/05)
     
  3633. HPV associated with flat lesions on penis - (01/11/05)
     
  3634. Breaking Taboo, Mandela Says Son Died of AIDS - (01/07/05)
     
  3635. NIH Specialist Denied Whistleblower Status Over ReportsConcerning Nevirapine Research Practices - (01/03/05)
     
  3636. Documents Said to Show Prozac Risks - (01/03/05)
     
  3637. Ex-Sales Director At Serono Pleads Guilty to Kickback - (12/23/04)
     
  3638. Chembio Completes US Clinical Trials for Two HIV Rapid Tests; Nears Pre-Marketing Approval Submission to the FDA - (12/23/04)
     
  3639. Many Now Worry AIDS Drug (Nevirapine) Will Be Halted - (12/17/04)
     
  3640. Support For Single-Dose Nevirapine - (12/17/04)
     
  3641. Nevirapine Linked to Pregnant Women's Death - (12/16/04)
     
  3642. Serono Rep Gets Federal Criminal Charges - (12/16/04)
     
  3643. Intrauterine insemination via HIV-infected men can be safe - (11/12/04)
     
  3644. Women over 50 in dark over HIV - (11/12/04)
     
  3645. HIV infection may increase COPD risk - (10/26/04)
     
  3646. Debate over Plan to Offer Clean Needles to Addicts in New Jersey - (10/26/04)
     
  3647. Ranbaxy (Generics) to resubmit dropped AIDS drugs by year-end - (10/19/04)
     
  3648. COX-2 inhibitors have changed prescribing practices for rheumatoid indications - (10/19/04)
     
  3649. Nevirapine better than efavirenz at raising HDL cholesterol - (10/19/04)
     
  3650. Former Maryland governor wants public registry for people with AIDS - (10/15/04)
     
  3651. Age influences response to HAART in children - (10/12/04)
     
  3652. FDA denies trying to block Vioxx results - (10/12/04)
     
  3653. Dominican Republic Receives AIDS Drugs Money from United States - (10/07/04)
     
  3654. Kenyan Company Signs Agreement with German Company to Make Drug to Combat AIDS, HIV Transmission from Mother to Child - (10/07/04)
     
  3655. House Boosts Abstinence-Only Funding - (10/07/04)
     
  3656. Apartheid gov't had AIDS plan for South Africa - (10/05/04)
     
  3657. Arthritis drug Vioxx recall sparks criticism of FDA - (10/05/04)
     
  3658. India World's Leader Of HIV Infections - Expert - (09/30/04)
     
  3659. The Immune Response Corp Presents New Phase II Clinical Data Indicating That REMUNE Induces A HIV-Specific Immune Response - (09/30/04)
     
  3660. Merck Plans to Pull Vioxx - (09/30/04)
     
  3661. Alcohol, Diabetes and Hepatitis Boost Liver Cancer Risk - (09/30/04)
     
  3662. NJ Needle Exchange Gets First Legislative Test - (09/29/04)
     
  3663. Exercise test predicts heart disease in "healthy" men - (09/28/04)
     
  3664. HIV in a Rural Community in the United States in Florida - (09/28/04)
     
  3665. Health Department Plans to End Enrollments for AIDS/HIV Program - (09/28/04)
     
  3666. Future of HIV/AIDS in Asia Depends on Harm-Reduction Policy for Injection Drug Users, Opinion Piece Says - (09/28/04)
     
  3667. New Jersey State Assembly Committee Approves Legislation Promoting Access to Clean Needles - (09/27/04)
     
  3668. AIDS-DEMENTIA LINK STUDY: Patients lack dopamine - (09/27/04)
     
  3669. NYC Mayor Bloomberg Will Offer HIV "Rapid Test' to Homeless - (09/27/04)
     
  3670. NJ Needle Exchange Gets First Legislative Test - (09/27/04)
     
  3671. NY should step up crystal meth curbs - (09/27/04)
     
  3672. HIV infection disclosure to partner can vary - (09/24/04)
     
  3673. Low-carb diet improves sugar control in diabetics - (09/24/04)
     
  3674. AIDS up 6 percent in South Africa - (09/24/04)
     
  3675. Vitamin E may help reduce diabetes risk - (09/24/04)
     
  3676. Indevus Announces Selection of PRO 2000 by Microbicide Development Programme as Sole Agent for Full-Scale, International Anti-HIV Trials - (09/22/04)
     
  3677. Scientists Identify Biochemical Abnormality That May Explain Link Between HIV, Dementia - (09/22/04)
     
  3678. Black Gay Republicans Break with Log Cabin Republicans, Endorse Bush - (09/22/04)
     
  3679. Senate Panel Votes to Raise AIDS Funding - (09/17/04)
     
  3680. Vermont HIV/AIDS Advocacy Group Decides Not To Apply for Federal Funding Due to New Regulations, Privacy Concerns - (09/17/04)
     
  3681. Most with HIV infection refrain from high-risk behavior - (09/17/04)
     
  3682. HAART-associated syndrome tied to leprosy in HIV patients - (09/13/04)
     
  3683. Europe sounds alarm over resurgent AIDS epidemic - (09/09/04)
     
  3684. Pancreatic endocrine dysfunction linked to growth failure in HIV-infected children - (09/09/04)
     
  3685. County Health Board Moves to Keep Needle Exchange - (09/08/04)
     
  3686. Depression Increases Risk for AIDS-Related Death but HAART & Depression-Therapy Can Decrease Depression & Increase Longevity - (09/08/04)
     
  3687. AIDS Stripping Widows of Their Rights - (09/08/04)
     
  3688. High Exposure to TV Sex Affects Teens - (09/08/04)
     
  3689. Zambia declares AIDS emergency to produce drugs - (09/08/04)
     
  3690. AIDS sharply cuts life expectancy in Mozambique - (09/07/04)
     
  3691. Epoetin alfa prompts few anti-EPO antibody responses - (09/07/04)
     
  3692. Brain attention network may be altered in HIV patients - (09/07/04)
     
  3693. HIV/AIDS Vaccine Experts Call for More Collaboration in Research, Say Effective Vaccine at Least Decade Away - (09/03/04)
     
  3694. AIDS VACCINE '04 Conference Calls for Increased Political and Financial Commitment - (08/30/04)
     
  3695. DNA changes no indicator of mitochondrial toxicity in HIV patients - (08/30/04)
     
  3696. HAART shortens manifestation of herpes simplex in HIV patients - (08/27/04)
     
  3697. North Carolina To Provide Treatment to All 960 HIV-Positive People on ADAP Waiting List, Officials Say - (08/23/04)
     
  3698. N.C. to Help AIDS Patients Get Drug Aid - (08/20/04)
     
  3699. Massachusetts May Start ADAP Wait-List - (08/17/04)
     
  3700. Rwanda set to offer free AIDS drugs - (08/09/04)
     
  3701. WHO pulls three Ranbaxy generics from AIDS drugs list - (08/09/04)
     
  3702. Hepatitis C virus-like particles induce immune responses in baboons - (08/04/04)
     
  3703. HIV microbicide acceptance high in phase I trial - (08/04/04)
     
  3704. HIV 'Fastest Growing' Health Problem in England, Report Says - (08/04/04)
     
  3705. Testing combo helps diagnose neurosyphilis in HIV patients - (08/03/04)
     
  3706. Tiny African Country Djibouti says it can pay for AIDS drugs until 2007 - (08/03/04)
     
  3707. Dispensing Needles Said to Keep Neighborhoods Clean - (08/03/04)
     
  3708. Mr. Condom' Takes On an Old Foe - (08/03/04)
     
  3709. "Human Services: A Proposal to Track New HIV Cases by Name Instead of Code Could Be the Most Vexing Part of a Health System Overhaul" - (08/03/04)
     
  3710. "Efficacy of an HIV Prevention Intervention for African American Adolescent Girls" - (08/03/04)
     
  3711. UK sexual disease figures rise to new high - (07/28/04)
     
  3712. Prevalence of HIV drug resistance high in the U.S. population - (07/27/04)
     
  3713. Work-time physical activity may reduce mortality in diabetics - (07/27/04)
     
  3714. Marlon Brando/Hepatitis C - (07/26/04)
     
  3715. Editorials on IAC from Bangkok from Kaiser Daily HIV/AIDS Reports - (07/26/04)
     
  3716. AIDS Drugs May Fight Cervical Cancer, Study Says - (07/22/04)
     
  3717. Access to Medicaid seen declining despite cost surge - (07/22/04)
     
  3718. Colo. adds $3 million to AIDS drug program - (07/20/04)
     
  3719. Hepatitis C Outbreak Adds a New Woe to Drug Rehab Centers - (07/20/04)
     
  3720. New Illinois Law Permits Organ Donors With H.I.V. - (07/19/04)
     
  3721. WHO warns state oppression of drug users fuelling AIDS rise - (07/19/04)
     
  3722. Tenofovir may prevent breast milk HIV transmission - (07/19/04)
     
  3723. Science takes back seat at AIDS conference: policy grabs limelight, microbicides, vaccines - (07/19/04)
     
  3724. Partners' serostatus sways condom use in HIV-infected women - (07/09/04)
     
  3725. Rate of PSA rise predicts death from prostate cancer after surgery - (07/09/04)
     
  3726. With World's Second-Largest Number of HIV-Positive, India Stands on Precipice of Full-Blown Epidemic - (07/08/04)
     
  3727. Glutamines curb diarrhea in AIDS patients - (07/07/04)
     
  3728. High-dose interferon alpha provides lasting benefit in chronic hepatitis D: cirrhosis is reversible - (07/07/04)
     
  3729. High-dose interferon alpha provides lasting benefit in chronic hepatitis D - (07/06/04)
     
  3730. Diabetes increases risk of cancer mortality - (07/06/04)
     
  3731. Nearly $6 billion needed to reach AIDS drug target - (07/06/04)
     
  3732. Hepatitis C virus genotype 3 infection may resolve spontaneously - (07/06/04)
     
  3733. Multivitamins May Slow Progression of HIV for Patients in Earliest Phase of Disease, Study Says - (07/06/04)
     
  3734. Alovudine helpful in patients with multidrug-resistant HIV - (07/01/04)
     
  3735. Low triglyceride levels are associated with more severe stroke - (06/30/04)
     
  3736. Microscience reports good phase I results with oral hepatitis B vaccine in chronically infected - (06/30/04)
     
  3737. Lack of vitamin D tied to insulin resistance - (06/30/04)
     
  3738. Fuzeon should be used when CD4 counts are above 100m cells per liter: panel - (06/24/04)
     
  3739. GB virus C inhibits replication of HIV-1 - (06/22/04)
     
  3740. Interferon may help curb AIDS-related cryptococcal meningitis - (06/22/04)
     
  3741. Minor HIV protease mutations point to antiretroviral failure - (06/17/04)
     
  3742. Dealing with HIV fatigue prompts many approaches - (06/17/04)
     
  3743. New Ultra-Sensitive HIV Viral Load Test Detects HIV Infection at Earlier Stage - (06/17/04)
     
  3744. New HIV assay sensitive to 2 copies/mL - (06/17/04)
     
  3745. Menstrual Cycle Affects Shedding of HIV in Cervical Secretions - (06/16/04)
     
  3746. Early Syphilis in the United States Identified in Corrections Facilities, 1999-2002" - (06/11/04)
     
  3747. AIDS/HIV Therapy: Crack Cocaine Use Reduces Antiviral Therapy Use in Women with HIV - (06/11/04)
     
  3748. Drug, doctor shortages slow world AIDS effort-WHO - (06/03/04)
     
  3749. U.S. Congressional panel explores NIH funding priorities - (06/03/04)
     
  3750. Progressive CD4 loss seen in long-term non-progressors with HIV - (06/03/04)
     
  3751. Stavudine analogue boosts anti-HIV activity in vitro - (06/03/04)
     
  3752. Aetna Drops Suit on Abbott Drug; No Deal to Change AIDS Drug Price - (06/01/04)
     
  3753. Newly Published Study Investigates Pegasys and Copegus (ribavirin) for the Treatment of Chronic Hepatitis C In Black Americans - (05/26/04)
     
  3754. Inadequate host immune system may lead to seronegative HIV-1 infection - (05/25/04)
     
  3755. Decline in lung function, impaired response to salbutamol in HCV+ asthmatics - (05/25/04)
     
  3756. San Francisco Serosorting May Explain Odd HIV Data: STDs Have Risen, butNot New HIV Infections; Internet Sex Apparently Not Issue - (05/25/04)
     
  3757. US Shifts Strategy to Curb HIV's Spread - (05/25/04)
     
  3758. 98 Arrested in Capitol Hill AIDS Protest - (05/24/04)
     
  3759. Veterans at high risk for HIV-HCV co-infection - (05/24/04)
     
  3760. DDW: Coffee, Caffeine Consumption Associated With Reduced Liver Disease - (05/20/04)
     
  3761. Rosiglitazone- Diabetes Drug -Could Help Lessen Metabolic Side Effects of Antiretroviral Drug Regimens - (05/20/04)
     
  3762. Boehringer Ingelheim and GlaxoSmithKline agreed to assess the development of important HIV medicines for the developing world - (05/19/04)
     
  3763. Views Mixed on US Shift on Drugs for AIDS - (05/19/04)
     
  3764. UN Health Bodies Welcome Revised US Guidelines on AIDS Treatments - (05/19/04)
     
  3765. FDA to Vow Fast Approval of AIDS Drugs - (05/17/04)
     
  3766. Protease inhibitor therapy ups risk of premature carotid lesions: study - (05/17/04)
     
  3767. New Recommended Fed AIDS Plan - (05/17/04)
     
  3768. Panel: Feds Should Help Pay for HIV Care - (05/17/04)
     
  3769. Black Men on 'Down Low' Contributing to 'Rapid Rise' in HIV Prevalence Among Black Women, Opinion Piece Says - (05/13/04)
     
  3770. Bush Makes AIDS Office Chief Permanent: new Federal AIDS Czar - (05/13/04)
     
  3771. U.S. Opposition to Using Fixed-Dose Generic Antiretroviral Drugs in Africa Could Be 'Lethal,' Opinion Piece Says - (05/10/04)
     
  3772. Dr. David Feigal, formerly head of FDA HIV Antivirals, Joins NDA Partners - (05/06/04)
     
  3773. AHF Law Suit Against GSK: GSK summary judegement request denied by judge - (05/04/04)
     
  3774. Herpes Vaccine Test Runs into Recruiting Hurdle - (05/03/04)
     
  3775. HIV prevalence rising rapidly in much of the UK - (05/03/04)
     
  3776. Hepatitis C common in some childhood cancer survivors - (05/03/04)
     
  3777. Third Adult Performer in Los Angeles Tests Positive for HIV - (05/03/04)
     
  3778. NYC Health Department's Anti-Crystal Campaign - (05/03/04)
     
  3779. Teens, Young Adults Exposing Themselves to HIV and AIDS - (05/03/04)
     
  3780. Veteran Denied Liver Transplant: files law suit - (05/03/04)
     
  3781. Gay Outbreak of Gonorrhea Worries CDC - (05/03/04)
     
  3782. U.S. sets hearing on Abbott AIDS drug license - (05/03/04)
     
  3783. Women with HIV can benefit from testosterone treatment - (04/27/04)
     
  3784. Nevirapine may increase liver fibrosis in HIV/HCV co-infected patients - (04/27/04)
     
  3785. Abbott defends AIDS drug price - (04/27/04)
     
  3786. AIDS protesters picket Abbott shareholder meeting - (04/26/04)
     
  3787. Antiretrovirals from overseas meet content standards when stored appropriately - (04/26/04)
     
  3788. Efavirenz treatment increases HDL-cholesterol - (04/26/04)
     
  3789. Correction: Porn-Moratorium Story - (04/26/04)
     
  3790. Married Couples' HIV Rate Rises in Uganda - (04/26/04)
     
  3791. Further evidence against polio vaccine origin of AIDS - (04/22/04)
     
  3792. Heart rate variability reduced in early HIV infection - (04/22/04)
     
  3793. Schering-Plough launches generic hepatitis C drug By Bill Berkrot and Ransdell Pierson - (04/12/04)
     
  3794. New techniques increase efficiency of RNA interference to block HCV replication - (04/12/04)
     
  3795. Little ventricular dysfunction evident in HIV patients - (04/12/04)
     
  3796. Novel prostate cancer marker spots cancer when the biopsy is negative - (04/12/04)
     
  3797. Keith Cylar- HIV+ Activist, Founder of Housing Works Dies at 45 - (04/08/04)
     
  3798. 75% HCV/HIV Coinfection Rates in SF Homeless- few treated - (04/07/04)
     
  3799. Hepatitis C worsens HIV-related neuropsychological dysfunction - (04/05/04)
     
  3800. Microbicides for Sex: Anti-HIV Cream for Women Gets Support - (04/05/04)
     
  3801. IPM will Take Over the Development of Tibotec's Promising Microbicide to Help in the Prevention of the Sexual Transmission of HIV - (03/29/04)
     
  3802. UMass researchers to test new AIDS vaccine - (03/25/04)
     
  3803. HIV Vaccine Not Likely in Next Decade, UNAIDS Executive Director Says - (03/24/04)
     
  3804. PACIFIC ISLANDS FACE RAPIDLY EXPANDING HIV EPIDEMIC, SAYS UNAIDS EXECUTIVE DIRECTOR - (03/24/04)
     
  3805. Intl AIDS Conference to Mobilize Political Will - (03/24/04)
     
  3806. Bone-enhancing effects of alendronate sustained for decade - (03/18/04)
     
  3807. HAART may reduce HHV-8 shedding in HIV-infected men - (03/18/04)
     
  3808. Genetic basis identified for abacavir hypersensitivity in HIV patients - (03/17/04)
     
  3809. Renal tubular dysfunction seen with tenofovir HIV therapy - (03/17/04)
     
  3810. HIV Study is Chilling to Black College Campuses - (03/17/04)
     
  3811. Syphilis Shows Some Resistance to Antibiotic in United States - (03/15/04)
     
  3812. New Test Finds HIV in Earlier Stages - (03/15/04)
     
  3813. New Type of HIV Outbreak: on college campuses among men who have sex with men and women - (03/11/04)
     
  3814. California Senate Budget Subcommittee Rejects ADAP Enrollment Caps, Waiting List - (03/10/04)
     
  3815. World's HIV/AIDS Cases Rising for Women - (03/09/04)
     
  3816. Betulinic acid derivatives show anti-HIV promise - (03/05/04)
     
  3817. Saquinavir useful in HIV patients with intestinal problems - (03/05/04)
     
  3818. NIH stops estrogen-only arm of Women's Health Initiative trial - (03/05/04)
     
  3819. Condom Fatigue' Shock in Epidemic - (03/02/04)
     
  3820. CROI: Marijuana Relieves HIV Neuropathy in Preliminary Trial - (03/01/04)
     
  3821. AIDS a threat to E. Europe, Central Asia economies - (02/26/04)
     
  3822. Once daily lopinavir/ritonavir effective in HIV therapy - (02/23/04)
     
  3823. HIV escape mutations do not always survive transmission - (02/23/04)
     
  3824. Incidence of Lipoatrophy and Lipohypertrophy in the Women's Interagency HIV Study - (02/23/04)
     
  3825. Maternal viral load tied to HIV progression in offspring - (02/20/04)
     
  3826. CD8+ cells key to HIV resistance among highly exposed uninfected subjects - (02/20/04)
     
  3827. Short-term risk of AIDS in HIV-positive individuals helps guide initiation of therapy - (02/20/04)
     
  3828. HPV testing helps stratify cervical cancer risk when Pap smear is equivocal - (02/20/04)
     
  3829. Nationwide New HIV Reporting to Bring Trends into Focus: Higher Proportions of Women & Minorities Being Infected - (02/20/04)
     
  3830. Hepatitis C Epidemic in Europe - (02/09/04)
     
  3831. Adefovir Effective for Resistant Hepatitis B - (02/09/04)
     
  3832. Tenofovir (Viread) Tested to Prevent HIV Infection - (02/09/04)
     
  3833. Vertical transmission of HPV rare - (02/06/04)
     
  3834. Efavirenz increases sleep latency and decreases sleep duration - (02/06/04)
     
  3835. HCV-HIV International Panel releases new management guidelines - (02/06/04)
     
  3836. CDC Recommends Condoms, Parents Prefer Abstinence, Gay Men Dislike Condoms - (02/05/04)
     
  3837. HHV-8 seropositivity linked with prostate cancer - (01/26/04)
     
  3838. President's Proposal for 2005 ADAP Funding - (01/20/04)
     
  3839. NIH Response: AIDS Vaccine Study in Thailand - (01/20/04)
     
  3840. World-class AIDS Vaccine Researcher Emilio Emini Joins IAVI - (01/15/04)
     
  3841. Gilead Initiates Studies for New Once Daily, One Pill HIV Protease Inhibitor - (01/15/04)
     
  3842. AIDS increases risk of stroke - (01/14/04)
     
  3843. Inhaled insulin effective in type 2 diabetics - (01/14/04)
     
  3844. Intrathecal ziconotide ameliorates refractory pain from cancer or AIDS - (01/14/04)
     
  3845. T-1249 Dow Jones Report - (01/14/04)
     
  3846. Antibody no bar to enfuvirtide's anti-HIV effect - (01/14/04)
     
  3847. FDA Approves Pegasys(R) (Peginterferon alfa-2a) Pre-filled Syringes for the Treatment of Hepatitis C - (01/14/04)
     
  3848. FDA Approves Invirase (saquinavir) 1000mg + Ritonavir 100mg: boosted PI regimen - (01/08/04)
     
  3849. Development of T-1249 Fusion Inhibitor Put on Hold, New Formulation Sought - (01/06/04)
     
  3850. Pegasys Market Share - (01/06/04)
     
  3851. Many Heterosexual Adults Have Not Been Tested for HIV: 80% of untested feel they are not at risk - (01/05/04)
     
  3852. Portugal Debates Setting Up Heroin Injecting Rooms in Prison - (01/05/04)
     
  3853. Many Inner-City HIV Patients Not on HAART - (01/05/04)
     
  3854. Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes - (01/05/04)
     
  3855. FDA Approves New Rapid 10-Minute HIV Test - (01/05/04)
     
  3856. STD Prevention Efforts Turn to Web Hook-Ups - (01/05/04)
     
  3857. New York Data Reveal Worrying HIV Trend in Women - (01/05/04)